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Abstract 
Starch metabolism during barley germination is important to seedling establishment and has 
applications in malting and brewing. There remains a lack of understanding of how this process 
is controlled. It has previously been shown that the iminosugar 1-deoxynojirimycin (DNJ) 
retards grain starch loss during germination but also causes stunted root growth in the 
presence of exogenous glucose, possibly by interfering with glycoprotein processing.  
 
To analyse the effects of other iminosugars on germination, a library of 391 N-substituted DNJ 
analogues were screened against Arabidopsis and a monocot alternative Eragrostis tef. The 
most potent compound identified, N-5-(adamantane-1-yl-ethoxy)pentyl-ido-DNJ (Ido-AEP-
DNJ), inhibited root growth by 92% and 89% in Arabidopsis and tef, respectively, at 10 µM. 
Further analysis implicated glucosylceramide synthase as a target responsible for the effect 
caused by Ido-AEP-DNJ. 
 
Effective small molecule inhibitors have previously been identified for the barley enzymes 
α-amylase, β-amylase and α-glucosidase. The debranching enzyme limit dextrinase (LD) is the 
sole enzyme responsible for the hydrolysis of α-1,6-linked dextrins during germination, to date, 
no potent inhibitors have been identified for LD.  When assayed against LD (expressed in Pichia 
pastoris) the glycosylated variants of DNJ: G1M and G2M show inhibition of 80% and 90%, 
respectively, at 1 mM. Potential peptide inhibitors, based on the sequence of the 
proteinaceous LD inhibitor (LDI) were also analysed. 
 
To enable further study, genes encoding LD and LDI were cloned and expressed as 
hexahistidine fusions in E. coli. Soluble LD was purified 75 fold by nickel affinity, β-cyclodextrin 
affinity and size-exclusion chromatography. LDI expressed in an insoluble form, but was 
solubilised and purified using β-mercaptoethanol, urea and nickel affinity chromatography. 
Polyclonal antibodies were raised against the recombinant proteins. Homozygous RNAi lines 
for knock-down of LD and LDI, alongside constructs to study subcellular localisation, were also 
generated to further probe the roles of these proteins in planta. 
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1 Chapter 1- Introduction 
1.1 The Importance of Carbohydrates 
Carbohydrates are the most abundant organic structures found within biology, playing vital 
roles in the functioning of all organisms on Earth. They are essential to the processes central to 
plant metabolism: photosynthesis and respiration. Other important roles include those of a 
structural and protective nature, as seen in plant cellulose, bacterial peptidoglycan and insect 
chitin (Hancock, 1997, Merzendorfer and Zimoch, 2003, Gilbert, 2010). Alongside this, 
carbohydrates also act as ligands, often conjugated to proteins, lipids or small molecules, 
involved in signalling and cell adhesion (Varki, 1993, An et al., 2009). 
 
Carbohydrate structures, both in solution and in the solid state, are still not fully understood. 
With major advances in genomics – the study of nucleic acids – and proteomics – the study of 
proteins – carbohydrates, the third biopolymer, have been left behind. This neglect derives 
from the amorphous nature of carbohydrates, their complicated regulation and the lack of 
specific genome based coding (Solís et al., 2015). 
1.2 Carbohydrate Rich Cereals  
A large proportion of the calories consumed by humans is in the form of starch, with the 
cereals (wheat, maize, rice and barley) constituting the largest part of human diet (Cordain, 
1999). Starch is a major constituent of staple food products including bread, breakfast cereals 
and pasta (Delcour and Hoseney, 2010b). The physical properties of starch are of paramount 
importance to the food industry with the gelling of desserts, the thickening of sauces and the 
structure of baked goods all being linked to starch structure. Raw starch can also be chemically 
or enzymatically converted into sugar syrups for use as sweeteners. Starch is also an important 
industrial commodity, particularly in the paper making and bioethanol industries (Smith, 2008).  
 
A cereal rich diet has both benefits and costs. It is proposed that starch rich foods were 
important factors in human evolution, as complex carbohydrates were able to fuel the 
metabolic demands of increasing brain size (Hardy et al., 2015). However starch rich diets are 
now associated with dietary imbalance, diabetes and autoimmune disease (Cordain, 1999). 
Modification strategies for the future have been suggested to improve cereals for diet and 
health (Blennow et al., 2013, Borrill et al., 2014, Lafiandra et al., 2014). 
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The focus of this thesis lies principally with Barley (Hordeum vulgare), the 4th major cereal 
grain (after maize, rice and wheat, respectively) when measured in terms of quantity produced 
(Faostat, 2014). It is a self-pollinating member of the grass family that has a diploid genome 
with 14 chromosomes (Zohary et al., 2012). The barley genome is relatively simple making this 
species a useful tool for research with a view to application to the more complex cereals such 
as wheat (tetraploid or hexaploid). Barley is important as an animal feed, with over half of the 
USA’s barley crop being used as cattle feed (Givens et al., 2004). It has been proposed that 
whole grain barley could provide a healthier alternative to other cereals. The high β-glucan 
content of barley is associated with lower cholesterol and increased satiety when part of the 
human diet (Baik and Ullrich, 2008). Further to its food use, barley is frequently used as a 
source of enzymes and fermentable material for the brewing of beer and the creation of 
distilled beverages such as whisky. 
1.3 Structures of Relevant α-Linked Carbohydrate Polysaccharides 
The majority of carbohydrate polymers are composed of glucose (Klemm et al., 2005). The 
simplest way of classifying the major polysaccharides is by the glycosidic bond anomeric 
configuration, giving α-linked and β-linked. Differences in these configurations gives rise to 
drastically different structures (e.g. helical amylose and linear cellulose, respectively, Figure 
1.1). 
 
 
 
 
 
 
 
 
 
Figure 1.1 The difference in structure caused by change in anomeric configuration. 
A. α-1,4 linked amylose and B. β-1,4 linked cellulose. Both polymers are composed of 1,4-linked glucose, 
the only difference driving their divergent properties and structure is their anomeric form. 
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The structure and function of the polysaccharides relevant to this work are outlined, namely- 
pullulan, starch and glycogen. 
1.3.1 Pullulan 
As it is soluble, easily purified and has a constant ratio of α-1,4 to α-1,6 glycosidic linkages, 
pullulan (Figure 1.2, A) is an ideal substrate for the assay of α-1,6 hydrolysing (debranching) 
enzymes (Mccleary, 1992). This linear polysaccharide of glucose is linked by both α-1,4 and α-
1,6 glycosidic bonds. Maltotriose is produced upon treatment with the pullulan degrading 
enzyme pullulanase, which hydrolyses the α-1,6 linkages specifically, leading to the description 
of pullulan as an α-1,6 linked polymer of maltotriose subunits (Bender and Wallenfels, 1961). 
Maltotetraose subunits have been identified in pullulan, being a minor constituent with a 
frequency between 1 % and 7 %, depending on the fungal strain (Aureobasidium pullulans) 
used to produce it (Carolan et al., 1983). Acid hydrolysis of pullulan results in a number of 
saccharide species, including isomaltose, maltose, panose and isopanose (Figure 1.2, B-F) 
(Bender et al., 1959, Bouveng et al., 1963).  
 
 
 
 
 
 
Figure 1.2 Structures associated with pullulan. 
A. Pullulan. B-F. The degradation products produced by acid hydrolysis of pullulan: B. maltose. 
C. isomaltose. D. panose. E. isopanose. F. maltotriose. 
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Very few details on the enzymes involved in the biosynthesis of pullulan have been elucidated 
(Cheng et al., 2011) and it’s physiological function remains uncertain. The accepted proposal is 
that pullulan serves as a protective layer, offering resistance to desiccation and allowing cells 
to adhere to environmental surfaces (Andrews et al., 1994). 
1.3.2 Starch 
Starch, a polymer of α-1,4 and α-1,6 linked glucose is the primary energy reserve in plants. It is 
synthesised as microscopic granules within many plant tissues: pollen, leaves, stems, roots, 
tubers, bulbs, rhizomes, fruits, flowers and seeds (Figure 1.3) (Preiss, 1996). Starch can be 
considered on three size levels: whole granule (µm), lamellae (9 nm) and molecular scale (0.1-1 
nm) (Waigh et al., 2000).  
 
 
 
 
 
Starch granules are roughly spherical, typically being 1 to 100 µm in diameter. Although starch 
granule size and shape varies depending on the plant of origin (Tester et al., 2004). Due to 
their compact nature, they are insoluble in water at ambient temperature (Halley and Avérous, 
2014). The granular form of starch is responsible for many of its unique physical properties. 
When heated above 60 °C, starch granules are able to swell to form a gel in a process known as 
gelatinization (Tester and Morrison, 1990). This process has important implications within 
cooking and industrial food processing (Lund, 1984). 
 
Starch granules are made up of two major α-glucan polymers, amylose and amylopectin, which 
constitute roughly 98-99 % of the dry weight (Vandamme et al., 2002). Cereal starches contain 
between 1-1.5 % lipid and usually <0.6 % protein and <0.4 % minerals. The ratios of the two 
polymers vary depending on plant species and variety (Vandamme et al., 2002). Barley has an 
 
Figure 1.3 Electron micrograph of starch granules in the barley endosperm 
Image from Vasilios Andriotis and Elaine Barclay. Large A type and small B type granules can be seen. 
Scale bar = 10 µm 
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amylose content of around 30 % with the remaining 70 % being amylopectin (Gupta et al., 
2010). Amylose and amylopectin have different structures and properties that are outlined in 
Figure 1.4 and Table 1.1 (Tester et al., 2004).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Amylose Amylopectin 
Content in granules (%) 15-35 65-85 
Molecular weight  1 × 106 1 × 107 - 1 × 109 
Branching Essentially linear α-1,4 linked ~5 % α-1,6 linkages 
Average α-1,4 chain length (glc units) 200-700 12-25 
 
Table 1.1 Structural features of amylose and amylopectin. 
Generated using data from (Mua and Jackson, 1997, Fredriksson et al., 1998). Unit chain length and 
branching pattern depend on botanical origin (Tester et al., 2004).  
 
 
 
 
 
Figure 1.4 The structure of amylose and amylopectin. 
Chemical structure of A.1 amylopectin, B.1 amylose. Cartoon representation of A.2 amylopectin. B.2 
amylose. Glucose is represented by blue circles.  
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The individual chains within amylopectin are classified depending on their chain length and 
position within the starch granule (Figure 1.5) (Hizukuri, 1985). Type A chains are unbranched 
and linked to B chains. B chains are branched and link to other B chains or the backbone (C 
chain) of the amylopectin molecule.  
 
 
 
 
 
The growth ring appearance of starch (Figure 1.6), as seen under a light or electron 
microscope, is proposed to arise because of its semi-crystalline nature (Tester et al., 2004). 
These growth rings consist of semi-crystalline and amorphous rings (Pilling and Smith, 2003). 
The blocklet structure model proposes that the growth rings are made up of amylopectin 
lamellae organized into effectively round 20-50 nm ‘blocklets’, with the semi-crystalline rings 
being made up of large or “perfect” blocklets and the amorphous rings contain smaller or 
“defect” blocklets  (Tang et al., 2006).  
 
 
 
 
 
 
Figure 1.6 Growth rings in starch granule from potato. 
Image adapted from (Pilling and Smith, 2003). 
 
Figure 1.5 Branching patterns within amylopectin. 
Figure adapted from (Hizukuri, 1986, Tester et al., 2004). 
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The semi-crystalline growth rings found in starch consist of alternating crystalline and 
amorphous lamellae with a repeat distance of 9 nm (Figure 1.8, C) (Jenkins et al., 1993). This 
pattern arises due to the existence of distinct branched (amorphous) and helical (crystalline) 
regions within amylopectin (Figure 1.8, C). The presence of helical structures within starch 
granules has been extensively studied using 13C NMR spectroscopy which reveals the capacity 
to form double helical amylopectin, single helical amylopectin and spacer regions between 
helices and branches (Tester et al., 2004). Three polymorphic forms of crystalline amylopectin 
chave been observed by X-ray diffraction: A-type, B-type and C-type; a combination of A and B 
(Figure 1.7) (Hsien-Chih and Sarko, 1978, Imberty and Perez, 1988). The helical nature of the 
polymorphs is identical, only the packing differs. Further work to understand the composition 
and architecture of the blocklets and growth rings is required. 
 
 
 
 
 
 
Figure 1.7 Helical packing of A and B polymorphs of amylopectin. 
Figure from (Hsien-Chih and Sarko, 1978). 
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The current combination of knowledge proposes a model in which the semi-crystalline growth 
rings (140 nm) contain radiating clusters of amylopectin exterior chains interspaced with 
amorphous lamellae (Figure 1.8). 
 
 
 
 
 
 
 
1.3.3 Glycogen 
Glycogen is a glucose polymer analogous to the amylopectin of starch. It is the secondary 
energy reserve within animal cells, the primary store being the fatty acids of the adipose tissue 
(Coelho et al., 2013). It is a polymer of α-1,4 linked glucose units with α-1,6 branch points 
occurring roughly every one in ten residues (Roach, 2002). Glycogen synthesis is initiated by 
glycogenin, an enzyme that auto-glucosylates using UDP-glucose to create a polymer at least 4 
glucose units in length which primes synthesis (Figure 1.9) (Chaikuad et al., 2011). This primer 
is then extended by glycogen synthase. Glycogen branching enzyme generates branches by 
transferring a glucose polymer from a non-reducing end to create a branch point within the 
glucan chain (Akram et al., 2011). 
 
Glycogen phosphorylase breaks down glycogen by the successive release of glucose in the 
form of glucose-1-phosphate (G-1-P) (Akram et al., 2011). This enzyme cannot cleave glucose 
within four residues of a branch point. Therefore glycogen debranching enzyme is required to 
remove branch points, this occurs in two steps (Liu et al., 1991). First, maltotriose is 
transferred from the branch to another chain leaving behind only one 1,6 linked glucose 
 
Figure 1.8 Growth ring model of the starch granule. 
A. Amylopectin double helix B. Amylopectin molecule C. Section of semi-crystalline growth ring 
consisting of crystalline and amorphous lamella, with a 9 nm repeat. D. Starch granule cross section. 
Figure adapted from (Hamley, 2010). 
9 
 
residue. This residue is then hydrolysed therefore removing the branch point. The 
phosphorylation and activity of glycogen synthase and glycogen phosphorylase are tightly 
controlled via hormones (Jensen and Lai, 2009). 
 
Starch and glycogen represent two physical states of the same type of storage polysaccharide. 
There are distinct similarities and differences between starch and glycogen as outlined in Table 
1.2 (D'hulst and Merida, 2010). 
 
 Starch Glycogen 
Monomer α-glucose α-glucose 
Linkages α-1,4 and α-1,6 α-1,4 and α-1,6 
Solubility in water Insoluble Soluble 
Size 0.1-100 um 40 nm 
Primer of synthesis Unknown Glycogenin 
Trimming of branches 
during synthesis 
Yes No 
Branching 
5-7 % total linkages with 
uneven distribution 
<10 % total linkages with 
even distribution 
 
Table 1.2 The similarities and differences between starch and glycogen. 
Generated using data from (Smirnova et al., 2015). 
 
 
 
 
 
 
 
Figure 1.9 The structure of glycogen. 
Dimeric glycogenin (red) is in the centre of the glycogen molecule. This is surrounded by α-1,4 and α-1,6 
linked glucose residues (blue circles). Glycogenin auto glycosylates at Tyr195 to prime glycogen 
synthesis. 
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1.4 The Metabolism of Starch within Plants 
The synthesis and degradation of starch is an area that has attracted substantial research 
efforts. Attention was first aimed at the characterization of enzymes directly involved, a large 
number of which have been identified in model and crop species (Grennan, 2006). Focus has 
now turned to understanding the nature and regulation of the processes (Kotting et al., 2010). 
There is increasing evidence for roles of redox regulation, protein phosphorylation, protein-
protein interactions and allosteric regulation by metabolites in the control of starch 
metabolism (Kotting et al., 2010). Both the circadian clock (Graf et al., 2010) and trehalose-6-
phosphate have also been implicated in whole plant signalling and orchestration of 
carbohydrate metabolism (Kolbe et al., 2005, Ponnu et al., 2011). To achieve manipulation of 
starch biochemistry a complete understanding of all processes involved in starch metabolism is 
required (Smith et al., 1997). Often a change in one gene can have unforeseen out comes due 
to the multiple pathways of synthesis and degradation, catalysed by a suite of enzymes that 
are able to compensate for each other (Smith et al., 2005, Streb et al., 2012). 
 
1.4.1 Starch Metabolism in Different Plant Tissues 
Starch biosynthesis occurs within three types of membrane bound organelle: chloroplasts, 
chloroamyloplasts and amyloplasts (Vandamme et al., 2002). Photosynthetic (source) tissues 
generate carbohydrate metabolic intermediates that are either utilised in transitory starch 
production or converted to sucrose and exported (Zeeman et al., 2004). Exported sucrose is 
either metabolised as an energy source or converted to reserve starch by tissues which are 
incapable of photosynthesis. Reserve starch biosynthesis occurs in storage (sink) organs such 
as tubers, roots and cotelydons of dicots or seeds (grains) of monocots. 
 
Starch degradation is an important process that occurs in both the leaves (transitory starch) 
and within storage organs (reserve starch) (Figure 1.10). Leaf starch degradation is required to 
provide plants with sugar for growth during non-photosynthetic (night) periods (Graf et al., 
2010). Reserve starch degradation, on the other hand, is required as a store of sugar for 
embryo development. Due to the different locations and temporal requirements the processes 
of transient and reserve starch biosynthesis and degradation have some distinct differences 
wich are outlined in the next sections (James et al., 2003, Lloyd and Kossmann, 2015). 
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Figure 1.10 Transitory and reserve starch biosynthesis and degradation. 
Transitory starch metabolism follows a diurnal cycle. During the light CO2 is fixed by the Calvin-Benson 
cycle, the products are converted to transitory starch or sucrose. Sucrose is transported to other organs 
either to fuel respiration of starch synthesis. During periods of no light, transitory starch is catabolised 
to generate sucrose. Reserve starch acts as an energy store to fuel seedling growth.  
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1.4.2 Starch Synthesis  
Three main enzymes are established in the synthesis of starch: ADP-glucose phosphorylase 
(AGPase), starch synthase (SS) and starch-branching enzyme (SBE) (Smith et al., 1997). A fourth 
enzyme family, debranching enzyme (DBE- ISA, LD) is also implicated in the regulation and 
control of branching during amylopectin synthesis (Figure 1.11) (Smith et al., 1997). 
 
 
 
 
 
 
ADP-Glucose Phosphorylase 
AGPase is the enzyme responsible for the synthesis of ADP-glucose: the glucosyl donor for 
starch synthesis. ADP-Glc is directly linked to the Calvin-Benson cycle by three catalytic steps 
catalysed by phosphoglucoisomerase (PGI), phosphoglucomutase (PGM) and AGPase. AGPase 
consists of large and small subunits that have different amino acid sequences (Smith-White 
and Preiss, 1992, Ventriglia et al., 2008). Differences between plant species exist in the number 
and expression patterns of encoding genes, with the genes encoding the different subunits 
also being differently regulated depending on organ (Smith et al., 1997).  
 
 
 
Figure 1.11 Proposed Pathway for Starch Synthesis. 
During the day, starch is synthesised from substrates mainly derived from the Calvin-Benson cycle, 
some Glc-1-P may also come from the cyctosol. PGI, phosphoglucose isomerase. PGM, 
phosphoglucomutase. AGPase, ADP-glucose phosphorylase. SS, Starch synthase. BE, branching enzyme. 
ISA, isoamylase. LD, limit dextrinase. Adapted from (Stitt and Zeeman, 2012). 
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Starch Synthases (SS) 
There are five gene classes of SS: granule bound (GB) SS and SSI-IV. SSs are responsible for the 
repeated addition of α-1,4-linked glucose units to growing amylose and amylopectin chains 
(Smith et al., 1997). Multiple isoforms of SS have been identified yet not enough is currently 
known for the construction of a model that relates particular isoforms to specific aspects of 
amylopectin biosynthesis (Marshall et al., 1996, Martin and Smith, 1995). GBSS is proposed to 
be responsible for amylose synthesis (Denyer et al., 1995). Recently a protein involved in 
targeting GBSS to starch granules has been identified. Protein targeting to starch (PTST) is 
required for amylose synthesis. This protein has an N-terminal coiled coil and a C-terminal 
starch binding CBM48, involved in protein-protein and protein-carbohydrate interactions 
(Seung et al., 2015). 
 
Starch Branching Enzymes (SBE) 
Multiple isoforms of SBE, that catalyse the formation of starch α-1,6 branch points, are found 
within plant organs (Martin and Smith, 1995, Burton et al., 1995, Smith et al., 2005). Three 
categories of SBE exist (I, IIa and IIb): their differences are based on primary sequence data and 
substrate affinities (Burton et al., 1995). In vitro, isoform IIa preferentially branches 
amylopectin whereas isoform IIb has a preference for amylose (Guan and Preiss, 1993, Takeda 
et al., 1993). Mutations in loci corresponding to the IIa isoform results in an increase in average 
amylopectin chain length but starch granule structure is not dramatically affected 
(Bhattacharyya et al., 1990, Burton et al., 1995, Mizuno et al., 1993). RNA interference (RNAi) 
knock-down of all SBE generates amylose-only starch in barley, highlighting their importance in 
amylopectin biosynthesis (Carciofi et al., 2012). 
 
Debranching Enzymes (DBE) 
Two families of DBE exist in plants, isoamylase (ISA) type and limit dextrinase (LD) (pullulanase) 
type, defined by their inability and ability to hydrolyse pullulan respectively. Mutations at the 
SUGARY1 locus of maize and rice affect the genes that encode DBE and lead to dramatic 
reductions in endosperm starch content alongside the production of water soluble, highly 
branched glucans, similar to glycogen (referred to as phytoglycogen) (Doehlert et al., 1993, 
Nakamura et al., 1996, Pan and Nelson, 1984). This gives rise to the suggestion that the native 
branching pattern is due to the concerted actions of both SBE and DBE (Smith et al., 1997). 
Limit dextrinase and isoamylase appear to have overlapping functions in starch synthesis. (Wu 
et al., 2002). 
 
14 
 
The three isoamylase isoforms, (ISA1-3) have been shown to have different catalytic 
properties. ISA1 and ISA2 were shown to be associated as a hetero- or homo- multimeric 
enzyme complex in Arabidopsis, potato and maize, whereas ISA3 is not associated with a 
complex (Lin et al., 2013, Myers et al., 2000). Data suggests that ISA1 and ISA2 act to debranch 
soluble glucans during starch synthesis, ISA3 has a different catalytic specificity indicating a 
different role in starch metabolism (Myers et al., 2000, Bustos et al., 2004, Delatte et al., 
2006). ISA1 can function in starch metabolism in the maize endosperm and leaf without ISA2 
but with reduced efficiency. Incorporation of ISA1 from maize into an Arabidopsis ISA1/2 
mutant confirmed that maize ISA1 is active alone whereas Arabidopsis ISA1 requires ISA2 to 
function (Facon et al., 2013). There is therefore some degree of functional conservation 
between monocot and dicot ISA (Streb and Zeeman, 2014). 
 
A glucan trimming model that implicates SBE and DBE as the enzymes responsible for 
branching levels, and therefore amylopectin structure, has been proposed (Ball et al., 1996, 
Smith et al., 1997). It is suggested that soluble SS elongates very short chains at the granule 
periphery. These chains are initially insufficient in length to act as substrates for SBE and 
remain unbranched. When an appropriate length is reached, branches are introduced by SBE 
and elongated by SS. DBE is then able to remove the outer chains from these unorganised 
glucans, however it is unable to access branch points formed close to the organised double 
helical zone. Thus the action of DBE leaves a zone of short chains arising from branch points at 
the top of the double helical region, a further round of elongation can then occur. 
 
Arabidopsis quadruple mutants lacking all four DBE proteins (ISA 1, 2 and 3 and LD) are devoid 
of starch granules and accumulate highly branched glucans, distinct from amylopectin and 
phytoglycogen (Wattebled et al., 2005, Streb et al., 2008). The branched glucan can be 
degraded by α- and β-amylases to produce maltose. Superficially these data support the 
hypothesis that starch DBEs are necessary for amylopectin synthesis. However, the additional 
loss of α-amylase (AMY3) partially reverts the phenotype of the quadruple DBE mutant, 
restoring starch granule biosynthesis (Streb et al., 2008). This leads to the proposal that DBEs 
function to promote amylopectin crystallisation during synthesis but may not be essential for 
starch granule synthesis. 
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1.4.3 Leaf Starch Degradation 
Glucose (Glc) and maltose (Mal) are the major products produced by starch degradation within 
the chloroplast. Degradation occurs via a network of reactions (Figure 1.12) (Smith et al., 2005, 
Zeeman et al., 2007). Reserve starch degradation in living storage tissues proceeds in a similar 
way to transitory starch degradation. 
 
 
 
 
 
 
 
Kinases and Phosphorylases 
Starch breakdown is facilitated by kinases which initiate and control degradation. Glucan water 
dikinase (GWD) and phosphoglucan waker dikinase (PWD) phosphorylate glucosyl residues at 
the C6 and C3 respectively (Ritte et al., 2006). The phosphate groups disrupt the semi-
crystalline surface of starch and hence affect the susceptibility of the granule surface to 
enzyme degradation by endo-acting hydrolases (Blennow et al., 2000, Blennow et al., 2002). 
Mutations that eliminate the GWD enzyme activity dramatically reduce the rate of starch 
 
Figure 1.12 The proposed pathway for starch metabolism 
Transitory starch degradation takes place in the plastid. The starch granule surface is disrupted by 
phosphorylation followed by simultaneous glucan hydrolysis and dephosphorylation. Glc, mal and Glc-1-
P are exported to the cytosol. GWD, glucan water dikinase. PWD, phosphoglucan water dikinase. SEX4 
and LSF2, phosphoglucan phosphatases. ISA, isoamylase. LD, limit dextrinase. AMY. α-amylase. BAM, β-
amylase. PHS1, α-glucan phosphorylase. DPE1, dispropotionating enzyme. 
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degradation (Mikkelsen et al., 2004). In vitro experiments show that in the presence of GWD 
(and ATP) enables hydrolytic enzymes to release more soluble glucans from starch (Edner et 
al., 2007). PWD is also required for normal starch breakdown in Arabidopsis though it relies on 
the prior action of GWD (Kotting et al., 2005, Baunsgaard et al., 2005). 
 
Two phosphorylases play a role in balancing glucan levels during starch metabolism. The 
plastidial PHS1 converts linear glucans to glucose-1-phosphate (Malinova et al., 2014). 
Cytosolic PHS2 removes glucose from a complex cytosolic heteroglycan to release glucose-1-
phosphate (Schopper et al., 2015).  
 
Phosphatases 
The removal of the phosphate groups present on glucans released from the surface of starch is 
performed by the phosphatases SEX4 (C3/C6 specific) (Hejazi et al., 2010) and LSF1 (C3 
specific) (Silver et al., 2014). Phosphate removal is required because exo-acting enzymes are 
blocked by phosphate groups (Hizukuri et al., 1983). Mutation of SEX4 in Arabidopsis decreases 
the rate of starch degradation and leads to accumulation of soluble phospho-oligosaccharides 
during the night (Zeeman et al., 1998, Niittyla et al., 2006, Kotting et al., 2009). LSF1 mutants 
also produce a starch excess phenotype (Comparot-Moss et al., 2010). 
 
β-Amylase 
Exo-acting β-amylase catalyses the release of maltose from the reducing end of linear glucans. 
Four of the nine β-amylase proteins encoded by the Arabidopsis genome are predicted to be 
chloroplastic (Zeeman et al., 2010). Two β-amylases, BAM1 and BAM3, are partially redundant, 
however the double mutant has a strong starch excess phenotype. BAM2 mutants are 
indistinguishable from wild type (Fulton et al., 2008). BAM4 is non-catalytic but it is still 
required for normal starch synthesis (Fulton et al., 2008). 
 
Debranching Enzymes (DBE) 
Only two debranching proteins, ISA3 and LD, are thought to function in starch degradation 
(Zeeman et al., 2007, Wischmann et al., 1999). Both enzymes preferentially remove short 
glucan branches. The precise substrate preferences differ but there is overlap between the 
two enzymes (Hii et al., 2012). Mutants of Arabidopsis ISA3 have more leaf starch and a slower 
starch breakdown rate. When fused to GFP, ISA3 localises to granule like structures in 
chloroplasts, implying ISA3 acts at surface of starch granule (Delatte et al., 2006). When LD or 
α-amylase are mutated in addition to ISA3 a starch excess phenotype is achieved (Figure 1.13). 
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However, removal of LD, α-amylase or both enzymes has no effect on starch degradation 
(Streb et al., 2012). This confirms that these enzymes are partially redundant and a severe 
phenotype is only produced when all steps are blocked (Streb et al., 2012). 
 
 
 
 
 
α-Amylase 
α-amylase is an endo-acting enzyme that cleaves in the middle of linear glucans. Arabidopsis 
mutants of α-amylase show that none of the isoforms are essential to starch degradation (Yu 
et al., 2005). In vitro analysis shows α-amylase is capable of releasing glucans from insoluble 
starch granules as well as soluble substrates (Seung et al., 2013). As discussed above, the 
absence of α-amylase can be compensated for by ISA3 (Streb et al., 2012).  
 
Disproportionating Enzymes 
β-Amylolytic degradation is expected to produce some maltotriose alongside maltose due to 
the inability of β-amylase to cleave chains shorter than four glucosyl residues in length (Lao et 
al., 1999). Disproportionating enzymes overcome this issue by catalysing the transfer of 
carbohydrate from soluble glucans and to other acceptor glucans. For insctance, DPE1 is active 
in the plastidial stroma and generates linear glucans from maltodextrins by transferring 1, 2 or 
3 glucose residues (Kartal et al., 2011). Cytosolic DPE2 transfers 1 glucose unit from maltose to 
high molecular weight glucan and releases a single glucose residue (Dumez et al., 2006). 
 
 
Figure 1.13 The effect of mutation in α-amylase, isoamylase 3 and limit dextrinase on Arabidopsis 
growth.  
Growth was proportional to starch excess phenotype. Image from (Streb et al., 2012). 
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1.4.4 Grain Storage Starch Degradation 
Starch degradation in the cereal endosperm takes place in non-living tissue; an acidic, 
apoplastic environment, devoid of compartmentalisation (Smith et al., 2005, Sreenivasulu and 
Wobus, 2013). Hydrolysis of starch is proposed to proceed via the concerted activities of four 
enzymes, α-amylase, β-amylase, LD and α-glucosidase, which result in the production of 
glucose and maltose for export to the growing embryo (Figure 1.14) (Smith et al., 2005, Aoki et 
al., 2006). The extent to which all four classes of enzyme are necessary for starch degradation 
in cereals is subject to considerable debate (Stanley et al., 2011). It is not clear whether 
additional enzymes are important for grain starch metabolism. Transcripts for other enzymes 
involved in starch synthesis and degradation are present during the grain filling period 
(Radchuk et al., 2009) and there is possibility that these may be carried over to germination. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.14 The steps involved in grain germination. 
Germination is induced by the imbibition of water which acts to break grain dormancy and induces 
hormonal (gibberellic acid, GA and abscisic acid, ABA) changes within the grain (Lovegrove and Hooley, 
2000). This results in the synthesis, release and activation of the starch degrading enzymes from the 
aleurone layer, a thin layer of cells surrounding the endosperm (Ritchie et al., 1999, Finnie et al., 2011). 
The maltose and glucose produced by hydrolysis of starch is utilised by the growing embryo. 
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α-Amylase 
In germinating barley there are two classes of α-amylase, these are more closely related to the 
extraplastidial Arabidopsis AMY1 than chloroplastic AMY3. α-amylase is a GH13, endo-acting 
enzyme capable of directly attacking the starch granule and releasing linear glucans (Figure 
1.15) (Nielsen et al., 2009). α-amylase has been extensively studied with regard to its 
gibberellic acid induced synthesis and release from the aleurone layer (Radchuk et al., 2009). 
α-amylase is not able to hydrolyse glucans within a close proximity to a branch point (Bak-
Jensen et al., 2004). 
 
β-Amylase 
The importance of β-amylase in grain germination is not clear (Rejzek et al., 2011). β-amylase 
is an exo-acting enzyme that removes maltose from the non-reducing end of glucans (Figure 
1.15). Rye and barley mutants with low β-amylase activities (Rorat et al., 1991, Kreis et al., 
1987) and Tibetan β-amylase deficient barley (Kihara et al., 1999) all germinate normally 
suggesting β-amylase may not be required for successful germination. In barley, β-amylase is 
synthesised during grain development and is one of the major proteins present in mature 
grains, accounting for 1-2 % of total protein present in the endosperm (Hejgaard and Boisen, 
1980, Evans et al., 1997), because of this fact β-amylase is often referred to as a storage 
protein. 
 
Limit Dextrinase (LD) 
LD is involved in both endosperm and leaf starch degradation alongside starch synthesis, as 
previously described. LD and its proteinaceous inhibitor (LDI) are further discussed in detail in 
chapter 5 (in vitro biochemistry and enzymology) and chapter 6 (in planta functions). LD is the 
only α-1,6-acting enzyme active during germination, hydrolysing the limit dextrins generated 
by α-amylase and β-amylase hydrolysis of starch (Macgregor et al., 1994). LDI is proposed to 
inhibit LD during germination (Macgregor et al., 2000), the in vitro interactions between the 
two proteins have been studied in detail (Møller et al., 2015), yet their roles in germination are 
unclear. 
 
α-glucosidase 
α-glucosidase has often been overlooked within the context of starch hydrolysis during 
brewing because of its heat lability. This fact has led to the belief that it is unimportant during 
the malting and mashing processes (Muslin et al., 2000, Bamforth, 2009). Evidence suggests 
that α-glucosidase can directly attack starch granules in vitro (Nakai et al., 2008, Sun and 
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Henson, 1991, Sissons et al., 1994). Multiple isoforms of α-glucosidase have been reported, 
with distinct specificities, in barley grain (Stark and Yin, 1987, Sun and Henson, 1990). Recent 
work using RNAi has shown that the α-glucosidase HvAGL97 is involved in the conversion of 
maltose to glucose in the endosperm (Stanley et al., 2011). However this enzyme is not 
essential for starch degradation or normal seedling growth. 
 
 
 
 
 
 
1.5 The Brewing Process 
1.5.1 Introduction 
Malting is the controlled germination of cereal grain. The activities involved in grain 
germination constitute one of the three essential “enzyme reactor” stages of the brewing 
process, the other two being the mash tun and the yeast cell. All three of these systems are 
highly complex, consisting of a plethora of soluble and insoluble substrates with varying levels 
of enzymes, activators and inhibitors (Bamforth, 2009). Enzymatic activities, together with 
physical and chemical processes, such as the gelatinization of starch and the Maillard reaction, 
make this a complicated “melting pot” (Coghe et al., 2006). 
 
Figure 1.15 Proposed Pathway of Endosperm Starch Degradation. 
α-Amylase attacks the starch granule and releases branched and linear glucans. Branched glucans are 
debranched by the action of LD. α-amylase and β-amylase act to hydrolyse linear glucans to produce 
maltose which is converted to glucose by α-glucosidase. Both glucose and maltose are taken up by the 
growing embryo. 
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1.5.2 Malting 
Brewing (Figure 1.16) begins with malting, in which the germination process of grain is 
induced. Barley grains are steeped in water then are left to germinate (Gupta et al., 2010). 
Germination is then halted by kilning, a process in which grain is dried. (Macwilliam, 1972, 
Coghe et al., 2006, Palmer, 2006).  
 
 
 
 
 
Figure 1.16 The brewing process. 
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1.5.3 Mashing 
During mashing, milled malt is combined with water and heated. Starch is converted to 
glucose, maltose, maltotriose and other 1,4-linked glucans by the concerted action of the four 
enzymes: α-glucosidase, α-amylase, β-amylase and limit dextrinase (Figure 1.17) (Bamforth, 
2009, Gupta et al., 2010,). Short, branched, limit dextrins are also formed, these cannot be 
metabolised by yeast but contribute to the mouthfeel and calorific value of beer (Tester and 
Qi, 2011, Ragot et al., 1989). Differences in 1,4 and 1,6 glucans contribute to the different 
qualities of different beer types (Petersen et al., 2012). Other sources of carbohydrate, termed 
adjuncts, can also be added to the malt to be converted to fermentable sugar. 
 
 
 
 
 
 
Following mashing the sweet liquid (wort) is separated from the spent grain by filtration. The 
wort is boiled with hops to sterilise the liquid and add flavour (Natsume et al., 2015). The wort 
is then cooled and combined with yeast. The yeast (Saccharomyces) ferments the glucose, 
maltose and simple sugars to alcohol and carbon dioxide. The beer is finally filtered, bottled 
and aged. Distilled spirits are produced by a similar procedure, however there is no boiling 
step after mashing and the fermentation product is distilled (Delcour and Hoseney, 2010a). 
 
 
Figure 1.17 The enzymatic hydrolysis of starch during malting and mashing. 
α-amylase cleaves in the middle of linear glucans. β-amylase releases maltose from the end of glucans. 
Limit dextrinase removes 1,6-branch points. Limit dextrinase activity is proposed to be inhibited by limit 
dextrinase inhibitor. α-glucosidase cleaves maltose to produce glucose. 
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1.6 Chemical Genetics 
1.6.1 Introduction to Chemical Genetics 
Due to the redundant nature of the enzymes involved in starch synthesis and degradation, 
genetic knockout can often produce unclear results. Chemical genetics offers a complementary 
approaches that can be utilised to gain a better understanding of starch metabolism. Recently 
chemical genetics has been utilised to dissect the enzymes involved in carbohydrate 
metabolism during barley germination (Stanley et al., 2011, Rejzek et al., 2011, Andriotis, 2015 
unpublished). This literature is discussed in detail in later chapters. 
 
Chemical genetics is defined as the systematic use of small molecules to elicit defined 
phenotypes in a biological system of interest (Stockwell, 2000). In contrast to traditional 
genetics, which disrupts a system at the nucleic acid level, chemical genetics affects a system 
at the protein level using small molecule (chemical) intervention (Spring, 2005). As with 
traditional genetics, both forward and reverse screens can be performed (Figure 1.18).  
  
 
 
 
 
 
 
 
 
 
 
Figure 1.18 Forward and Reverse chemical genetics. 
Within a forward screen a library of compounds is screened for a defined phenotype using the organism 
of interest (Stockwell, 2000). Following this, attempts are made to identify the target responsible for the 
change in phenotype, alongside the mode of action. Reverse chemical genetics involves screening a 
library of compounds against a purified protein of interest. Identified “hit” compounds are then tested 
on the biological system of interest to define the phenotype generated (Stockwell, 2000). 
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The use of small molecules has a number of advantages over molecular genetics (Spring, 
2005). Small molecule inhibitor effects are reversible, titratable and conditional; they can be 
added at specific time points and in controlled concentrations, therefore allowing temporal 
and dose-response control (Stockwell, 2000). Further to this, they have a rapid effect, enabling 
study of immediate effects following addition of the compound compared with genetic 
manipulation in which a steady state is observed (Spring, 2005). As inhibitors typically work at 
a protein level a single compound can often affect several members of a multi-gene family 
thereby overcoming redundancy which would otherwise require time consuming and 
expensive multi-gene knockouts to study (O'Connor et al., 2011).  
 
Small molecules can be used to study processes that would be affected beyond easy analysis 
by traditional genetic knock out, such as embryo development (Spring, 2005). As well as this, 
compounds can often be applied across species, overcoming issues such as large genomes, 
polyploidy and slow generation time which can often limit genetics, particularly in crop species 
(O'Connor et al., 2011). Perhaps the only disadvantage of chemical genetics is that currently it 
cannot be applied generally because of the requirement of a selective small molecule ligand 
for the protein of interest. To date, only a small fraction of known proteins have a suitable 
specific small molecule binder (O'Connor et al., 2011). 
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1.6.2 Requirements for Chemical Genetics 
Three things are required for effective chemical genetics: a selective small molecule, biological 
target and a suitable biological screen or assay (Figure 1.19). This area has been the subject of 
numerous detailed reviews (Spring, 2005, Tóth and Van Der Hoorn, 2010, Toth and Van Der 
Hoorn, 2010, Fu, 2012). 
 
 
 
1.6.3 Chemical Genetics in Plants 
Chemical genetics are well established in eukaryotic systems (Sacchatomyces cerevisiae, 
Caenorhabitis elegans, Drosphila melanogaster, Xenopus laevis and Danio rerio) (reviewed 
(O'Connor et al., 2011, Stockwell, 2000, Gangadhar and Stockwell, 2007, Mayer, 2003)) and is 
emerging as a powerful complementary technique to classical biochemistry and genetic 
techniques within plant research. 
 
Arabidopsis is the chosen plant for chemical genetics due to its ease of manipulation enabled 
by the small size of plants and seeds. These seeds can be utilised in microtitre plates (Zhao et 
al., 2007) and can be easily stored for long periods (Mccourt and Desveaux, 2010). It is further 
supported by being the first plant to have its genome sequenced (Arabidopsis-Genome-
Initiative, 2000) making it a foundation for plant research (Bevan and Walsh, 2005). The 
genome, which is five times larger than that of yeast, is well annotated (TAIR- 
www.arabidopsis.org) and the plant is easily genetically manipulated, with extensive 
germplasm resources available. Comparison of human disease genes with the Arabidopsis 
genome reveals that 48 % (139/289) have homologues in Arabidopsis, making this plant a good 
 
Figure 1.19 The pipeline of chemical genetics. 
Adapted from (Fu, 2012) 
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model for many human diseases (Arabidopsis-Genome-Initiative, 2000, Xu and Møller, 2011). 
Arabidopsis is also able to act as a model for other plants, although the evolutionary 
relationship between organisms and conservation of protein sequence, structure and function 
must be considered. Differences between plants, in particular, monocots and dicots can be 
extreme (Sreenivasulu and Wobus, 2013). Chemical genetic techniques have enabled recent 
advances within numerous areas of plant biology. This introduction will only focus on two 
aspects: cell wall biosynthesis and hormone signalling. 
 
Inhibitors of Cellulose and Cell Wall Biosynthesis 
The biosynthesis and deposition of cellulose within plant cell walls is not fully understood; 
being a complex process involving precise regulation, composition and arrangement of the 
proteins that catalyse it. Chemical genetics has played an important role in advancing the 
understanding of this process. (Debolt and Brabham, 2013). Cellulose synthase (CESA) proteins 
form a complex which is active at the plasma membrane where microfibrils are synthesised. 
There are 10 genes encoding CESA in Arabidopsis highlighting the likelihood of functional 
redundancy (Desprez et al., 2002). Three principle responses to chemical inhibition of cellulose 
biosynthesis have been documented utilising fluorescently tagged reporter proteins in 
combination with confocal microscopy (Brabham and Debolt, 2012), the compounds are 
outlined in Figure 1.20 and Table 1.3. 
.  
 
 
 
 
Figure 1.20 The structures of molecules able to interfere with cellulose biosynthesis. 
A. Isoxaben. B. Quinoxyphen. C. DCB. D. Cobtorin. E. Morlin 
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Compound Target Use Reference 
Group 1. Deplete CESA from plasma membrane 
Isoxaben 
Targets CESA3 
& CESA6. 
The observation that both compounds affect 
YFP-CESA6 localisation supports the notion 
that CESA 1, 3 and 6 interact to form 
functional cellulose synthase complex (CSC) 
required for cell wall biosynthesis. 
These inhibitors are useful for the study of 
non-CESA proteins associated with cellulose 
biosynthesis. 
(Desprez et al., 
2002, Robert et 
al., 2005). 
Quinoxyphen Targets CESA1. 
(Gutierrez et al., 
2009, Harris et al., 
2012, Brabham 
and Debolt, 
2012). 
Group 2. Increase accumulation and cessation of CSC movement within the plasma membrane 
DCB 
Targets 
MAP20, a 
microtubule 
associated 
protein. 
Studies using this compound indicate MAPs 
could be necessary for primary and 
secondary cell wall development 
(Delmer, 1987, 
Debolt et al., 
2007, Rajangam 
et al., 2008). 
Group 3. Disturb CESA and cortical microtubules 
Morlin 
Causes 
disorganised 
CESA and 
hyper-bundled 
microtubules. 
Molecular rail hypothesis suggests that 
microtubules act as a guidance mechanism 
for CSC; both morlin and cobtorin are useful 
tools to dissect the interplay between 
cellulose deposition and cortical 
microtubules. 
(Giddings Jr and 
Staehelin, 1988, 
Debolt et al., 
2007). 
Cobtorin 
Distorts the 
parallel 
alignment of 
microtubules 
and the 
behaviour of 
CESA. 
(Yoneda et al., 
2007, Yoneda et 
al., 2010). 
 
Table 1.3 Molecules able to interfere with cellulose biosynthesis, identified by chemical genetics. 
Structures are given in Figure 1.20. 
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Inhibitors of Hormone Signalling 
Plant hormones including auxins (AUX), cytokinins (CK), giberellins (GAs), abscisic acid (ABA), 
ethylene (ET), brassinosteriods (BRs), salicylic acid (SA) and jasmonates (JA) regulate multiple 
aspects of plant cell division, tissue patterning, gravitropism, root development, defence and 
adaptation (Wang and Irving, 2011). Recent development in genomics, genetics and molecular 
techniques have led to the discovery of a range of compounds capable of affecting most 
known hormone pathways, some of those with identified targets are outlined in Figure 1.21, 
Table 1.4 and Table 1.5 (Fonseca et al., 2014). 
 
 
Figure 1.21 The structures of molecules involved in interfering with hormone signalling within plants. 
A. Sirtinol. B. HNC. C. HNA. D. Gravacin. E. BUM. F. Brassinazole. G. Pyrabactin. H. Bikinin. 
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Compound/
hormone 
affected 
Screen Notes Use Reference 
Pyrabactin 
ABA 
Arabidopsis 
seedling 
development. 
Targets a sub set of novel ABA 
receptors (PYR/PYLs), which bind 
and inhibit type 2C protein 
phosphatases. Multiple genetic 
knockouts of the receptors 
showed no phenotype indicating 
genetic redundancy. 
Affects ABA 
signalling. 
Quinabactin, a 
similar molecule 
also interacts 
with PYLs and is 
shown to 
regulate 
stomatal 
closure. 
(Park et 
al., 2009, 
Okamoto 
et al., 
2013). 
Brassinazole 
BR 
Arabidopsis 
screen for 
inhibitors 
causing 
dwarfism and 
altered leaf 
morphology. 
Binds DWF4, a cytochrome p450 
monooxygenase that catalyses 
the hydroxylation of BRs. These 
compounds can 
complement the 
use of BR-
deficient 
mutants to 
clarify the 
function of BRs 
in plants. 
(Asami et 
al., 2000). 
Bikinin 
BR 
Phenotype 
based 
Arabidopsis 
screen. 
Target was identified as 
glycogen synthase kinase 3 
(GSK3)- BIN2 a key regulator in 
signalling pathways. 
Genome-wide transcript 
analyses demonstrate that 
bikinin simultaneously inhibits of 
seven GSK3s; a phenotype that 
could not be produced using 
genetics. 
(De Rybel 
et al., 
2009) 
 
Table 1.4 Molecules able to interfere with hormone metabolism, identified by chemical genetics. 
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Compound/
hormone 
affected 
Screen Notes Use Reference 
Sirtinol 
ABA 
First identified in 
yeast screens. 
Targets SIR1, an NAD-dependent 
deacetylase inhibitor 
causing stunted root growth 
phenotypes. 
More detailed studies revealed 
sirtinol is not an active 
compound but is a pro-drug that 
is taken up and activated to 
functional HNA and HNC by 
plant metabolic enzymes. 
Affects ABA 
signalling.  
(Grozinger 
et al., 
2001, Dai 
et al., 
2005) 
Gravacin 
AUX 
Identified using 
Arabidopsis in a 
24-well plate 
based screen, 
involving a 90° 
reorientation of 
the plates during 
growth. 
Inhibitor of root and shoot 
gravitropism, targets the p-
glycoprotein-19, an auxin efflux 
transporter belonging to a family 
containing up to 129 genes.  
Both gravacin 
and BUM leave 
PIN proteins 
unaffected 
making these 
compounds 
useful tools in 
auxin research. 
(Surpin et 
al., 2005, 
Rojas-
Pierce et 
al., 2007, 
Kim et al., 
2010) 
BUM 
AUX 
Visual screen of 
Arabidopsis 
seedling 
development. 
Inhibitor of ABCB (ATP binding 
cassette protein subfamily B) 
auxin efflux carriers. 
(De Rybel 
et al., 
2009) 
 
Table 1.5 Molecules able to interfere with hormone metabolism, identified by chemical genetics 
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The Future of Chemical Genetics 
New herbicides, pesticides and other agricultural chemical tools are required. Naturally 
occurring bioactive compounds have the potential to fulfil this requirement (Walsh, 2007, 
Dayan et al., 2012, Duke, 2012). Alleochemicals are found naturally in plants, only a few well 
studied examples exist: sorgoleone, a phytotoxic compound excreted by Sorghum bicolor roots 
(Figure 1.22, D) (Dayan et al., 2010), meta-tyrosine, a herbicidal root exudate from fescue grass 
(Figure 1.22, A) (Bertin et al., 2007), juglone, from black walnut Juglans nigra (Figure 1.22, C) 
(Hejl and Koster, 2004) which disrupts root plasma membrane H+ ATPase and strigolactones 
(SLs) from the parasitic plant Striga asiatica which induce host germination (Figure 1.22, B) 
(Gomez-Roldan et al., 2008, Umehara et al., 2008). 
 
 
 
 
 
Alongside natural products, combinatorial libraries have the potential to produce new 
agrochemicals. Analysis of the molecular properties of herbicides resulted in Tice’s Rule-of-five 
(Tice, 2001), which follow the rules for drug design outlined by Lipinsky (Lipinski et al., 2001). 
In contrast, diversity oriented synthesis libraries represent new chemical space and have the 
potential for identification of novel biological modulators (Ibbeson et al., 2014). 
 
Figure 1.22 The structures of well studies alleochemicals. 
A. Meta-tyrosine. B. Strigolactone. C. Juglone D. Sorgoleone. 
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1.7 Experimental Approach 
Discovering the roles and importance of the enzymes directly and indirectly involved in starch 
degradation in vivo has been hampered by the lack of tools for analysis of these pathways. The 
existence of multiple genes and isoforms that correspond to different activities, expressed in 
different plant organs, makes genetic manipulation a non-trivial task.  
 
However, a chemical genetic approach has been used within our group to dissect the pathway 
in question. These studies identified reversible and irreversible inhibitors for a number of 
starch active enzymes (Rejzek et al., 2011, Stanley et al., 2011) alongside providing evidence 
for the existence of previously unidentified enzymatic activities that are key to starch 
metabolism (Stanley et al., 2011). 
 
This thesis will describe a similar chemical genetic approach which has been utilised to study 
barley limit dextrinase, the enzyme responsible for the hydrolysis of α-1,6-linked branch points 
found within glucans derived from starch. The aims of this work are fourfold: 
 
 Identify novel iminosugar compounds which are able to interfere with germination and 
plant growth within dicots and monocots. 
 
 Clone the genes encoding LD and the proteinaceous inhibitor, LDI, express protein in 
E. coli and purify the proteins to homogeneity. 
 
 Carry out chemical genetic screens against LD protein in order to identify small 
molecule inhibitors. 
 
 Establish LD and LDI RNAi transgenic barley lines and develop systems by which to 
analyse the roles of LD and LDI in planta. 
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2 Chapter 2- Materials and Methods 
2.1 Materials 
2.1.1 Chemical Reagents 
Reagents specific to particular techniques have the supplier given in the methods text. All 
other reagents were purchased from Sigma. 
 
2.1.2 Plasmids 
Vectors used for cloning are outlined in Table 2.1. Gateway compatible vectors were 
propagated in E. coli ccdB Survival 2 T1R cells, other vectors were propagated in E. coli TOP10. 
 
Name 
Antibiotic 
Resistance 
Use Vector Size (bp) 
pCR8/GW/TOPO SpcR Entry vector for Gateway cloning. 2817 
pDEST17 AmpR/ CarR 
Gateway compatible destination vector 
for E. coli protein expression with 
N-terminal His6 tag. 
6354 
pETG-10A AmpR/ CarR 
Gateway compatible destination vector 
for E. coli protein expression with 
N-terminal His6 tag. 
7103 
pDEST42 AmpR/ CarR 
Gateway compatible destination vector 
for E. coli protein expression with 
C-terminal His6 tag. 
7440 
pOPIN27b  KanR 
In-Fusion compatible vector for E. coli 
protein expression with N-terminal 
bacterial PelB secretion sequence and 
His6 tag. 
5360 
 
Table 2.1 Plasmid vectors used within this study. 
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Figure 2.1 Plasmid map pCR8/GW/TOPO Gateway entry vector. 
 
Figure 2.2 Plasmid map pDEST17 and pETG-10A Gateway destination vectors. 
 
Figure 2.3 pETDEST42 Gateway destination and pOPIN27b In-Fusion vectors. 
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2.1.3 Bacterial Strains 
A number of bacterial strains were used for cloning and protein overexpression, these are 
outlined in Table 2.2. Bacterial strains were stored as 25 % glycerol stocks. Stocks were 
prepared by combining 750 µL from a 5 mL overnight culture and 750 µL of sterile 50 % 
glycerol. 
 
Supplier and Strain  Resistance Use and Features 
Invitrogen  
One Shot TOP10 
StrR 
Cloning. Efficient transformation and 
plasmid propagation. 
Invitrogen 
One Shot ccdB Survival 2 T1R 
StrR 
Cloning. Propagation of Gateway plasmids 
containing the ccdB gene. 
Agilent  
BL21 Codon Plus 
CamR 
Protein expression. Contains tRNAs for rare 
codons AGG/AGA (arginine), AUA 
(isoleucine) and CUA (leucine). 
Novagen 
Rosetta 2 (DE3) 
CamR 
Protein expression. Contains tRNAs for rare 
codons - as above, plus CGG (arginine), CCC 
(proline), and GGA (glycine). 
Novagen 
Rosetta 2 (DE3) pLysS 
CamR 
Protein expression. As above, plus 
supresses basal expression, via T7 
lysozyme, prior to induction. 
Novagen  
Rosetta-gami (DE3) pLysS 
CamR 
Protein expression. As above, plus 
enhanced disulfide bond formation. 
Genlantis 
SoluBL21 
None 
Protein expression. Enhanced protein 
solubility. 
NEB 
SHuffle 
StrR, SpcR 
Protein expression. Engineered to form 
proteins containing disulfide bonds in the 
cytoplasm. 
 
Table 2.2. E. coli strains used within this study. 
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2.1.4 Primers 
All primers were purchased from MWG Eurofins (Ebersberg, Germany) at HPSF purity. Primers 
were diluted with nuclease free H2O to a stock concentration of 100 µM. Primers are outlined 
in Table 2.3. 
ID Name Sequence (5'-3') Use Tm°C CG % nt 
MR1 GAPDH F CCACCGGTGTCTTCACTG Housekeeping gene 63 61 18 
MR2 GAPDH R GCCTTAGCATCAAAAGATG Housekeeping gene 58 42 19 
MR3 LD F ATGCCAATGCCGATGCGAACGA LD Full length cloning 77 54 22 
MR4 LD R TCAACACCGAGGTTCGACAAAGAC LD Full length cloning 70 50 24 
MR5 LDI F ATGGCATCCGACCATCGTC LDI Full length cloning 68 57 19 
MR6 LDI R TCATCCATCTGCCAGTAGCAC LDI Full length cloning 65 52 21 
MR9 LD NoSto R ACACCGAGGTTCGACAAAGAC LD No stop cloning 65 52 21 
MR10 LDI NoSto R TCCATCTGCCAGTAGCAC LDI No stop cloning 60 55 18 
MR12 LD NoSec F ATGGCGGTCGGGGAGA LD No sec signal cloning 68 68 16 
MR13 LDI NoSec  F ATGACCCTGGAGAGCGTCAAG LDI No sec signal cloning 68 57 21 
MR23 LD Probe F GTGCATTTGCATATCAGG LD Probe 58 44 18 
MR24 LD Probe R TAAGGCTTTGAAGAGCAGA LD Probe 58 42 19 
MR25 LD KpnI F 
GATCGGTACCATGGCGGTCGGGGAGAC
CGG 
LD Fragment cloning 86 70 30 
MR26 LD XbaI F CAGGCCCTCAATCGCATAGG LD Fragment cloning 69 60 20 
MR27 LD BglI F GGGAATACCCTTCTTCCACGC LD Fragment cloning 67 57 21 
MR28 LD NotI R 
GCTGGCGGCCGCTCAACACCGAGGTTC
GACAA 
LD Fragment cloning 88 6 32 
MR29 LD XbaI R GAGCTGATACCGCAGGGGCC LD Fragment cloning 72 70 20 
MR30 LD BglI R CCAGAGTTATATGAATCTCGG LD Fragment cloning 58 42 21 
MR 35 LDI Sec Sto R TCAGGCGGCGGCGAC Stop Codon LDI Sec  72 80 15 
MR 36 LDI Sec NoSto R L 
GGCGGCGGCGACGGCGAGGACCGAGA
GCAAGA 
LDI sec signal cloning 92 75 32 
MR 37 LDI Sec NoSto R S GGCGGCGGCGACGGCGA LDI sec signal cloning 82 88 17 
MR38 GFP Fusion F ACACGCTGAACTTGTGG GFP fusion cloning 58 52 17 
MR39 GFP Fusion R CCACAAGTTCAGCGTGT GFP fusion cloning 58 52 17 
MR40 LD Gene Art F ACTATAGGGCGAATTGTAGAAG LD Sequencing 58 40 22 
MR41 LD Gene Art R GGAAAGCGGGCAGTGATAGAAG LD Sequencing 68 54 22 
MR42 GW1 GTTGCAACAAATTGATGAGCAATGC Gateway Sequencing 70 40 25 
MR43 GW2 GTTGCAACAAATTGATGAGCAATTA Gateway Sequencing 65 32 25 
MR44 M13 F GTAAAACGACGGCCAGT Gateway Sequencing 59 52 17 
MR45 M13 R CAGGAAACAGCTATGAC Gateway Sequencing 51 47 17 
MR46 LD Sec R GGGCGTCCTCCGCCG LD Secretion cloning 72 86 15 
MR53 pOPINLDI Full F 
AAGTTCTGTTTCAGGGCCCGATGGCATC
CGACCATCGTCGCTT 
LDI pOPIN cloning 89 55 43 
MR54 pOPINLDI NoSec F 
AAGTTCTGTTTCAGGGCCCGATGACCCT
GGAGAGCGTCAA 
LDI pOPIN cloning 86 55 40 
MR55 pOPINLDI NoSt R 
ATGGTCTAGAAAGCTTTATCCATCTGCC
AGTAGCACCAA 
LDI pOPIN cloning 77 43 39 
MR47 Hyg F ACTCACCGCGACGTCTGTCG PCR of transgenic lines 71 65 20 
MR48 Hyg R GCGCGTCTGCTGCTCCATA PCR of transgenic lines 70 63 19 
MR49 UbiPro F ATGCTCACCCTGTTGTTTGG PCR of transgenic lines 65 50 20 
MR50 IV2intron R CATCGTTGTATGCCACTGGA PCR of transgenic lines 65 50 20 
MR51 IV2intron F CCAAAATTTGTTGATGTGCAG PCR of transgenic lines 63 38 21 
MR52 NosTerm R TGTTTGAACGATCCTGCTTG PCR of transgenic lines 64 45 20 
MR56 Hv GCS F ATGAGGCGCAAAATGGCA GCS cloning 68 50 18 
MR57 Hv GCS R TCAGACATCATACTTCTTCG GCS cloning 55 40 20 
 
Table 2.3. Primers used within this study. 
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2.1.5 Antibiotics 
Antibiotics were used to select for positive transformants following transformation, as well as 
being used in culture medium, these are outlined in Table 2.4. 
 
Antibiotic Abbreviation Stock Concentration Final Concentration 
Ampicillin Amp 100 mg/mL in H2O 100 µg/mL 
Carbenicillin Car 100 mg/mL in H2O 100 µg/mL 
Kanamycin Kan 50 mg/mL in H2O 50 µg/mL 
Rifampicin Rif 50 mg/mL in MeOH 50 µg/mL 
Spectinomycin Spt 50 mg/mL in H2O 50 µg/mL 
Chloramphenicol Cam 34 mg/mL in EtOH 34 µg/mL 
 
Table 2.4. Antibiotic stocks used within this study. 
2.1.6 Media 
The composition of bacterial and plant culture media is outlined in Table 2.5. 
 
Abbreviation Medium Name Composition 
LB Lysogeny Broth 
1 % (w/v) tryptone, 0.5 % (w/v) yeast extract, 
171 mM NaCl, pH 7.0. 
LB-Agar Lysogeny Broth Agar As above, with 1.5 % (w/v) agar added. 
SOC 
Super Optimal broth with 
catabolite repression 
0.5 % (w/v) yeast extract, 2 % (w/v) tryptone, 
10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 
mM MgSO4 pH 7.5, following sterilisation by 
autoclave, add glucose to final concentration of 
20 mM. 
½MS 
Half strength Murashige 
and Skoog medium 
Micro and macro nutrients including vitamins 
at half standard concentration. 
½MS-Agar 
Half strength Murashige 
and Skoog medium agar 
As above, with 1 % (w/v) agar added. 
Agar Agar 1 % (w/v) agar in H2O. 
 
Table 2.5. Bacterial and plant culture media used within this study. 
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2.2 Molecular Biology 
2.2.1 General 
All nucleic acid concentrations were determined using a Nanodrop (Thermo) set to Nucleic 
Acid mode. PCRs were performed using a G-Storm thermocycler (Gene Technologies), specific 
cycling conditions are given in the necessary sections. Successful cloning was confirmed by 
colony PCR, restriction digest and sequencing (Eurofins MWG). The buffer components of kits 
are given by their abbreviated names, for more details see manufacturer’s instructions. 
2.2.2 Preparation of RNA using QIAGEN RNeasy Kit 
A QIAGEN RNeasy Kit was used for the preparation of RNA. All surfaces and equipment were 
cleaned using 70 % EtOH then RNase Away (Sigma). Up to 100 mg of plant tissue sample was 
homogenised in a mortar and pestle by grinding under liquid nitrogen. Sample was transferred 
to a pre-chilled Eppendorf and resuspended in 450 µL RLT buffer. This was then centrifuged, 
14,000 rpm, 1 min, and the supernatant transferred to a QIAshredder column. The flow 
through from this column was combined with half a volume of EtOH then added to an RNeasy 
spin column and centrifuged. The flow through was discarded and 700 µL RW1 buffer added to 
the column. The column was again centrifuged and the flow through discarded. Column was 
then washed by centrifugation two times with 500 µL RPE buffer. Finally RNA was eluted with 
30 µL H2O. RNA samples were flash frozen in liquid nitrogen and stored at -80 °C. 
2.2.3 Preparation of RNA using Phenol-Chloroform 
A second method of RNA purification was also used based on phenol-chloroform extraction. 
Homogenised plant tissue samples were prepared as for RNA using a QIAGEN RNeasy Kit. 
Following homogenisation, sample was transferred to a 2 mL Eppendorf to which 600 µL RE 
buffer (0.1 M Tris pH 8.0, 5 mM EDTA, 0.1 M NaCl, 0.5 % SDS, 1 % β-ME) was added. This was 
mixed thoroughly and incubated at 60 °C for 30 s to thaw samples. 200 µL of Plant RNA 
Isolation Aid (Life Technologies) was added to this and mixed. Sample was centrifuged at 
14,000 rpm for 10 min and the supernantant transferred to a 1.5 ml Eppendorf.  300 µL of 
acidic phenol:chloroform (pH 4.3) (Sigma-Aldrich) was then added and mixed thoroughly for 10 
min. Sample was centrifuged, 14,000 rpm for 5 min then the upper aqueous phase was 
transferred to a fresh Eppendorf containing 240 µL isopropanol and 30 µL sodium acetate (3 
M, pH 5.2) and mixed thoroughly. Nucleic acids were precipitated at -80 °C for 15 min followed 
by centrifugation at 14,000 rpm for 30 min. The supernantant was discarded and the pellet 
washed with 600 µL 70 % EtOH followed by centrifugation at 14,000 rpm for 5 min. 
Supernatant was discarded and RNA pellets allowed to dry in a fume hood at RT for 30-60 min. 
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RNA was dissolved in 100 µL H2O. Samples were flash frozen in liquid nitrogen and stored at -
80 °C. 
2.2.4 Synthesis of cDNA from RNA Template 
cDNA was generated from the RNA prepared from plant tissues. RNA for use in cDNA synthesis 
was first treated with DNase I (Sigma-Aldrich). 8 µL of RNA (50-100 ng/µL) was combined with 
1 µL 10x reaction buffer and 1 µL DNase I (1 U/ µL). The reaction was incubated at room 
temperature for 15 min then terminated by the addition of 1 µL Stop solution (50 mM EDTA) 
and heating to 70 °C for 10 min. First strand cDNA synthesis was carried out using Superscript II 
Reverse Transcriptase (Invitrogen). 10 µL of DNase treated RNA sample was combined with 1 
µL of Oligo(dT)15 primers (Promega) (500 µg/µL) and 1 µL dNTP mix (10 mM each). This mixture 
was heated to 65 °C for 5 min then chilled on ice. 4 µL of 5x buffer and 2 µL DTT (0.1 M) were 
then added and incubated at 42 °C for 2 min. Finally, 2 µL Superscript II RT was added to the 
mix and incubated at 42 °C for 50 min then 70 °C for 15 min. cDNA was stored at -20 °C. 
2.2.5 Standard Polymerase Chain Reaction 
For routine analytical PCR Taq DNA polymerase (NEB) was used. Reactions were set up as 
shown in Table 2.6. 
Component 1x 
10x Taq Buffer 5 µL 
dNTP mix (10 mM each) 1 µL 
Primer F  (10 µM) 1 µL 
Primer R (10 µM) 1 µL 
Template DNA 100 ng 
DMSO 1.5 µL 
Taq Polymerase 0.25 µL 
H2O to 50 µL 
 
Table 2.6. Standard PCR setup. 
 
The thermal cycler program consisted of initial denaturation at 95 °C for 30 s. Followed by 30 
cycles of denaturation at 95 °C for 20 s, annealing at a temperature suitable for the primers 
used for 30 s and elongation at 68 °C for 2 min. Final extension was at 68 °C for 5 min. For a 
colony PCR, template DNA was replaced by a colony sample taken by touching the colony with 
a sterile toothpick then adding it to an individual reaction mix. 
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2.2.6 High-Fidelity Polymerase Chain Reaction 
Phusion polymerase (NEB) was used for applications which required a high-fidelity polymerase, 
such as amplifying genes of interest for cloning. Reactions were set up as shown in Table 2.7. 
 
Component 1x 
5x Phusion Buffer 10 µL 
dNTP mix (10 mM each) 1 µL 
Primer F  (10 µM) 2.5 µL 
Primer R (10 µM) 2.5 µL 
Template DNA 100 ng 
DMSO 1.5 µL 
Phusion Polymerase 0.5 µL 
H2O to 50 µL 
 
Table 2.7 High-fidelity PCR setup. 
 
Thermal cycler program: denaturation at 98 °C for 30 s. Followed by 35 cycles of denaturation 
at 98 °C for 10 s, annealing at a temperature suitable for the primers used for 30 s and 
elongation at 72 °C for 90 s. Final extension was at 72 °C for 10 min. 
2.2.7 GC-Rich Polymerase Chain Reaction 
The Roche GC-Rich PCR System was used to amplify GC rich genes. Reactions were set up as 
shown in Table 2.8. 
Component 1x 
Primer F (2 µM) 5 µL 
Primer R (2 µM) 5 µL 
dNTP mix (10 mM each) 1 µL 
Template DNA 50 ng 
5x GC-Rich Buffer 10 µL 
GC-Rich Enzyme Mix 1 µL 
H2O to 50 µL 
 
Table 2.8 GC Rich PCR setup. 
 
Thermal cycler program: initial denaturation at 95 °C for 3 min. Followed by 35 cycles of 
denaturation at 95 °C for 30 s, annealing at annealing at a temperature suitable for the primers 
used for 30 s and elongation at 68 °C for 2 min. Final extension was at 68 °C for 10 min. 
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2.2.8 Reverse Transcription- Polymerase Chain Reaction 
RT-PCR was performed using QIAGEN OneStep RT-PCR kit. Components were thawed on ice 
and a reaction mix was prepared according to Table 2.9.  
 
Component 1x 
5x RT-PCR Buffer 10 µL 
dNTP mix (10 mM each) 2 µL 
Primer F (6 µM) 5 µL 
Primer R (6 µM) 5 µL 
Enzyme Mix 2 µL 
5x Q Solution 10 µL 
Template RNA 2 µg 
H2O to 50 µL 
 
Table 2.9. RT-PCR Setup. 
 
Thermal cycler program: reverse transcription at 50 °C for 30 min, then PCR activation at 95 °C 
for 15 min. Followed by 35 cycles of denaturation at 94 °C for 30 s, annealing at a temperature 
suitable for the primers used for 40 s and elongation at 72 °C for 2 min. Final elongation was at 
72 °C for 10 min. 
2.2.9 Isolation of Plasmid DNA from E. coli 
Isolation of plasmid DNA from E. coli was performed using a QIAGEN Miniprep kit. The kit 
utilises alkaline lysis of cells followed by purification of DNA by adsorption to silica. E. coli was 
grown in 5 mL LB cultures supplemented with suitable antibiotic(s) overnight at 37 °C. Cells 
were harvested by centrifugation at 4,000 rpm for 10 min and the supernatant discarded. The 
cell pellet was resuspended in 250 µL of buffer P1, lysed with 250 µL buffer P2 followed by 
inversion to mix, and then neutralised by addition of 350 µL buffer N3. Cell debris was 
precipitated by centrifugation at 14,000 rpm for 10 min. The supernatant was added to a 
QIAprep spin column and centrifuged for 1 min at 14,000 rpm. The column was washed with 
500 μL of buffer PB and centrifuged again. The column was washed with 750 μL of buffer PE 
and centrifuged again. DNA was eluted with 35 µL H2O. Plasmid DNA was stored at -20 °C. 
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2.2.10 Preparation of Competent E. coli Cells 
Chemically competent E. coli cells were produced from a starter culture (5 mL) grown for 16 h 
at 37 °C with shaking. This was then sub-cultured 1:100 into 50 mL fresh LB medium and 
allowed to grow at 37 °C, with shaking, until an OD600 reading of 0.4-0.5. Cells from this culture 
were then harvested by centrifugation at 4,000 rpm and 4 °C for 10 min. Cells were washed by 
resuspension in 50 mL ice cold 0.1 M MgCl2, pelleted again by centrifugation and washed once 
more in 0.1 M CaCl2. The final pellet, following washes, was resuspended in 2.5 ml 0.1 M CaCl2, 
20 % glycerol, divided into aliquots, frozen in liquid nitrogen and stored at -80 °C 
2.2.11 Transformation of E. coli Cells 
Competent cells were allowed to thaw on ice. 1-2 µL of plasmid DNA (approx. 100 ng DNA) was 
then added to cells and incubated on ice for 30 min. Cells were then heat shocked at 42 °C for 
30 s and returned immediately to ice. 250 µL SOC media was then added to cells, followed by 
incubation at 37 °C for 1 hour with shaking. For plating out, 50 µL was spread onto LB agar 
plates containing suitable antibiotic(s). After this the culture was pelleted by centrifugation, 
the supernatant decanted and the pellet resuspended in residual media and plated out. Plates 
were incubated overnight at 37 °C. Antibiotic concentrations used are given in Table 2.4. 
2.2.12 Agarose Gel Electrophoresis 
Agarose gels were produced using 1 % w/v acrylamide dissolved by heating (microwave) in TBE 
buffer (89 mM Tris-HCl, 89 mM Boric acid, 2 mM EDTA). SYBR Safe DNA gel stain (Invitrogen) 
was added at a 1:10,000 dilution once the gel had cooled but was still liquid. 2 µL of 6x loading 
buffer (NEB) was combined with 10 µL of DNA/RNA sample. Samples were loaded into the gel 
and ran at 100 V until the dye front reached the bottom of the gel. TBE buffer was used as the 
running buffer. Gels were visualised and imaged using a GeneGenius bioimaging system 
(Syngene). 
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2.2.13 DNA Sequencing 
DNA was sequenced using the chain termination method including dideoxynucleotide 
triphosphates (ddNTPs). Sequencing reactions were performed using a BigDye Terminator v3.1 
Cycle Sequencing kit (ThermoFisher) with the setup shown in Table 2.10. 
 
Component 1x (µL) 
Plasmid DNA   1 
Primer (10 µM) 1 
Big Dye Buffer (5x) 2 
H2O 5 
BigDye 3.1 1 
Total 10 
 
Table 2.10. DNA Sequencing reaction setup. 
 
The sequencing reaction included 25 cycles of 96 °C for 10 min, 50 °C for 10 min and 60 °C for 4 
min. Products of the reactions were analysed by Eurofins MWG. Sequencing data was analysed 
using BioEdit Biological sequence alignment editor (Tom Hall, Ibis Biosciences). 
2.2.14 Restriction Digest 
Restriction digests were performed with enzymes and reagents from either Invitrogen or NEB. 
Conditions were dependent on the DNA and restriction enzymes used. Manufacturer’s 
instructions were followed. The general reaction setup is shown in Table 2.11. For double 
digests compatible buffers were used. 
 
Component 1x 
DNA < 1 µg 
10x Buffer 2 µL 
Restriction Enzyme(s) 1 µL (each) 
H2O to 20 µL 
 
Table 2.11. Restriction digest setup. 
 
Digests were incubated at 37 °C overnight. Reactions were scaled up as necessary for 
downstream purposes. Products from digests were used immediately or stored at -20 °C. 
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2.2.15 Gel Purification of DNA 
Gel purification was carried out using a QIAGEN QIAquick Gel Extraction kit. DNA was 
separated on an agarose gel. Bands were visualised using a Dark Reader Transilluminator 
(Clare Chemical Research) and excised using a clean razor blade. Gel samples were transferred 
to a 1.5 mL Eppendorf and combined with 3 volumes buffer QG and incubated at 50 °C for 10 
min. One volume of isopropanol was added to melted samples. Samples were loaded into a 
spin column and centrifuged (14,000 rpm, 1 min), the flow through was discarded. The column 
was then washed by centrifugation at 14,000 rpm for 1 min with 500 µL buffer QG then 750 µL 
buffer PE. DNA was eluted using 35 µL H2O. DNA was used immediately after purification or 
stored at -20 °C. 
2.2.16 PCR Product Clean-up 
QIAGEN QIAquick PCR Purification kit was used for PCR product clean-up. 5 volumes of buffer 
PB was added to the PCR reaction mixture, this was then added to a spin column and 
centrifuged at 14,000 rpm for 1 min. Supernatant was discarded and the column washed by 
centrifugation at 14,000 rpm for 1 min with 750 µL PE buffer. DNA was eluted with 35 µL H2O. 
DNA was used immediately after purification or stored at -20 °C. 
2.2.17 TOPO Cloning 
TOPO cloning utilises DNA topoisomerase I technology. A linearised DNA vector with 
topoisomerase covalently attached to at the 5’ and 3’ ends is used. Free 5’ and 3’ ends of a 
purified PCR product attack the bond between topoisomerase and vector forming covalent 
attachment and a circularised vector containing the PCR product (Figure 2.4).  
 
 
 
 
Figure 2.4 TOPO cloning reaction. 
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TOPO cloning requires 3’ A- overhangs, these were added using Taq (NEB), as proof reading 
enzymes (Phusion, NEB) removes overhangs, producing blunt-end PCR fragments. Addition of 
poly(A) to PCR products from Phusion amplifications was performed according to Table 2.12. 
  
Component 1x (µL) 
Gel Purified PCR Product 35 
dNTP mix (10 mM each) 0.4 
10x Buffer 4 
Taq Polymerase 0.2 
H2O 0.4 
 
Table 2.12. Poly(A) addition reaction setup. 
 
The reaction was incubated at 72 °C for 10 min then placed on ice. The product of the poly(A) 
extension was purified following the PCR Product Clean-up protocol. Cloning of PCR fragments 
into pCR8/GW/TOPO was then performed according to Table 2.13. 
 
Component 1x (µL) 
Clean PCR Product 3 
Salt Solution  1 
H2O 1.5 
pCR8/GW/TOPO 0.5 
 
Table 2.13. TOPO cloning reaction setup. 
 
The reaction was incubated at RT for 10 min then placed onto ice. The reaction product was 
transformed into chemically competent E. coli.  
2.2.18 Gateway Cloning LR Recombination Reaction 
The gene cloned into the pCR8 entry plasmid is flanked by attL sites, the Gateway cassette in 
the destination vector is flanked by attR sites. The clonase enzyme exchanges these sequences. 
For the LR reaction a Gateway LR Clonase II (ThermoFisher) enzyme mix was used. 100 ng of 
entry plasmid DNA was combined with 150 ng destination vector and TE buffer (10 mM Tris, 
1mM EDTA, pH 8.0) in a final volume of 8 µL. To this mix, 2 µL LR Clonase enzyme mix was 
added. The reaction was incubated at 25 °C for 1 h then terminated by addition of 1 µL 
Proteinase K solution and incubation at 37 °C for 10 min. Reaction product was used directly in 
an E. coli transformation. 
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2.2.19 In-Fusion Cloning 
In-Fusion cloning utilises the addition of flanking regions to the gene of interest by PCR and 
linearization of the destination vector, these two DNA fragments are combined by a 
proprietary enzyme. A PCR product from a gel purification and linearised vector from a cleaned 
up restriction digest were combined with reaction mix (Table 2.14) and incubated at 50 °C for 
15 min. The product of this reaction was used directly in an E. coli transformation. 
 
Component 1x 
PCR Product 50 ng 
Linearised Vector 100 ng 
5x In-Fusion HD Enzyme Mix 2 µL 
H2O to 10 µL 
 
Table 2.14. In-Fusion cloning setup. 
 
Figure 2.5 Gateway reaction. 
att sites enable recombination catalysed by LR clonase. The ccdB cassette encodes a DNA gyrase 
inhibitor that aids selection of positive recombinants. 
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2.3 Protein Expression and Purification 
2.3.1 Protein Quantification 
Protein Quantification was performed by Bradford assay using Bradford Ultra (Expedeon). 
Standards of BSA ranging from 2 mg/ml to 0.2 µg/mL were utilised depending on the protein 
sample being analysed. The assay was performed in 96 well plates. For high range samples (0.1 
mg/mL to 1.5 mg/mL) 10 µL of sample was combined with 150 µL of Bradford Ultra. For low 
range samples (1 µg/mL to 25 µg/mL) 100 µL of sample was combined with 100 µL of Bradford 
Ultra. Samples were mixed thoroughly. Assays were performed in either duplicate or triplicate. 
Absorbance of samples was measured at 595nm. A standard curve was produced and used to 
determine the sample concentration. 
 
A Direct Detect IR Spectrophotometer (EMD Millipore) was also used to quantify protein 
samples by measuring in the amide region between 1600-1690 cm-1. 2 µL of sample was 
loaded onto the supplied card and analysed following manufacturer’s instructions. 
2.3.2 Protein Concentration and Buffer Exchange 
Protein samples were concentrated using Amicon Ultra Centrifugal Filters, 15  mL or 50 mL size 
units (EMD Millipore). Sample cut-offs of 10 kDa, 30 kDa or 50 kDa were used depending on 
the size of the protein being concentrated. Centrifugation was performed at 4,000 rpm. 
 
Buffer exchange and desalting was performed using NAP-5 or NAP-10 columns (Illustra, GE). 
For NAP-5: the column was equilibrated with 10 mL buffer, 0.5 mL sample applied and eluted 
with 1 mL of appropriate buffer. For NAP-10: the column was equilibrated with 15 mL buffer, 1 
mL sample applied and eluted with 1.5 mL of appropriate buffer. 
2.3.3 Protein Dialysis 
Dialysis of proteins was performed against 5 L of appropriate buffer. SnakeSkin dialysis tubing, 
Mw cutoff: 3.5 kDa (Life Technologies) was prepared by pre-soaking in appropriate buffer. 
Protein sample was added to the tubing and incubated in pre-cooled buffer at 4 °C overnight 
with constant stirring. 
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2.3.4 Protein Analysis by Sodium Dodecyl Sulphate Polyacrylamide Gel 
Electrophoresis (SDS-PAGE)  
Protein samples were analysed by SDS-PAGE, which separates proteins according to mass, to 
determine their size and purity. Precision Plus Protein Prestained Standards (BioRad) were 
used. 10 %, 12 %, 15 % or 4-12 % RunBlue pre-cast gels (Expedeon) were used with RunBlue 
Tris-Tricine run buffer (Expedeon). Gels were also prepared using the Laemmli method 
(Laemmli, 1970). SDS-PAGE samples were prepared by combining 20 µL of sample with 5 µL of 
5x SDS sample loading buffer (250 mM Tris-HCl pH 6.8, 5 % β-ME, 0.02 % bromophenol blue, 
10 % SDS, 30 % glycerol). Samples were heated to 70 °C, briefly centrifuged and loaded into 
the gel. Protein gels were stained using InstantBlue (Expedeon). Gels were run at 180 V 
(Expedeon gel tank) Gels were imaged using a GeneGenius bioimaging system (Syngene). 
2.3.5 Native Polyacrylamide Gel Electrophoresis and Zymography 
For native gel electrophoresis, 7.5 % gels were made according to Laemmli (Laemmli, 1970), 
however SDS was omitted from the gel and SDS and β-ME were omitted from sample loading 
buffer. Samples were not heated. Gels were run at 4 °C and 100 V. 
 
For red pullulan zymography, gels were run as for native PAGE, 10 mg/mL red pullulan 
(Megazyme) was added to the gel before it set. Gels were incubated in incubation buffer (10 
mM NaOAc, 0.5 M NaCl, 1 mM DTT,  1 mM CaCl2, 1 mM MgCl2, pH 5.5) at 37 °C until zones of 
clearing could be seen. Gels were imaged using a GeneGenius bioimaging system (Syngene). 
2.3.6 Western Blot Analysis of Proteins 
Western blot analysis was used to determine the presence of specific proteins. Equal loading 
was achieved either by quantifying the amount of protein in the sample loaded or by using 
samples which had been treated identically. SDS-PAGE was performed on protein samples as 
described previously. Following this, proteins were transferred to a nitrocellulose membrane 
(Sigma) by electrophoresis in transfer buffer (25 mM Tris-HCl, 250 mM glycine, 10 % MeOH). 
Blots were run at 4 °C for 80 min at 95 mA or 16 h at 35 mA. Following blotting the membrane 
was removed from the cassette, washed once with TBS buffer (50 mM Tris, 150 mM NaCl, pH 
7.6) and blocked with blocking buffer (5 % Marvel milk powder in TBS) for 1 hour at RT or 16 h 
at 4 °C. Following blocking the membrane was washed three times with TBST (TBS with 0.05 % 
Tween 20) and once with TBS. Primary antibody was added (1:4,000 dilution in TBS, 1 % 
Marvel milk powder) and incubated for 1 h at RT. Membrane was then washed three times 
with TBST and once with TBS. Secondary antibody was added (1:5,000 dilution in TBS, 1 % 
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Marvel milk powder) and incubated for 1 h at RT. Membrane was washed three times with 
TBST and once with TBS. Imaging the blot involved using ECL western blotting substrate 
(Promega), 0.5 mL of component A and 0.5 mL of component B were combined in a petri dish, 
into this the membrane was placed and incubated at room temperature for 1 min. The blot 
was dried with paper towel to remove excess substrate. Chemiluminescence was then imaged 
using the ImageQuant LAS 500 (GE). Blots were stained for protein with ponceau stain and 
imaged with a GeneGenius bioimaging system (Syngene). For detection of His6 QIAexpress 
anti-His mouse antibody (QIAGEN) was used as the primary antibody and goat anti-mouse IgG-
HRP (Santa Cruz Biotechnology) was used as the secondary. For detecting primary antibodies 
produced in rabbit, goat anti-rabbit IgG-HRP (Santa Cruz Biotechnology) was used as the 
secondary antibody. 
2.3.7 Preparation of Protein Gel Slices for Mass Spectrometry Analysis 
Mass Spectrometry was used to identify proteins present in SDS-PAGE bands. Bands were 
excised from gels using a clean, sterile scalpel and transferred to a low bind Eppendorf. Gel 
slices were destained with three washes in 30 % EtOH at 65 °C for 15 min. Then washed with 
50 mM TEAB (Sigma)/50 % ACN for 15 min (all further wash steps were 15 min unless stated). 
Followed by incubation with 10 mM DTT at 55 °C for 30 min. DTT was decanted and IAA (30 
mM iodoacetamide in 50 mM TEAB) was add and incubated for 30 min at RT, with protection 
from light. IAA was removed and the gel washed with TEAB/50 % ACN, then washed with 50 
mM TEAB. Buffer was removed and the gel sliced into small pieces on a petri dish and 
transferred to a low bind Eppendorf. Sliced gel was washed with 50 mM TEAB/50 % ACN. 
Finally gel was washed with ACN, this was then decanted and residual solvent evaporated. 
Protein sample was then digested with trypsin and the product of digestion was analysed by 
MS. 
2.3.8 Cell Culture and Protein Expression in E. coli 
Starter cultures were prepared by picking a colony or adding 20 µL of a glycerol stock to 5 mL 
LB plus antibiotic. The culture was incubated at 37 °C with shaking for 16 h. Cells were 
subcultured by a 1:100 dilution in LB and allowed to  grow until reaching OD600 of 0.6. The 
culture was then induced with IPTG (to a final concentration of 1 mM, 0.5 mM or 0.2 mM- 
dependent on the expression conditions being tested). Induced cultures were grown for 16 h. 
The temperature used for growth varied with experiment (18 °C, 20 °C, 22 °C, 28 °C or 37 °C). 
Cells were harvested by centrifugation at 4,000 rpm for 10 min and either used immediately or 
stored at -20 °C. 
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2.3.9 E. coli Cell Lysis 
A cell pellet was resuspended in a maximum of 50 mL lysis buffer (50 mM Tris-HCl pH 7.5, 0.5 
mM NaCl, 20 mM imidazole, protease inhibitor cocktail (Sigma) 1/100 v/v, 2 mg DNase, 2 mM 
DTT). The suspension was passed through a Cell Disruptor (Constant Systems) in one shot 
mode at a pressure of 25 kpsi. Samples were run through the disruptor 3 times to ensure 
complete lysis. Following lysis the lysate was centrifuged at 21,000 rpm for 15 min at 4 °C to 
produce a soluble supernatant and an insoluble pellet. 
2.3.10 Preparation of Inclusion Bodies and β-Mercaptoethanol Soluble Protein from 
E. coli 
Inclusion bodies were purified from the insoluble pellet produced after cell lysis and 
centrifugation. The pellet from 4 L of culture was resuspended in 100 mL urea buffer (50 mM 
Tris-HCl pH 8.0, 6 M urea) then centrifuged at 21,000 rpm for 10 min at 4 °C. This wash step 
was repeated twice more, each time the supernatant was removed and kept for further 
analysis. The urea acts to solubilise and unfold proteins by interacting with hydrogen bonds 
that would otherwise hold the protein in shape. The unfolded proteins were centrifuged to 
separate out the highly insoluble proteins that contain mixed inter- and intra-molecular 
disulfides. Urea is not able to fully denature and solubilise disulfide linked proteins therefore 
they remain present in the insoluble material.   
 
The pellet was then resuspended in 50 mL β-ME buffer (50 mM Tris-HCl pH 8.0, 6 M urea, 140 
mM β-ME) and β-ME soluble proteins were solubilised by vortexing.  The β-ME breaks the 
disulfide bonds that form between cysteine residues, reducing them back to free thiol groups 
therefore enabling solubilisation. The solution was then centrifuged at 21,000 rpm for 10 min 
at 4 °C. The supernatant was saved as the β-ME soluble fraction. Other reducing agents (DTT, 
TECP) were tested in this process but produced lower yields of solubilised protein. 
2.3.11 Preparation of Periplasmic Fraction from E. coli 
Osmotic shock was used for purification of proteins that have been targeted to the periplasmic 
space. A pellet from a 100 mL bacterial culture was resuspended in 25 mL ice cold sucrose 
buffer (25 mM Tris pH7.5, 1 mM EDTA, 20 % sucrose) and incubated on ice with stirring for 10 
min. The sample was then centrifuged at 4,000 rpm, 4 °C for 10 min. Supernatant was 
removed and the pellet resuspended in 10 mL ice cold 5 mM MgCl2. This was then incubated 
on ice with stirring for 10 min. The sample was then centrifuged at 4,000 rpm, 4 °C for 10 min. 
The supernatant was the cold osmotic shock fluid and contained periplasmic proteins. 
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2.3.12 General Protein Chromatography Systems 
For protein purification an ÅKTA FPLC chromatography system (GE) was used. The system was 
maintained at 10 °C to prevent protein degradation during purification. The system lines were 
stored in 20 % EtOH when not in use. Prior to use, pumps were washed and lines cleaned with 
1 ml/min H2O for 10 min. The column was connected to the system and washed with 1 ml/min 
H2O until traces of EtOH were removed, the column was then disconnected. Pumps were 
washed with buffer(s) and the lines cleaned with 1 ml/min buffer for 10 min. The column was 
then reattached and equilibrated with buffer. Following use the pumps, lines and columns 
were washed with 1 ml/min H2O for at least 1 CV. Pumps, lines and columns were finally 
washed with 1 ml/min 20 % EtOH for at least 1 CV. Columns were stored at 4 °C in 20 % EtOH. 
2.3.13 Nickel Affinity Chromatography 
Crude soluble extract or solubilised protein was first filtered through a 0.45 µm syringe filter to 
remove any aggregates that may block the system. The protein sample was loaded into a super 
loop (GE) loading column. Either a 1 mL or 5 mL His-Trap chelating column (GE) was used. The 
column was attached to the ÅKTA system and equilibrated with buffer A (50 mM Tris-HCl pH 
7.5, 0.5 mM NaCl, 20 mM imidazole). The extract was then loaded onto the column. The flow 
through was retained for analysis. The column was washed with 10-25 CV of buffer A to 
remove non-specifically bound proteins. Wash samples were retained. Bound protein was 
eluted with buffer B (50 mM Tris-HCl pH 7.5, 0.5 mM NaCl, 500 mM Imidazole) in one step. The 
elution fractions were retained. A gradient elution was tested but was shown to make little 
difference during these purifications. Fractions were analysed by SDS-PAGE, fractions 
containing protein of interest were combined and concentrated. 
2.3.14 Synthesis of 6-deoxy-6-amino-β-cyclodextrin  
To enable coupling to a resin (NHS activated Sepharose, Sigma), β-CD was derivitised to 
produce 6-deoxy-6-amino-β-cyclodextrin.  Derivitisation and coupling of β-cyclodextrin was 
performed according to (Chung et al., 2009). 10 g of dry β-cyclodextrin was transferred to a 
flask containing 10 ml fresh pyridine. A solution of carbonyldiimidazole (1.4 g) was dissolved in 
10 mL fresh pyridine and added to the reaction mixture dropwise over 5 min, with gentle 
stirring. The activation reaction was allowed to proceed at room temperature for 2 h. 
Following this the activated cyclodextrin solution was added dropwise to a flask containing 
1,3-diaminopropane (3.6 mL) with stirring. The reaction proceeded for 1 h at room 
temperature, after which, the cyclodextrin mixture was precipitated by adding the reaction 
solution dropwise to a flask containing 1 L CH2Cl2 with vigorous stirring. A flaky white 
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precipitate was isolated via suction through a fritted funnel. The precipitate was re-dissolved 
in toluene and dried by rotary evaporation three times to remove any residual toluene. The 
cyclodextrin product was analysed by MALDI-ToF MS (Appendix) and used without any further 
purification. 
2.3.15 Generation of β-CD Sepharose Resin 
Excess (2 g) activated β-CD (6-deoxy-6-amino-β-cyclodextrin) was dissolved in 10 mL 0.2 M 
NaHCO3, 0.5 mM NaCl, pH 8.3 to form the coupling solution. 20 mL of NHS-activated 
Sepharose 4 fast flow (GE) was suspended in H2O to form a slurry. This was added to a fritted 
column attached to a vacuum line and washed with 10 volumes of cold 1 mM HCl. The resin 
was transferred to a 50 mL tube, the coupling solution was added and incubated for 4 h at RT. 
Coupling solution was removed using a fritted column and vacuum line. The resin was 
transferred to a 50 mL tube and blocking of non-reacted NHS groups was performed by the 
addition of 20 mL 0.1 M Tris-HCl pH 8.5 for 2 h. Resin was transferred to a fritted column and 
washed with 3 x 25 mL 0.1 M Tris-HCl and 3 x 25 mL 0.1 M NaOAc pH 5.0. Resin was stored in 
20 % EtOH.  
2.3.16 β-Cyclodextrin Affinity Chromatography 
β-CD affinity chromatography was carried out using 25 mL of β-CD-Sepharose loaded into an  
XK 26/20 column (GE). The preparation of β-CD-Sepharose is outlined in below. Protein sample 
was exchanged into buffer A (10 mM NaOAc, 0.5 M NaCl, 5 mM CaCl2, pH 5.5) and loaded into 
a 2 mL loading loop. The column was attached to the ÅKTA system and equilibrated with Buffer 
A. The protein was loaded onto the column and the flow through retained for analysis. The 
column was washed with 4 CV of buffer A to remove non-specifically bound proteins, wash 
samples were retained for analysis. Bound protein was eluted with buffer B (10 mM NaOAc, 
0.5 M NaCl, 5 mM CaCl2, 7 mM β-CD, pH 5.5) in one step, elution fractions were retained. 
Fractions were analysed by SDS-PAGE, fractions containing protein of interest were combined 
and concentrated. The column was cleaned with buffer A, then water and stored in 20 % EtOH. 
2.3.17 Anion Exchange Chromatography 
Anion exchange chromatography was performed using a MonoQ 4.6/100 PE column (GE). The 
column was equilibrated with buffer A (50 mM Tris-HCl pH 7.5). Prior to loading, the protein 
sample was exchanged into buffer A. The sample was loaded onto the column using a 1 mL 
loading loop. Following injection onto the column, unbound proteins were eluted by washing 
with 10 CV buffer A. Flow through and wash fractions were retained for analysis. Bound 
proteins were eluted with either a linear or stepwise elution using buffer B (25 mM Tris pH7.5 
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1 M NaCl). Fractions were analysed by SDS-PAGE. For cleaning, the column was reversed and 
washed with 1 CV of each of the following: 2 M NaCl, 2 M NaOH, 2 M NaCl, 1 M HCl, 75 % 
AcOH, 2 M NaCl, in between each wash step the column was washed with 5 mL H2O. Column 
was stored in 20 % EtOH. 
2.3.18 Size-Exclusion Chromatography 
Size exclusion chromatography was carried out on a 16/60 Superdex S200 column (GE), which 
is capable of protein fractionation between 10-1500 kDa. The column was equilibrated with 2 
CV of buffer (50 mM Tris pH 7.5). The protein sample was exchanged into compatible buffer 
and loaded onto the column using a 2 mL loading loop. Isocratic elution was carried out over 2 
CV. Fractions containing protein were collected and analysed by SDS-PAGE. Fractions 
containing protein of interest were combined and concentrated. Column was cleaned with 1 
CV of 0.2 M NaOH at 1 ml/min. 
2.3.19 Protein Refolding by Dilution 
Protein refolding was performed on 100 mL β-ME soluble supernatant. This was first dialysed 
over night against 1.5 L of 50 mM Tris-HCl pH 8.0, 1 M guanidine hydrochloride, to remove a 
large proportion of the β-ME. The dialysed sample was combined with 100 mL 6M guanidine 
hydrochloride and incubated at room temp 30 min. DTT was added to 4 µM and incubated for 
1 h. Cystine was then added to 14 mM and incubated for 10 min. The mixture was added 
dropwise to 1 L of 50 mM Tris HCl pH 8.0, 5.5 mM cysteine and incubated for 1 h. The product 
was concentrated by nickel affinity chromatography. 
2.3.20 On-Column Protein Refolding  
The β-ME soluble fraction from a protein solubilisation procedure was loaded into a super loop 
(GE) loading column. A 1 mL His-Trap chelating column (GE) was used. The procedure for nickel 
affinity chromatography was followed. Eluted fractions containing protein of interest were 
combined and concentrated. 
2.3.21 Protein Refolding Using Quick Fold 
QuickFold is a commercially available kit that can be used for screening different protein 
refolding conditions.  The screen includes 15 different buffers which vary in their composition 
two basic buffers are used- MES pH 6.0 or Tris pH 8.5 with varying levels of DTT, 
reduced/oxidised glutathione, guanidine hydrochloride, Triton X-100, PEG, arginine, sucrose, 
and different NaCl concentrations. 50 µL of 1 mg/mL solubilised protein was slowly added to 
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each of the 950 µL refolding buffer and incubated at 22 °C for 2 h. Samples were then 
centrifuged to pellet insoluble material and analysed by SDS-PAGE. 
2.3.22 Antibody Generation 
Samples of recombinant LD (1.6 mg) and LDI (2 mg) were submitted to Eurogentec for 
antibody generation in rabbit (3 month programme). Each immunisation consisted of 1/8th of 
total submitted protein sample.  Initial immunisation occurred at day 0 with boosters at 14, 28 
and 56 days. Blood samples were taken at 0 days (pre-immune), 38 days (small bleed), 66 days 
(large bleed) and 87 days (final bleed), from which sera was produced. Isolated sera were 
stored at -20 °C. 
2.3.23 Standard Enzyme Linked Immunosorbent Assay (ELISA) 
Absorbance readings were performed using a FLUOstar Omega (BMG labtech) plate reader in 
absorbance mode at wavelength 405 nm. Each sample was run in either duplicate or triplicate, 
with the average result and standard error used for data analysis. Controls of no antigen, no 
primary antibody and no secondary antibody were included in each experiment and found to 
be within the expected range for each experiment. 
 
A Corstar high binding polystyrene 96 well plate (Corning) was coated with 100 ng of antigen 
(in 100 µL) per well and incubated for 16 h at RT. The plate was washed three times with PBST 
(PBS with 0.1 % Tween 20). The plate was then blocked with 5 % w/v Marvel milk powder in 
PBST (200 µL per well) and incubated at room temperature for 1 h. During this incubation time 
serial dilutions of individual animal sera (1 in 100, 1 in 300, 1 in 900, 1 in 2700, 1 in 8100, 1 in 
24,300 1 in 72,900, 1 in 218,700) were prepared in PBST. The plate was washed three times 
with PBST. 100 µL of serum dilution was added to each well and incubated at 37 °C for 1 h. The 
plate was washed three times with PBST. Secondary antibody, goat anti-rabbit IgG-HRP (Santa 
Cruz Biotechnology) at a 1:5,000 dilution in PBST was loaded (100 µL per well) and incubated 
at 37 °C for 1 h. The plate was washed three times with PBST. 100 µL ABTS peroxidase 
substrate (5 mg in sodium citrate with 0.02 % H2O2) was added to each well and incubated at 
room temperature for 30 min. Absorbance measurements were read at 405 nm. 
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2.4 Enzyme Assays 
2.4.1 Bicinchoninic Acid Reducing End Assay of LD 
BCA assay was performed using a modified protocol from (Doner and Irwin, 1992). Hydrolysis 
of pullulan (Sigma) by LD (recombinant) or Kp pullulanase (Megazyme, Specific activity: 34 
U/mg at 40 °C, pH 5.0, 1% pullulan) was measured by the release of reducing ends. The 
concentration of reducing ends was measured by the reduction of Cu2+ to Cu+ which 
subsequently complexes with bicinchoninic acid creating a coloured complex that absorbs at 
540nm. Enzyme was diluted to final concentrations (dependent on assay setup) in reaction 
buffer (20 mM NaOA pH 5.5). Inhibitors were added to a final concentration between 0.001 
mM to 1mM (dependent on the assay setup). The inhibitor was incubated with LD at 30 °C for 
30 min. Pullulan substrate was then added to a final concentration of 0.1 mg/ml. The reaction 
was allowed to proceed at 30 °C for 30 min. The reaction was terminated by the addition of 40 
mM sodium carbonate, 5 mM disodium 2,2’-bicinchoninate, 5 mM copper (II) sulfate and 12 
mM L-serine. This was then incubated at 80 °C for 30 min then at 4 °C for 15 min. Absorbance 
readings were performed at 540 nm using a FLUOstar Omega (BMG labtech) plate reader. 
Controls containing inactivated (boiled) enzyme were used to determine background readings. 
All assays were performed in triplicate. 
2.4.2 Limit Dextrizyme and Red Pullulan Assays 
Limit Dextrizyme and red pullulan assays were performed according to manufacturer’s 
instructions (Megazyme). For Limit Dextrizyme assay 500 µL of protein extract in NaOAc pH 
5.5, 25 mm DTT was equilibrated at 40 °C for 5 min. To this a Limit-Dextrizyme tablet was 
added. The hydrolysis was allowed to proceed for 10 min at RT. The reaction was terminated 
by the addition of 5 mL 1 % Tris followed by vortexing. Samples were clarified by filtration 
through filter paper and absorbance readings were performed at 590 nm. Controls containing 
no enzyme were included in the assays. 
For red pullulan assay 1 mL of protein extract in NaOAc pH 5.5, 25 mm DTT was equilibrated at 
40 °C for 5 min. To this 0.5 mL red pullulan solution (0.5 g in 25 mL of 0.5 M KCl) was added. 
The hydrolysis was allowed to proceed for 10 min at 40 °C. The reaction was terminated by the 
addition of 2.5 mL 95 % V/V EtOH followed by vortexing. Samples were allowed to equilibrate 
for 10 min then were centrifuged at 4000 rmp for 10 min. Supernatants were decanted and 
absorbance readings were performed at 510 nm. Controls containing no enzyme were 
included in the assays. Miniaturisation of both assays was attempted using 1/10th of 
recommended reagents but yielded poor reproducibility. 
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2.4.3 Fluorimetric and Colorimetric Assay of LD using Hexafluor and Hexachrom 
Assays using hexachrom (4,6-O-benzylidene-2-chloro-4-nitrophenyl-β-63-α-D-maltotriosyl-
maltotriose) and hexafluor (4,6-O-benzylidene-4-methylumbelliferyl-β-63-α-D-maltotriosyl-
maltotriose) were performed according to manufacturer’s instructions (Megazyme). An assay 
mix consisting of substrate, either 12.4 mM hexachrom or 6.2 mM hexafluor in 1 mL DMSO 
(final assay concentration 4 mM or 2 mM, respectively), 50 µL α-glucosidase (1500 U/mL), 50 
µL β-glucosidase (400 U/mL) and 2 mL H2O was prepared. The 40 µL mix was pre-incubated at 
40°C for 5 min. 40 µL limit-dextrinase containing protein extract (in NaOAc pH 5.5, 25 mm DTT) 
was also pre-incubated at 40°C for 5 min. Both pre incubated samples were combined and 
incubated at 40°C for 30 min. At the end of the 30 min incubation period, 100 µL 0.1 mM Tris 
pH 9.0 was added. The absorbance of the solutions and the reaction blank were measured at 
400 nm using a FLUOstar Omega (BMG labtech) plate reader. Assays were performed in 
triplicate. 
 
Preliminary assays were performed to ensure the correct assay setup. No inhibitor and boiled 
enzyme controls were included to account for background reading produced by the presence 
of protein and some compounds. These background data were subtracted from the assay 
results. 
2.4.4 Glucosylceramide Synthase Assay 
Assay was based on those reported in (Ichikawa et al., 1996, Niino et al., 2013), this utilises a 
synthetic fluorescent substrate- C6-NBD-Ceramide (ThermoFisher). Mung bean microsomes (a 
kind gift from Irina Ivanova) were created following (Abas and Luschnig, 2010). Substrate 
liposomes were prepared by combining 50 µg C6-NBD-Cer and 500 µg lecithin in 100 µl EtOH. 
Solvent was then evaporated. Mixture was resuspended in 1 ml water by sonication in 
sonication bath 10 min. 30 uL of microsomes, 10 µL of liposomes, and 1mM UDP-Glc were 
combined to a 50 µL final volume in buffer (100 mM MOPS KOH, pH7.2). Reactions were 
incubated at 30 °C with samples taken at 0, 4, 8, 16 hour time points. 
 
After incubation lipids were extracted with CHCl3/CH3OH 2:1 (vol/vol) and evaporated to 
dryness. Then the lipid extract (lower phase) was redissolved in 10 µL CHCl3/CH3OH 2:1 
(vol/vol). A TLC run using a silica plate in CHCl3/CH3OH/H2O 65:25:4 (vol/vol). Lipid migration 
was visualised by UV illumination. 
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LC-MS was attempted using a Luna NH2 Luna 3 µm NH2 100 Å, LC Column 150 x 2 mm column 
(Phenomenex) coupled to a Thermo-Finnigan MS instrument equipped with a Deca XP ion 
trap. 10 µL of sample injected. A linear gradient of 90 % H2O: 10 % Acetonitrile to 10 % H2O: (0 
% Acetonitrile was performed 5 min to separate sample components. A UV detector was used 
to detect absorbance, masses corresponding to peaks in absorbance were analysed.  
 
2.5 Computational Methods 
2.5.1 Peptide Molecular Modelling 
Peptide secondary structure was analysed using PEP-Fold online software (Thevenet et al., 
2012). 
2.5.2 Molecular graphics 
The PyMOL Molecular Graphics System (Version 1.7.4 Schrödinger, LLC.) and SPDB-viewer 
(Guex and Peitsch, 1997) were used to generate protein and peptide 3-D images. 
2.5.3 Subcellular localisation prediction 
SignalP-4.1, Protein Prowler and ChloroP-1.1 were used to predict the subcellular location of 
porteins from their primary sequences. SignalP-4.1 is a eukaryotic secretory protein predictor 
(Petersen et al., 2011) this server predicts the presence and location of signal peptide cleavage 
sites in amino acid sequences. Prowler determines the localisation of the protein among the 
following categories: secretory pathway, mitochondrion, chloroplast or other (nucleus, 
cytoplasmic) (Bodén and Hawkins, 2005). ChloroP predicts the presence of a chloroplast transit 
peptide and the location of potential cleavage sites (Emanuelsson et al., 1999).  
2.5.4 Image Processing 
Image processing was performed using Fiji (Schindelin et al., 2012). 
2.5.5 Sequence Alignment 
Sequence alignment was performed using BioEdit (Hall, 1999). 
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2.6 Plant methods 
2.6.1 Barley Growth 
Barley (var. Tipple) was surface sterilised by immersion in 4 % bleach (Parazone) solution.  
Traces of bleach were removed by repeated washing (ten times or more) with H2O. Ten grains 
were plated out on two layers of filter paper pre-soaked with 2 mL H2O in a petri dish. The 
petri dish was wrapped in foil to protect form the light and transferred to a dark Hybaid 
incubator (Thermo) at 17 °C. For inhibitor screens 2 mL H2O was replaced with the compound 
dissolved in 2 mL H2O. 
 
For leaf material, germinated grains were moved into a sterile culture vessel containing ½MS 
agar and grown in light conditions at RT until reaching a suitable size. Sterile conditions were 
maintained during growth. Plant samples were harvested using a sterile scalpel and frozen in 
liquid nitrogen. 
2.6.2 Arabidopsis and Tef Growth 
Arabidopsis and tef were sterilised in an open Eppendorf for 4 h inside a desiccator jar with 50 
mL of bleach acidified with 0.3 mL concentrated HCl. The desiccator jar was kept in a fume 
hood. 
 
2 mL of 1 % Agar, ½ MS medium was added to the base of 20 mm wells (Sterilin, UK) of 25-well 
sterile plastic plates. ½MSAgar media was mixed with 2 µL of aqueous solution of inhibitor (in 
the case of water insoluble compound in DMSO solution). DMSO concentrations less than 0.1 
% are shown to have no effect on seed germination (Erdman and Hsieh, 1969). 
 
12 Arabidopsis seeds (var. Col-0) or 8 tef grains (var. Trotter) were placed in a straight line  
across each well. This was performed using a sterile toothpick. Plates were covered with a lid 
and sealed with micropore tape. Plates were stratified for 2 d at 4 °C then and incubated 
vertically. Arabidopsis was incubated at 22 °C in a controlled environment room (16 h light : 8 
h dark, 22 °C, 250 µmol photosynthetically active radiation m-2 s-1) for 10 d. Tef was incubated 
in a dark Hybaid incubator (Thermo) at 17 °C for 3 d. 
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2.6.3 Root and Shoot Length Analysis 
Barley 
Root and coleoptile length was measured by hand using a ruler. The length of the longest root 
was measured from the point where it emerges from the grain to the tip. Coleoptile length was 
measured from the point it meets the embryo to the root tip. 
 
Arabidopsis and Tef 
Roots were imaged by photography of the plate, then root length was manually measured 
using ImageJ (FIJI) software.  
2.6.4 Grain weight measurement 
Grain measurements were performed using a MARVIN grain analyser (GTA Sensorik GmbH) set 
to barley mode. 
2.6.5 Barley grain dissection 
Plant samples were dissected using a sterile scalpel and tweezers, then frozen in liquid 
nitrogen. 
 
 
 
 
 
 
Figure 2.6 Barley grain sections used in dissection  
Dashed lines represent points where cuts are made to separate roots, endosperm and embryo 
samples. Created using information from (Palmer, 2006). 
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2.6.6 Protein extraction 
Protein extracts were prepared using 500 µL extraction buffer (100 mM MOPS-KOH pH7.2, 1 
mM EDTA, 1 mM DTT, 10 % v/v ethylene glycol, protease inhibitor cocktail 10 µL/mL) per grain. 
Samples were homogenised by grinding in a mortar and pestle under liquid nitrogen. Samples 
were passed through a layer of muslin to remove solid material. Samples were incubated on 
ice for 15 min then centrifuged 4,000 rpm for 10 min at 4 °C. Supernatant was decanted and 
used as crude protein extract. To extract LDI samples were incubated overnight at 4 °C. 
 
2.6.7 Preparation of barley protein extracts for glycoprotein MS analysis 
To enable analysis of protein samples by MS a modified extraction process was utilised. Barley 
grains were germinated as previously described, for 5 days in either H2O or 500 µM DNJ. 20 
grains were harvested for each growth condition. Germinated barley grains were dissected 
into three parts: 
 
- “Endosperm”- the grain including the endosperm, the aleurone and the pericarp 
- “Root”- the roots, cut away from the rest of the growing embryo 
- “Shoot”- the coleoptile and embryo including the scutellum 
 
All dissected samples were homogenised by grinding in a mortar and pestle under liquid 
nitrogen. 3 mL MS extraction buffer (25 mM Tris-HCl pH7.4, 150 mM NaCl, 5 mM EDTA, 
protease inhibitor cocktail 10 µL/mL. 1 % CHAPS) was used. Samples were passed through a 
layer of muslin to remove solid material. Then crude extracts were incubated on ice for 15 min 
then centrifuged 4,000 rpm for 10 min at 4 °C. Supernatant was decanted and used as crude 
protein extract.  
   
Protein samples were processed by treatment with different Peptide-N-Glycosidases (PNG-A 
and -F) and analysed by MALDI-TOF  mass spectrometry. 
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2.7  Protein Localisation in N. benthamiana 
2.7.1 Generation of Plasmid Constructs 
pCR8 LD and LDI no stop vectors were used in Gateway LR reactions with pK7FWG2.0 (Figure 
2.7) to generate plant expression C-terminal GFP fusion constructs. 
2.7.2 Transformation of Agrobacterium 
Agrobacterium tumifaciens LBA4404 cells were transformed with plasmid DNA by 
electroporation for 1 second at 2.5 kV. Cells were added to 200 µl SOC media and recovered 
for 2 h at 28 oC.  Cells were plated on LB plates containing Spc and Rif and incubated at 28 oC 
for 3 d.  
 
 
 
 
2.7.3 Protein Expression in N. benthamiana 
Agrobacterium colonies were picked into 100 mL LB (spc and rif) and incubated at 28 oC for 3 
d. The cells were pelleted by centrifugation at 4,000 rpm, 10 min, 4 °C. 
Then resuspended in an appropriate volume of MMA buffer (10 mM MES pH 5.6, 1 mM MgCl2, 
10 µM acetosyringone) to give an OD600 of 0.4.   
 
 
Cultures were used to infiltrate leaves of two plants (3 weeks old). Leaves were nicked using a 
sterile needle and infiltrated by forcing the solution into the extracellular space (Figure 2.8, A). 
 
Figure 2.7 pK7FWG2.0 C-terminal GFP plant expression vector. 
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Plants were grown in a glasshouse maintained at 25 oC with supplemental lighting to provide 
16 hours of daylight (Figure 2.8, B).  The leaves were harvested 3 days post infiltration. 
 
 
 
 
2.7.4 Confocal Microscopy of N. benthamiana 
Leaves expressing the protein of interest were cut into 1 cm discs, mounted on a microscope 
slide and visualised using a Leica SP5 confocal microscope (Leica Microsystems) with a HCX PL 
APO CS 63.0x1.20 water immersion objective. For visualisation of GFP, samples were excited at 
488 nm and the emission detected at 500-580 nm, laser power between 40-60 %. 
 
 
 
Figure 2.8 A. The infiltration process. B. Infiltrated plants in the glasshouse. 
Image from Matthew Donaldson. 
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2.8 Transgenic Plant Generation 
2.8.1 Generation of Agrobacterium vectors for plant transformation 
Performed following (Smedley and Harwood, 2015). Fragments of the sequences for LD (301 
bp) or LDI (243 bp) were PCR amplified from genomic DNA purified from barley cultivar Golden 
Promise using primers: LD F  aaagcgaaacattgcaaacc, LD R aaagatcttcggttgcttcg, LDI F 
ctgcgcatcctcatggac, LDI R actccgcttcattaccttgg. PCR products were cloned into pCR8/GW/TOPO 
using TOPO cloning. A Gateway LR reaction was used to transfer sequences from entry vector 
into pBRACT207 destination vector (Figure 2.9). pBRACT204 (Figure 2.10), a GUS 
overexpression construct was used to generate control plants. Correct sequences were 
confirmed by sequencing. 
 
Agrobacterium strain AGL1 was transformed with pBRACT vectors, cells recovered at room 
temperature for 24 h, with shaking. A large culture was grown for 2-3 days, then used to 
transform immature plant embryos. 
 
 
 
 
 
 
 
Figure 2.9 pBRACT207 vector used for RNAi.  
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2.8.2 Transformation of Barley Plants 
Plant transformation was carried out at the Biotechnology Resources for Arable Crop 
Transformation facility (BRACT, John Innes Centre). Transformation of plants was performed 
according to (Harwood et al., 2009), in which details of growth media and precise methods are 
given. In brief, immature embryos of barley Golden Promise were collected at a size of 1.5-2 
mm in diameter. A small drop of agrobacterium was added to immature embryos and excess 
agrobacterium was removed. Embryos were placed scutellum side down on plates containing 
callus induction medium and co-cultivated for 3 d at 23 °C in the dark. Material was 
transferred to plates containing hygromycin as the selective agent and timentin to remove 
agrobacterium from cultures. Embryos were cultured at 23 °C in the dark for 2 weeks then 
transferred to fresh plates and grown for a further two weeks. Embryos were transferred to 
fresh plates a third time and grown for six weeks.  Embryo derived callus was transferred into 
transition medium (containing hygromycin and timentin) and grown for 2 weeks at 23 °C with 
low light. At this point transformed lines produced small shoots and green areas. 
 
 
Figure 2.10 pBRACT204 vector used as control plasmid. 
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Plants were regenerated, embryo derived material was transferred to regeneration medium 
(containing hygromycin and timentin) and grown until shoots were 2-3 cm long. Plantlets were 
transferred to glass culture tubes and grown until strong roots formed. Plats were then 
transferred to soil and covered with propagators to keep humidity levels high and establish 
growth in soil. 
2.8.3 Plant growth conditions 
Plants were grown in barley growth mix, consisting of 2:2:1 mix of Levington M3 compost: 
Perlite: Grit. The mix also included slow release fertiliser, Osmoote, added following 
manufacturers recommendations. Seedlings were sown in 5 cm pots and potted on into 13 cm 
pots roughly 30 days later, using the same growth mix. Plants were grown in a controlled 
environment room set to 15 °C day and 12 °C night temperatures, 80 % relative humidity, light 
levels 500 µmol/m2/s1. 
2.8.4 Copy number analysis 
Young leaf samples were taken to provide DNA samples. DNA preparation and copy number 
analysis was performed by iDna Genetics (Norwich BioIncubator, UK) using g-count genotyping 
technology. This utilises quantitative real-time PCR using primers for the hygromycin 
resistance cassette present in the pBRACT T-DNA insertion sequence.  
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3 Chapter 3- Chemical Genetics in Planta Identifies Novel 
Iminosugar Inhibitors of Root Growth 
3.1.1 Iminosugars as Small Molecule Inhibitors of Carbohydrate Active Enzymes 
Iminosugars are sugar-like molecules in which the endocyclic oxygen is replaced by a basic 
nitrogen atom. These molecules have a varied structure and represent the largest class of 
carbohydrate mimics (Compain and Martin, 2007). Mankind’s exploitation of iminosugars 
began with the use of plant extracts as herbal remedies, these were only later revealed to 
contain high levels of iminosugars. One particular example is the white mulberry, Morus alba, 
one of the natural sources of deoxynojirimycin (DNJ) (Figure 3.1, B) (Asano et al., 1994b). The 
scientific interest in iminosugars began with early work on chemical synthesis of sugar 
derivatives containing heteroatoms (Jones and Turner, 1962, Paulsen and Todt, 1968). Shortly 
after this the first synthetic strategy for DNJ was outlined alongside the isolation of nojirimycin 
(NJ) (Figure 3.1, A) from Streptomyces (Paulsen, 1966, Ishida et al., 1967a, Ishida et al., 1967b). 
Interest soon turned to the use of iminosugars in medical applications following the discovery 
that DNJ inhibits α-glucosidase activity (Asano et al., 1994a). Advances in chemical synthesis 
and purification techniques have led to the modification of original scaffolds, enabling the 
generation of many iminosugar analogues and glycoconjugates (Gloster and Vocadlo, 2012).  
 
 
 
 
 
 
 
 
The presence of nitrogen within the ring gives some iminosugars a positive charge under 
physiological pH; the imino group is protonated forming a structure that mimics the 
oxocarbeneim ion transition state seen within glycosyl hydrolase enzymes (Figure 3.2, A) 
(Borges De Melo et al., 2006). Other iminosugars are mimics of a transition state shape (Figure 
3.2, B). There are also compounds that mimic both shape and charge. Further affinity and 
specificity can be driven by extension of a molecule, for example, hydrophobic aromatic or 
alkyl groups can be used to extend binding to cover an enzymes sub-sites (Gloster and 
Vocadlo, 2012). 
 
Figure 3.1 The structures of A. Nojirimycin and B. DNJ. 
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A wide range of other, non-iminosugar, α- and β- glucosidase inhibitors exist, these include 
carbasugars, pseudoaminosugars and thiosugars (Borges De Melo et al., 2006). Many covalent 
inhibitors for glycosidases have also been developed (Rempel and Withers, 2008). These 
molecules work by covalently trapping a substrate mimic within an enzymes active site (Figure 
3.3). Compounds that function in this way are of particular use as molecular probes for 
labelling of glucosidases in vivo, enabling activity based protein profiling (Chandrasekar et al., 
2014, Kallemeijn et al., 2012). This is a powerful method to identify functional targets within 
complex proteomes. 
 
 
 
 
Figure 3.2 Mechanisms of glycosyl hydrolase inhibition by iminosugars. 
A. Transition state charge mimic. DNJ is protonated to form a minic of the oxocarbonium transition state 
formed by glycosyl hydrolases. B. Transition state shape mimic.  Nojirimycin forms a half-chair transition 
state mimic. Adapted from (Borges De Melo et al., 2006, Gloster and Vocadlo, 2012). 
 
Figure 3.3 Mechanism of covalent glycosyl hydrolase inhibitor probes. 
A. Cyclophellitol-epoxide type. B. Cyclophellitol-aziridine type. Adapted from (Kallemeijn et al., 2012). 
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There are now many examples of iminosugars that have either been synthetically developed or 
identified and purified from numerous different plant sources (Kumar et al., 2012). Due to 
their ability to alter carbohydrate metabolism, iminosugars have shown potential as 
therapeutics for conditions such as cystic fibrosis, psoriasis, cancers, viral diseases, diabetes as 
well as genetic disorders in metabolism (Nash et al., 2011). Various iminosugar derivatives are 
currently in clinical trials (Nash et al., 2011). A select few iminosugars are approved drugs, 
these are outlined in Table 3.1 and Figure 3.4. 
 
Brand name Name Chemical name Use Reference 
Glyset Miglitol N-hydroxyethyl-DNJ 
Treatment of type II 
diabetes. 
(Nash et al., 
2011) 
Zavesca Miglustat N-Butyl-DNJ 
Treatment for Gaucher’s 
disease (sphingolipid 
metabolism). 
(Nash et al., 
2011) 
Galafold Migalastat Deoxygalactonojirimycin 
Treatment of Fabry disease 
(sphingolipid metabolism). 
(Winchester, 
2009) 
 
Table 3.1 Current iminosugars marketed as drugs. 
 
 
 
 
 
 
 
Figure 3.4 The structures of iminosugars marketed as drugs. 
Structures of A. Miglitol- N-hydroxyethyl-DNJ. B. Miglustat- N-Butyl-DNJ and C. Migalastat- 
deoxygalactonojirimycin. 
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3.1.2 The Effect of Iminosugars on Glycoprotein Processing 
N-linked glycoprotein processing occurs during the synthesis of membrane and secreted 
proteins (Peyrieras et al., 1983, Lerouge et al., 1998). The process begins with the 
cotranslational transfer of a Glc3Man9GlcNAc2 precursor from a dolicol carrier onto an 
asparagine residue of a protein containing the correct glycosylation sequence (Asn-X-Ser/Thr, 
where X is any of the canonical amino acids except proline) (Elbein, 1991, Medzihradszky, 
2008). Initial trimming begins in the endoplasmic reticulum (ER) with the removal of the 
outermost α-1,2 linked glucose unit by Glucosidase I. Glucosidase II then removes the two 
remaining α-1,3 linked glucose residues. The glycoprotein is then transported to the Golgi 
where it undergoes a number of hydrolytic trimming steps and is further processed by the 
addition of other carbohydrates (Figure 3.5). 
 
 
 
 
 
 
Figure 3.5 Proposed routes to the formation of complex N-linked glycans in plants. 
A preassembled oligosaccharide (Glc3Man9GlcNAc2) is transferred en bloc to the asparagine of a suitable 
protein. The first reactions occur in the endoplasmic reticulum (ER) and involve trimming of glucose 
residues via the actions of α-glucosidase I and II, alongside removal of mannose by α-mannosidase 3 
(MNS3). The glycoprotein is transferred to the Golgi and further trimmed by α-mannosidase I (two 
largely redundant forms found in Arabidopsis) (MNS1/2). Complex glycan formation is initiated by 
addition of GlcNAc by β-1,2-N-acetylglucosaminyltransferase I (GNTI). The glycan is then further 
trimmed (carbohydrate removal) and processed (carbohydrate addition) by Golgi α-mannosidase II 
(GMII), β-1,2-N-acetylglucosaminyltransferase II (GNTII), β-1,3-xylosyltransfrase (XYLT), core α-1,3-
fucosyltransferases (two largely redundant forms found in Arabidopsis) (FUT11/12), Lewis-type β-1,3-
galactosyltransferase (GALT1) and α-1,4-fucosyltransferase (FUT13) to produce a range of complex 
glycans. Adapted from (Strasser, 2014). 
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Numerous iminosugars have been shown to be capable of inhibiting steps in glycoprotein 
trimming and processing. N-methyl-DNJ is able to inhibit both human α-glucosidase I and II 
(Figure 3.6, A) (Peyrieras et al., 1983). 1,4-dideoxy-1,4-iminoarabinitol (DAB), a potent inhibitor 
of yeast α-glucosidase, has also been identified as having activity against ER α-glucosidase II, 
Golgi α-mannosidase I and II, and human digestive α-glucosidase (Asano et al., 1994a). 
 
Castanospermine (Figure 3.6, C) is isolated from the Australian legume Castospermum 
australae. When added to mammalian cell culture it prevents glycoprotein precessing, causing 
a build-up of Glc3Man9GlcNAc2 meaning the actions of glucosidase I and II were blocked, thus 
preventing further trimming (Sasak et al., 1985, Palamarczyk and Elbein, 1985). 
Castanospermine is also a potent inhibitor of lysosomal α-glucosidase and disrupts lysosomal 
glycogen degradation (Saul et al., 1985, Molyneux et al., 1986). 
 
α-homonojirimycin (α-HNJ) (Figure 3.6, D), alongside a glucosylated derivative (Glc-HNJ) were 
originally generated as potential diabetes treatments (Liu, 1987, Rhinehart et al., 1987). α-HNJ 
was evaluated for inhibition of N-linked oligosaccharide processing of viral glycoproteins 
influenza virus infected kidney cells. A build up in high mannose type viral glycoproteins 
proteins was produced, the predominant structure being Glc3Man9GlcNAc2, again representing 
inhibition of glucosidase I and II (Zeng et al., 1997). Viral envelope glycoproteins are essential 
for viron assembly and infectivity, DNJ, N-Bu-DNJ and castanospermine all show some antiviral 
effects in vitro (Taylor et al., 1991, Fischer et al., 1995). However issues arise with achieving a 
sufficiently high concentration, in vivo, to elicit an effect without generating side effects, such 
as diarrhea (Cook et al., 1995). Many other antiviral applications of iminosugars are being 
investigated (Mehta et al., 1998, Jacob et al., 2007, Qu et al., 2011, Chang et al., 2013) 
 
 
 
Figure 3.6 Structures of iminosugars which interfere with glycoprotein processing. 
A. Methyl-DNJ. B. DAB. C. Castospermine. D. α-HNJ. 
85 
 
3.1.3 Iminosugar Inhibitors of Lysosomal Storage Disorders  
A range of human genetic diseases are associated with disorders in lysosomal 
glycosphingolipid (GSL) metabolism. Lysosomes are membrane bound cytoplasmic organelles 
that are the major degradative compartment in eukaryotic cells (Kornfeld and Mellman, 1989). 
Disorders occur when mutation of one of the GSL glycosyl hydrolases blocks metabolism, these 
mutations affect protein folding and lead to build up of mutant proteins in ER or targets the 
protein for ER-associated degradation. This, in turn, causes a build-up of metabolites which 
cause symptoms such as osteoporosis and hepatomegaly (enlarged liver) (Bychkova and 
Ptitsyn, 1995). Examples of these diseases include Gaucher’s disease, Sandhoft disease, Tay-
Sachs disease and Fabry disease.  
 
There are a number of possible treatment strategies for lysosomal storage disorders. Enzyme 
replacement therapy offers one potential solution, however this is only useful for treatment of 
a disease absent of neuropathy as enzymes are unable to cross the blood-brain barrier (Brady, 
2006). This technique is also expensive. Pharmacological chaperone therapy offers another 
alternative. Intracellular activity of mutant enzymes can be restored by the addition of a 
competitive inhibitor that act as a folding chaperone to stabilise native folding in ER, thus 
allowing maturation and trafficking to lysosome (Fan, 2003, Cohen and Kelly, 2003). Gaucher’s 
disease is caused by mutations in the gene encoding glucosylceramidase (GCase) (Figure 3.7), 
resulting in glucosylceramide (GC) accumulation (Brady et al., 1966). N-Bu-DNJ acts as a 
chemical chaperone for GCase, however it also inhibits glucosylceramide (GC) synthesis by 
inhibiting the action of glucosylceramide synthase (GCS). 
 
 
 
 
Figure 3.7 The reactions catalysed by glucosylceramide synthase and glucosylceramidase. 
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The direct inhibition of GCS led to the development of a third treatment strategy, termed 
substrate reduction therapy (Aerts et al., 2006, Platt et al., 2001, Mceachern et al., 2007).  
N-Bu-DNJ lowers GC levels that can then be dealt with in mildly affected Gaucher’s sufferers 
(Platt et al., 1994a, Cox et al., 2000). GCS has become an established target for treatment of 
Gaucher’s disease. There are two archetypal GCS inhibitors: PDMP (Vunnam and Radin, 1980) 
and N-Bu-DNJ (Platt et al., 1994a) (Figure 3.8). Most reported inhibitors are based on these 
scaffolds. Reduction in GCS activity has been proposed to be beneficial to numerous disorders 
in lysosomal GSL metabolism by restricting flux through the pathway (Platt et al., 2001, Aerts 
et al., 2003, Aerts et al., 2006). 
 
 
 
 
 
 
 
 
 
 
Specificity of iminosugar drugs is important, inhibition of glucosidase I and II can affect 
glycoprotein processing (Fan, 2003). Further to this there are two forms of GCase: lysosomal 
(GBA1) and non-lysosomal (GBA2). Whilst GBA1 is responsible for Guacher’s disease, the 
precise function of GBA2 remains unclear (Korschen et al., 2013). DNJ derivatives with longer 
chains appended to the imino group enhance GCS inhibitory activity (Yu et al., 2006) 
(Overkleeft et al., 1998, Wennekes et al., 2007). In particular, N-5-(adamantane-1-yl-
methoxy)pentyl-DNJ (AMP-DNJ) (Figure 3.9) has been developed as a very potent inhibitor of 
GCS, however this was accompanied by increased potency against GCase. (Overkleeft et al., 
1998). 
 
 
 
 
Figure 3.8 The structures of the two archetypal glucosylceramide synthase inhibitors. 
A. PDMP. B. N-Bu-DNJ. 
 
Figure 3.9 The structure potent glucosylceramide synthase inhibitor AMP-DNJ. 
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In mouse models AMP-DNJ is also associated with markedly lower circulating glucose levels, an 
improvement in sensitivity to insulin and shows inhibitory activity towards digestive 
glucosidases (Wennekes et al., 2010). To improve the selectivity of AMP-DNJ towards GCS the 
potential that changing stereochemistry could lead to better inhibitors was investigated. 
Indeed, N-Bu-galacto-DNJ and N-pentyl-ido-DNJ had previously been shown to have activity 
against GCS (Platt et al., 1994b, Weiss et al., 2003). A panel of structural and stereochemical 
analogues of AMP-DNJ were generated and screened against a range of glycosidases. This 
included 3 epimers at C-4/C-5 positions (galacto, ido and altro) of AMP-DNJ with a range of 
N-alkyl substituents (Ghisaidoobe et al., 2011). 
 
Ido-AMP-DNJ (Figure 3.10) showed increased specificity towards GCS, compared to 
gluco-AMP-DNJ, with very little inhibitory activity against intestinal glucosidases or sucrase 
(Wennekes et al., 2010). Ido-AMP-DNJ was also 10-fold more specific for GCS over GBA1/2 
(Ghisaidoobe et al., 2011). Generation of partially deoxygenated DNJ derivatives revealed the 
C2 hydroxyl is important for GCS inhibition, whereas the C6 hydroxyl is much less important 
(Van Den Berg et al., 2011). These guidelines provide a foundation for the development of GCS 
inhibitors that have lower affinity or other glycoprocessing enzymes. 
 
 
 
 
 
 
 
 
Many of the compounds generated by Overkleef and collaborators have been grouped 
together into a library. This includes iminosugars that cover a large range of C2, C3, C4, C5 
stereochemistry alongside numerous N-alkyl and deoxygenated derivatives. This is one of the 
libraries that has been utilised within this study. 
3.1.4 The Effects of Iminosugars on Plants 
There have been very few studies on the effect of iminosugars on plants. One of the first 
examples involved castanospermine, this compound acts as a plant growth regulator causing 
inhibition of root elongation (Stevens and Molyneux, 1988). There is a distinct difference in the 
effective concentration between monocots and dicots (dicot 300 ppb, monocot 200 ppm) 
 
Figure 3.10 The structure potent glucosylceramide synthase inhibitor Ido-AMP-DNJ. 
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(Stevens and Molyneux, 1988). The reason for this difference remains unclear. Changes in 
N-linked glycoprotein processing have been reported in castanospermine treated plant cell 
cultures (Hori, 1984). Glucose trimming was prevented causing accumulation of 
Glc3Man7GlcNAc2. It has not been shown whether the root growth phenotype is directly linked 
to perturbed glycoprotein processing. 
 
The effect of N-hydroxyethyl-DNJ was tested on germinating wheat seeds (Konishi et al., 1994) 
and mung beans (Konishi, 1998). This produced lower levels of α-glucosidase activity, with 
accumulation of maltose and a decrease in the rate of starch degradation. This observation 
was further investigated within our group (Stanley et al., 2011). The effects of the inhibitors 
DNJ, NB-DNJ, and N-hydroxyethyl-DNJ were tested on germinating barley grains. Results 
showed a decrease in the glucose:maltose ratio implying inhibition of α-glucosidase activity. 
Starch levels were also elevated in inhibitor treated seeds. All three compounds inhibited root 
elongation in presence of exogenous sugars. This suggests the inhibitors have a direct effect on 
proteins in roots and growth inhibition is not simply due to lack of sugar required for growth 
(Stanley et al., 2011). DNJ in particular inhibited root growth strongly but shoot growth was 
similar to water treated grains (Figure 3.11). It was concluded the likely targets were enzymes 
involved in N-linked glycoprotein processing. 
 
 
 
 
Mutational analysis of Glucosidase I and II, which trim N-linked glycans within the ER, shows 
that both are required for normal embryo development in Arabidopsis (Burn et al., 2002, 
Furumizu and Komeda, 2008, Soussillane et al., 2009). In mutants that are capable of 
germination root growth is retarded (Burn et al., 2002, Furumizu and Komeda, 2008, 
Soussillane et al., 2009). Iminiosugars have been shown to be capable of inhibiting 
glucosidases I and II in other plant species (Mega, 2004). Radish leaves treated with DNJ show 
a correlation between trimming of glucosyl moieties within N-linked glycans and retardation of 
growth (Mega, 2005). 
 
Figure 3.11 The effect of DNJ on germinating barley root and shoot growth. 
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3.2 Aims of this Chapter 
Iminosugars have been shown to impact on plant germination, understanding how these 
molecules interfere with this process is of fundamental interest but also has real world 
application in the understanding of barley malting for the use in brewing and distilling. The 
currently identified targets for DNJ are glycosyl hydrolases involved in maltose breakdown and 
cell wall hydrolysis. There is a need to better understand the other in vivo targets for DNJ. 
Alongside this, the identification of novel inhibitors opens up new avenues for exploration and 
can be used to compare with existing inhibitors. 
 
This chapter presents the test of iminosugars against Arabidopsis, barley and tef root growth. 
The effect of DNJ on barley glycoprotein processing is also outlined. The use of Arabidopsis and 
tef as alternatives to barley has enabled the development of a medium throughput screen to 
detect compounds capable of inducing a stunted root growth phenotype. Novel iminosugar 
root growth inhibitors have been identified within a library of compounds developed by 
Overkleeft et al. Steps towards target identification for these novel inhibitors are also 
discussed. 
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3.3 Results 
3.3.1 DNJ Inhibits Root Growth in Barley and Arabidopsis in a Concentration 
Dependent Manner 
Previous data generated within our lab shows DNJ to significantly inhibit barley root growth 
after 10 days in the presence of 500 µM. To confirm this data and explore the effect of 
different DNJ concentrations, barley grains were germinated in the presence of 5 mM to 10 
µM DNJ (Figure 3.12). Root length was measured at 5 dpi (days post imbibition) or 10 dpi. 10 
dpi was utilised as this gives a more pronounced phenotype, 5 days was chosen as this is a 
more relevant time scale to that used in the malting process. 
 
5 mM DNJ blocked almost all root growth in grains grown for both 5 and 10 days, although 200 
µM was a high enough concentration of DNJ to significantly inhibit root growth. 100 µM DNJ 
was a high enough concentration to see a significant difference compared to water treated 
within the 10 day roots, however the difference at this concentration for 5 day grains is not 
significant. DNJ has a concentration dependent effect on both 5 day and 10 day samples. 5 
days germination gave much smaller root lengths, with a less pronounced growth difference 
between DNJ concentrations. Measuring growth at 10 dpi increases the likelihood of seeing a 
difference in growth. 
 
The effect of DNJ was also tested on Arabidopsis to determine whether the observed effects 
were specific to monocot species. Arabidopsis shows a stunted root phenotype, similar to that 
of barley. The concentration of DNJ required to elicit 50 % inhibition of root growth, compared 
to control, is 10-fold lower that is required than barley (20 µM vs 200 µM). The level of 
variation in root length measurements per condition is much higher with Arabidopsis, growth 
inhibition is only statistically significant at 200 µM and 500µM.  
 
 
91 
 
 
 
 
 
 
 
Figure 3.12 Barley and Arabidopsis root growth in the presence of DNJ 
A. Grains of barley were grown for 5 or 10 dpi in the presence of water (control) or DNJ. B. Arabidopsis 
was grown for 10 days on ½ MS Agar supplemented with DNJ or water (control). Values of root length 
shown are the mean value for 10 seedlings. Error bars represent SEM. Values marked with asterisks are 
statistically significant from the control (water) values (t-test, * P <0.05). 
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3.3.2 Glycoprotein Processing is Specifically Affected in DNJ Treated Barley Roots 
DNJ has previously been implicated to interfere with glycoprotein processing. To test whether 
the stunted root growth of barley grown in the presence of DNJ was associated with 
modification of N-linked glycans, the effect of 200 µM DNJ was analysed on root, shoot and 
endosperm samples from germinated grain. Soluble protein samples were generated from 
dissected tissue, treated to release the glycans from glycoproteins, and analysed by MALDI-ToF 
mass spectrometry.  
 
Two different enzymes were used to cleave N-linked glycans from glycoproteins (Figure 3.13): 
PNGase A, which cleaves the bond between the innermost GlcNAc and an Asn residue, and 
PNGase F, which cannot cleave when the innermost GlcNAc is linked to an α-1,3 fucose 
residue, as commonly seen in plant complex glycans. 
 
 
 
 
 
 
 
 
 
Samples treated using PNGase A showed no distinct differences in the glycan profiles for DNJ 
or H2O treated grains (Appendix), complex glycans were detectable within all samples and the 
relative levels are not affected by DNJ. 
 
When PNGase F was utilised to remove N-linked glycans, an a change in the relative intensity 
of peaks corresponding to masses of 2192 (Man8GlcNAc2) and 2396 (Man9GlcNAc2) compared 
to other peaks was specifically produced in DNJ treated root samples (Figure 3.14). This may 
be due to increased levels of 2192 (Man8GlcNAc2) and 2396 (Man9GlcNAc2) or a decrease in 
the prevalence of other glycans. No differences were detected between DNJ and H2O treated 
shoot or endosperm samples. Comparison of H2O treated root, shoot and endosperm samples 
also yielded no extreme differences in the glycan profiles (Appendix). Mannosidase digestion 
and MS/MS was utilised to confirm the identified masses were high mannose structures and 
not glucose containing structures of the same mass (Appendix). 
 
Figure 3.13 The specificity of PNGase A and F on N-linked glycans. 
Legend detail as for Figure 3.5. 
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Figure 3.14 Analysis of the glycans present on glycoproteins from barley roots treated with H2O or DNJ 
Grains grown in the presence of 200 µM DNJ, 5 dpi. Glycoprotein samples treated with PNGase F. 
Structures were confirmed by mannosidase digestion and MS/MS experiments. 
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3.3.3 Screening an Iminosugar Library Against Arabidopsis Identified Novel 
Inhibitors of Root Growth 
The Overkleeft library is a collection of 391 DNJ derivatives with different iminosugar 
stereochemistry and N-substitution. These compounds were designed to be active against 
glucosylceramide synthase, glucosylceramidase and other glycosidases of medical relevance, 
including those involved in diabetes. 
 
In an attempt to identify variants of DNJ with a more potent effect on plant growth, this library 
was blind screened, at a concentration of 10 µM, for perturbation of Arabidopsis root growth. 
From this library 6 compounds were identified as having a strong effect on root growth; a 
threshold of 50 % growth, compared to control, was used to define hit compounds, this 
produced a hit rate of 1.5 %. 
 
Three ido-configured sugars were identified from the screen (Figure 3.15). Compound 41 gives 
almost complete inhibition of root growth (8 % of control), germination occurred as small 
roots can be seen. This compound is only one carbon different from the potent GCS inhibitor 
Ido-AMP-DNJ: N-5-(adamantane-1-yl-methoxy)pentyl-ido-DNJ compared to N-5-(adamantane-
1-yl-ethoxy)pentyl-ido-DNJ (Ido-AEP-DNJ). The N-substituent of this molecule contains 17 
carbon molecules making it lipophillic. 
 
Three other ido configured compounds were identified within the screen (Figure 3.15). 
Compound 360, containing a 20 carbon N-substituent, gave 23 % of control. The other two ido 
compounds, 64 and 441, are identical and give 47 % and 36 % growth, respectively, when 
compared to control. The 11 % difference between these two compounds highlights the 
variation within the assay but also acts as a good internal control. Castanospermine, a known 
potent inhibitor of root growth, was also identified, giving 28 % growth, this acts a another 
internal control. 
 
One gluco configured DNJ variant (523), with a large lipophilic biphenyl group, gave 49 % 
growth compared to control. Other gluco configured compounds caused significant root 
inhibition, however these were not below the cut off of 50 % (Appendix). Using a 60 % cut off, 
12 extra hits are identified, 11 of these have biphenyl ring system. 
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Figure 3.15 Inhibition of Arabidopsis root growth by iminosugars from the Overkleeft library. 
A. The structures of compounds which inhibit root growth by more than 50 % of control. B. Images of 
the root growth phenotype. C. Mean values of root length in the presence of 10 µM inhibitor. Mean 
value from 10 plants. Error bars represent SEM. Values marked with asterisks are statistically significant 
from the control (water) values (t-test, * P <0.05). 
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3.3.4 Eragrostis tef: a Monocot Alternative to Arabidopsis Screening 
Arabidopsis does not use starch as the primary energy store within the seed, yet iminosugars 
are capable of interfering with starch metabolism (Stanley et al., 2011). As such, a monocot 
alternative for screening was sought. Grains including millet, Brachypodium and Eragrostis tef 
(tef) were tested, of these, tef was found to be the easiest to work with and gave the most 
reliable germination rates. 
 
The grains of the tef plant are of a very small size making them suitable for medium 
throughput screening (Figure 3.16) (G. Belay et al., 2009). α-amylase, β- amylase and LD 
activities have been identified in malted tef (Gebremariam et al., 2012, Gebremariam et al., 
2013), making it a good model for other cereals which utilise starch as their main energy 
reserve. Also the tef genome sequence has recently been published, identifying the closest 
cultivated relatives as sorghum, foxtail millet and maize (Figure 3.17) (Cannarozzi et al., 2014). 
 
 
 
Figure 3.16 Eragrostis Tef- the plant and seed size.  
A. Eragrostis tef plant. B. The seed size of: Barley, Hordeum vulgare. Millet, Setaria italica. Tef, 
Eragrostis tef. Arabidopsis, Arabidopsis thaliana. Scale bar: 1 cm. 
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Figure 3.17 Phylogenetic tree of all plants that have sequenced genomes. 
Data generated December 2014. Arrows highlight Arabidopsis, barley and tef. Branch lengths are not 
proportional to anything. Adapted from (Lyons and Freeling, 2008). 
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3.3.5 Comparison of Chemical Genetic Screens Performed Using Barley, Arabidopsis 
and Tef 
Barley is not amenable to high throughput compound screening, due to the size of the grain 
screening is limited to using one plate per condition and measuring growth by hand. 
Arabidopsis offers a convenient model to screen high numbers of compounds (Figure 3.18). 10-
12 seeds are grown in a 20 mm x 20 mm well of a 25 well plate, enabling the analysis of many 
different compounds or concentrations in one experiment. Plates can be digitally imaged and 
measured manually using a computer. Tef is a monocot that can be treated in same way as 
Arabidopsis and has similar attributes, however it is 7 days quicker to germinate (Figure 3.18). 
 
 
  
 
 
Figure 3.18 Comparison of barley, Arabidopsis and Tef for chemical genetic compound screening. 
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3.3.6 DNJ Inhibits Root Growth in Tef in a Concentration Dependent Manner, 
Similar to Barley and Arabidopsis 
Arabidopsis does not give statistically significant root growth inhibition in the presence of DNJ 
concentrations below 200 µM. Similar concentrations to this are required to elicit a 
comparable phenotype in barley, a much larger seed. This indicates a possible difference in the 
action of DNJ between dicots and monocots. Tef was germinated in the presence of a range of 
DNJ concentrations to compare growth inhibition with barley and Arabidopsis grown in similar 
conditions. 
 
Tef produces a similar trend to DNJ-treated barley (Figure 3.19). 50 % root inhibition is 
achieved at 10 µM, this is a 20-fold lower concentration required to elicit a similar phenotype 
in barley. At 10 µM DNJ, Arabidopsis root growth is not affected, this indicates a difference in 
the susceptibility to DNJ between monocots and dicots of similar grain size. 
 
 
 
 
 
 
 
Figure 3.19 Tef root growth in the presence of DNJ. 
A. Grains of tef were grown for 3 days on ½ MS Agar supplemented with DNJ or water (control). Values 
of root length shown are the mean value for 8 seedlings. Error bars represent SEM. Values marked with 
asterisks are statistically significant from the control (water) values (t-test, * P <0.05). 
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3.3.7 Screening an Iminosugar Library Against Tef Identified Inhibitors of Root 
Growth Similar to those Identified in Arabidopsis 
To determine the effect of a range of iminosugars in a monocot system a screen was 
performed using the Overkleeft library and tef. 391 iminosugar derivatives were screened at a 
concentration of 10 µM. 8 compounds were identified as hits, using a threshold of 30 % 
growth, compared to control. This generated a 2 % hit rate. 
 
All hit compounds identified are ido configured iminosugars (Figure 3.20). Compounds 41, 514 
and 540 (11 %, 27 % and 18 % of control, respectively) all possess an adamantane group with 
different length linkers. 4 compounds identified had alkoxy groups with lengths differing by 2 
carbons: 60, 433, 61/437. Two of these compounds have the same structure and, as with the 
Arabidopsis screen, act as an internal control. Compound 361 inhibited growth to 15 % of the 
control, this molecule contains a lipophilic bromophenyl group. 
 
Both the Arabidopsis and tef screens identified compound 41 (ido-AEP-DNJ) as the strongest 
inhibitor, making this a prime candidate for further analysis. When the results of both screens 
are compared a number of similar criteria are noted: a large proportion of the identified hits 
are ido configured and possess long N-substituents containing adamantane or alkoxy 
functional groups. In contrast castanospermine is not identified as an inhibitor of tef root 
growth, thus indicating differences between monocots and dicots. A larger number of 
compounds were found to have an effect on tef root growth, indicating monocots are more 
susceptible to inhibition by iminosugars. The second round hits, which failed to make the 
stringent 30 % cut-off, are gluco-configured (Appendix). 
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Figure 3.20 Inhibition of Tef root growth by iminosugars from the Overkleeft library. 
A. The structures of compounds which inhibit root growth by more than 30 % of control. B. Images of 
the root growth phenotype. C. Mean values of root length in the presence of 10 µM inhibitor. Mean 
value from 8 plants. Error bars represent SEM. Values marked with asterisks are statistically significant 
from the control (water) values (t-test, * P <0.05). 
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3.3.8 The Impact of Non-Iminosugar Glucosylceramide Synthase Inhibitors on 
Arabidopsis and Barley Root Length 
As the Overkleeft library was designed against GCS, and the most potent inhibitors identified in 
both Arabidopsis and tef screens are very similar to the lead compound for GCS inhibition (ido-
AMP-DNJ) it was hypothesised that the root growth inhibition was due to inhibition of GCS. 
Other, commercially available, non-iminosugar inhibitors of GCS were tested on Arabidopsis 
and barley.  
 
At a concentration of 10 µM PDMP (D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-
propanol) elicited a similar root growth phenotype to those seen with ido-iminosugars on 
Arabidopsis and tef (Figure 3.21), giving root lengths below 50 % of control. A 10-fold increase 
in concentration (100 µM) of PDMP (DL-threo-1-Phenyl-2-palmitoylamino-3-morpholino-1-
propanol) almost abolishes root growth, this is comparable with compound 41, the strongest 
ido-iminosugar.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.21 Inhibition of Arabidopsis root growth by non-iminosugar glucosylceramide synthase 
inhibitors.  
A. The structures of PDMP and PPMP B. Images of the root growth phenotype. C. Mean values of root 
length in the presence of inhibitor. Mean value from 10 plants. Error bars represent SEM. Values 
marked with asterisks are statistically significant from the control (water) values (t-test, * P <0.05). 
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The difference in alkyl chain length has an impact on the level of root growth inhibition seen 
within Arabidopsis. At 10 µM, PPMP (15 C alkyl chain) has small but not significant effect on 
root growth, this is almost a 3-fold decrease in potency compared to PDMP (7 C alkyl chain) 
(Figure 3.21). Significant inhibition of root growth is produced using 100 µM PPMP. 
 
When PDMP was tested on germinating barley (Figure 3.22) a concentration of 500 µM was 
required to elicit a significant phenotype after 5 or 10 day germination. This is 50-fold higher 
than the concentration required for significant inhibition in Arabidopsis.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.22 The effect of glucosylceramide synthase inhibitor PDMP on barley root growth. 
A. The structure of PDMP. B. Grains of barley were grown for 5 or 10 dpi in the presence of water 
(control) or PDMP. Mean values of root length in the presence of inhibitor. Mean value from 10 plants. 
Error bars represent SEM. Values marked with asterisks are statistically significant from the control 
(water) values (t-test, * P <0.05). 
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3.4 Discussion 
3.4.1 The Effect of DNJ on Glycoprotein Processing 
DNJ causes a proportional increase in mannosylated structures (high mannose, Man8GlcNAc2 
and Man9GlcNAc2) on glycoproteins from barley roots. Mannosidase digestion of these glycans 
confirms that they are indeed high mannose structures and not other glucosylated glycans. It 
would be expected that DNJ should act as a glucosidase I/II inhibitor, therefore giving rise to a 
build-up of glucosylated structures (Glc1-3Man9GlcNAc2), this does not appear to be the case. 
 
There are two direct ways to increase levels of high mannose glycans: the first is to inhibit their 
breakdown by preventing the actions of ER and Golgi α-mannosidase. The second would be to 
inhibit the synthesis of structures that are based upon Man9GlcNAc2: i.e. block the action of 
the glycosyltransferases that convert Man9GlcNAc2 to Glc1-3Man9GlcNAc2 during synthesis of 
the dolichol-P-P-linked glycan.  
 
The inhibitory activity of an iminosugar is not always specific with regard to carbohydrate 
configuration, for example gluco-configured DNJ is capable of the in vitro inhibition of 
α-galactosidase, a galactose specific enzyme (Kato et al., 2005). Furthermore 4 gluco-
configured iminosugars have been shown to be capable of inhibiting α-mannosidase II from 
Drosophila, three of these compounds- glucoimidazole, N-octyl-6-epi-valienamine and gluco-
hydroxyiminolactam were low µM inhibitors (Kuntz et al., 2008). There is a possibility that DNJ 
may be able to inhibit mannosidase in a similar way. 
 
The ER and Golgi mannosidases have been shown to be important for development in 
Arabidopsis (Liebminger et al., 2009). Three class I mannosidases are required for N-glycan 
processing and root development: ER-mannosidase I (MNS3) and golgi mannosidase I (MNS1 
and 2) (Liebminger et al., 2009). A double mutation (MNS1/MNS2) causes Man8GlcNAc2 
accumulation and a triple mutant (MNS1/MNS2/MNS3) causes the almost exclusive presence 
of Man9GlcNAc2. The triple mutant plant has a swollen root and impaired cell wall/pectin 
biosynthesis. Chemical inhibition with the α-mannosidase inhibitor kifunensine generated a 
similar phenotype (Liebminger et al., 2009). Mutation of the rice N-
acetylglucosaminyltransferase has also been shown to cause accumulation of high mannose 
glycans leading to defective post seedling development, incomplete cell wall biosynthesis and 
impaired cytokinin signalling (Fanata et al., 2013). These data support the hypothesis that the 
root growth inhibition caused by DNJ may possibly be due to mannosidase inhibition. 
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The alternative way to increase the concentration of Man9GlcNAc2 is to block the synthesis of 
lipid linked Glc3Man9GlcNAc2. Indeed, DNJ has been shown to inhibit the formation of 
Glc3Man9GlcNAc2-P-P-dolichol, leading to higher levels of Man9GlcNAc2-P-P-dolichol in human 
epithelial cell culture (Romero et al., 1985). A build-up of Man8 and Man9 structures has also 
been reported in mammalian thyroid slices in which energy deprivation has been induced by 
chemically uncoupling oxidative phosphorylation. The precise reason for the glycan build-up 
was not resolved but addition of exogenous glucose did not prevent accumulation (Spiro et al., 
1983). It is possible that oligosaccharyltransferase is able to transfer the Man9GlcNAc2 to 
proteins allowing for their identification on glycoproteins (Castro et al., 2006). It is not 
unbelievable that DNJ, a glucose mimic, could interfere with metabolism and induce a state of 
energy deprivation which leads to the build-up of Man9GlcNAc2. It remains unclear why the 
build-up of high mannose structures is restricted to the roots. There is the possibility that roots 
actively take up DNJ leading to high local concentration or shoots may be unable to take up the 
compound. DNJ may also be actively exported or metabolised in certain tissues. 
3.4.2 Differences in the Effects of Compounds on Barley, Arabidopsis and Tef 
The screen of a range of DNJ concentrations against barley, Arabidopsis and tef highlights 
differences in the susceptibility of monocots and dicots to iminosugars. The data presented 
herein indicate that Arabidopsis may be more resistant to effects of DNJ, requiring a higher 
concentration (when compared with tef, a monocot of similar size) in order to elicit a 
significant root inhibition response. This might be explained as Arabidopsis is a dicot organism 
which doesn’t rely on starch metabolism for germination and seedling growth, whereas DNJ 
has been shown to impact on starch metabolism in germinating monocots (Stanley et al., 
2011). DNJ does, however, affect Arabidopsis root growth indicating a universal mechanism for 
DNJ action, which exists across monocots and dicots. The effect of castanospermine on 
Arabidopsis and tef further highlights the difference between monocots and dicots. At a 
concentration of 10 µM, castanospermine causes significant inhibition of root growth in 
Arabidopsis but not tef. This phenomenon has previously been noted, with a 1000-fold higher 
concentration of castanospermine being required to inhibit monocot root growth (Stevens and 
Molyneux, 1988). These differences highlight why tef is useful as an alternative model for 
screening for cereal specific effects. 
 
The use of a large library containing similar compounds enables the analysis of structures to 
help understand how this relates to the function. The structures of similar hit compounds 
identified in both Arabidopsis and tef screens enable an understanding of the requirements for 
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potent root growth inhibition. 3 out of 6 hits in Arabidopsis and all of the 8 hits identified in tef 
are ido-configured iminosugars indicating this configuration is important for potent inhibition 
of root growth. The other recurring theme within the identified compounds is the presence of 
large, lipid soluble, N-substitiuents. These are likely important for compound uptake, enabling 
diffusion across cell membranes (Kornhuber et al., 2010). A similar phenomenon can be seen 
with the effect of GCS inhibitors PDMP and PPMP on Arabidopsis and barley root growth. An 
increase in alkyl chain length by 5 carbon atoms produces a 10-fold drop in the concentration 
required for effective inhibition. This the reflects the membrane bound nature of GCS. 
3.4.3 Glucosylceramide Synthase as a Target for Root Growth Inhibition in Plants 
The lead compounds identified from chemical genetic screens are ido-AMP-DNJ and ido-AEP-
DNJ, these compounds are some of the most potent inhibitors of mammalian GCS known 
(Wennekes et al., 2010, Ghisaidoobe et al., 2011). To test the hypothesis that inhibition of root 
growth is linked to inhibition of GCS, the effect of PDMP, a known mammalian 
glucosylceramide synthase inhibitor (Atilla-Gokcumen et al., 2011), was tested on Arabidopsis 
and barley, this presented a similar phenotype to that generated by ido-AMP-DNJ and ido-AEP-
DNJ. 
 
GCS from cotton and Arabidopsis have been biochemically characterised (Leipelt et al., 2001). 
To date, there is no literature precedent for the effect of iminosugars on GCS in planta. A 
number of studies have investigated the effect of PDMP on plants. PDMP is able to inhibit 
overexpressed Arabidopsis GCS both in vivo and in vitro. When treated with PDMP Golgi 
morphology and protein secretion are perturbed (Melser et al., 2010). PDMP also affects 
vacuole morphology in Arabidopsis root cells (Kruger et al., 2013). There is a possibility that GC 
mediated interference with the membrane structure of subcellular compartments is 
responsible for the inhibition of root growth. Very recently, mutants of GCS have been 
reported in Arabidopsis (Msanne et al., 2015). Null mutants were viable as seedlings with 
strongly reduced size but failed to develop beyond seedling stage. GC was proposed to be 
important for organ-specific cell differentiation, null mutants had altered Golgi morphology. 
The inhibited growth phenotype observed in the present study supports the proposal that the 
root growth inhibition caused by ido-AMP-DNJ is mediated by GCS inhibition, but further 
verification is required 
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3.4.4 Identification of Other Potential Iminosugar Targets  
The effect of an iminosugar is often attributed to inhibition of one or two enzymes within an 
organism, these are often easily assayed enzymes for which there is literature precedent. 
However, there can be numerous other targets capable of interacting with iminosugars within 
complex systems (Cruz et al., 2013). Recently a glycomimetic affinity enrichment proteomics 
technique (Figure 3.23) was developed to identify binding partners for N-Bu-DNJ (Cruz et al., 
2013). This drug has been shown to induce reversible, dose-dependent, infertility in certain 
mouse strains however other strains, with a different genetic background, were insensitive. 
The known targets for N-Bu-DNJ include: β-glucosidase 2, lysosomal acid β-glucosidase and 
GCS (Cruz et al., 2013). Using this proteomics technique 18 proteins capable of interacting with 
N-Bu-DNJ were identified, these were narrowed down to give 6 strong lead targets (Table 3.2). 
These previously unidentified targets identify plausible pathways for investigation to identify 
the cellular target responsible for the infertility side effect (Cruz et al., 2013). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.23 Identification of protein targets for iminosugars by glycomimetic affinity enrichment 
proteomics. 
Glycomimetic affinity enrichment proteomics involves the generation of an affinity resin containing the 
molecule of interest. This is generated by chemical synthesis of an inhibitor derivative containing a 
carboxylic acid group, which can then be coupled to an amino derivatised resin. Following this, the resin 
can be used to enrich protein targets from tissue samples. Targets are then identified by 2D-PAGE and 
mass spectrometry. From (Cruz et al., 2013). 
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Protein Name Function Reference 
Hypoxia up-regulated protein 1 
Hsp70 protein, directly regulates insulin 
and vascular endothelial growth factor. 
(Kobayashi 
and Ohta, 
2005) 
Junction plakoglobulin 
Junctional plaque protein involved in 
formation of tight junctions. 
(Kowalczyk 
et al., 1999) 
Heat shock-related 70 kDa protein 2 
Hsp70 protein, role during germ cell 
differentiation and necessary for 
progression of meiosis. 
(Vos et al., 
2008) 
Acid leucine-rich nuclear 
phosphoprotein 32 family member A 
Implicated in cell cycle progression, 
differentiation and apoptosis. 
(Reilly et al., 
2011) 
Protein SET (I2PP2A) 
Histone chaperone for nucleosome 
assembly, inhibits multifunctional protein 
phosphatase PP2A. Binds sphingolipids, 
including ceramide. 
(Saddoughi 
et al., 2013) 
T-complex protein 1 subunit zeta 
Chaperone involved in folding of tubulin 
and actin. 
(Gao et al., 
1992) 
 
Table 3.2 Targets of N-Bu-DNJ in mouse cells. 
Data from (Cruz et al., 2013). 
  
BLAST analysis reveals that plant orthologues exist for all of the proteins outlined above. Two 
of the plant orthologues have been studied: Protein SET and Hsp70. Plant SET/I2PP2A is 
member of family of nucleosome assembly proteins (NAPs), which plays a similar role to the 
mammalian protein in the dephosphorylation during heat shock response (Biro et al., 2012). 
Simultaneous knockout of two Arabidopsis NAPs generates a strong root inhibition phenotype 
alongside perturbed expression of around 100 genes, including some involved in root cellular 
organisation (Zhu et al., 2006). Plant 70-kDa HSPs are essential for plant development and 
thermotolerance in germinating seeds, T-DNA insertion knockout mutants cause impaired root 
growth, while knockout of the two genes for Hsp70 was lethal (Su and Li, 2008). 
 
Recently, a similar glycomimetic affinity enrichment proteomics technique has been utilised 
within our group to identify proteins from barley endosperm that are able to bind to DNJ 
(Andriotis, 2015, submitted to Plant Cell). The proteins, identified using mass spectrometry, 
were those responsible for hydrolysing barley endosperm cell walls. The identification that 
these proteins can be partially inhibited by DNJ explains the inhibition of endosperm starch 
metabolism caused by the iminosugar. 
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3.5 Future Directions 
3.5.1 Understanding the Targets of DNJ Action 
It is clear that DNJ causes an effect on glycoprotein processing. However, the mechanism by 
which this occurs and how this links to inhibition of root growth remains unclear. There is the 
potential that multiple enzymes in the N-linked glycan synthetic pathway are inhibited, DNJ 
may have effects on α-glucosidase I/II and α-mannosidase with different potency. Changing 
the concentration of DNJ used in experiments may reveal the concentration dependence of 
DNJs effect on N-linked glycans. Comparison of DNJ with other iminosugars which interfere 
with glycoprotein processing could be used to dissect the mode of action. The application of 
DNJ on Arabidopsis at different stages of growth may reveal how DNJ impacts on plant 
development. Furthermore, a T-DNA mutant library could be screened for enhanced 
susceptibility or resistance to the effects of DNJ which may help identify targets of inhibition. 
 
Affinity enrichment could be performed on root and shoot protein samples generated in the 
presence or absence of DNJ, this will enable a comparison which may help determine the 
reason for root specific effects. It remains likely that DNJ interacts with a number of other 
proteins within plants, glycomimetic affinity enrichment proteomics offers a useful technique 
which can be utilised to identify other targets responsible for the DNJ induced phenotype. 
Putative targets can be overexpressed in heterologous hosts and inhibition can be validated in 
vitro. 
3.5.2 Identification of the Target for Ido-DNJ Derivatives 
It is probable that ido-AMP-DNJ targets GCS within plants, which leads to the stunted root 
growth phenotype. Overexpression of plant GCS and in vitro inhibition will help validate GCS as 
the target for the ido-iminosugars identified in chemical screens. Glycomimetic affinity 
enrichment proteomics using ido-DNJ may reveal the specific targets for ido-configured 
iminosugars. Comparison of gluco-DNJ and ido-DNJ affinity enrichment will help elucidate 
similar and different protein targets of these molecules. 
3.5.3 Further screening using Tef 
As tef has proved to be a suitable plant for medium throughput chemical genetic screens, 
there is scope for the screening of numerous other compound libraries. This will enable 
comparison of the differences in response to different chemicals by monocots and dicots. The 
identification of specific growth inhibitors has potential implications in herbicide development 
and is not only for the malting and brewing scenario. 
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4 Chapter 4- In Vitro Chemical Genetics Reveals Potential 
Avenues for the Inhibition of Limit Dextrinase 
4.1 Introduction 
4.1.1 Iminosugars and Other Small Molecule Inhibitors on Barley Enzymes In vitro 
α-Amylase 
The inhibition of amylase has attracted a large amount of attention due to the potential for the 
treatment of diabetes and reduction of blood glucose levels (Jayaraj et al., 2013). Acarbose 
(Figure 4.1) is a potent amylase inhibitor from Actinoplanes sp. SE50/11 (Müller et al., 1980, 
Schwientek et al., 2012), this compound is currently marketed as Glucobay, a type II diabetes 
treatment. A number of compounds similar to acarbose, the acarviostatins, trestatins and 
amylostatin, have been identified in Streptomyces and show potential as amylase inhibitors 
(Deshpande et al., 1988, Geng et al., 2008). Study of these type of compounds has been 
transferred from mammalian systems to the study of amylases from other organisms including 
bacterial plant pathogens and plants. Acarbose and analogues thereof can be prepared by 
transglycosylation using cyclomaltodextrin glucosyltranferase (Yoon and Robyt, 2003), the 
products of these types of reaction are µM/nM range inhibitors, depending on the source of 
the α-amylase being assayed. 
 
 
 
 
 
 
 
 
 
 
 
The crystal structure of barley α-amylase I has been solved in complex with acarbose. The 
inhibitor was bound within the active site and also on a surface binding site (Kadziola et al., 
1998, Mori et al., 2001). The valienamine ring found within acarbose mimics the transition 
state of the enzymes substrate complex (Gloster and Davies, 2010). 
 
Figure 4.1 The structure of the barley α-amylase inhibitor acarbose. 
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More recently, a new class of amylase inhibitors has been discovered from a screen of 30,000 
extracts from terrestrial or marine organisms. This family of three glycosylated acyl-flavonols, 
named montbretins, inhibit human α-amylase with nM affinity (Tarling et al., 2008). The crystal 
structures of these compounds bound to α-amylase have been solved, this identified the 
myricetin (Figure 4.2, M) and caffeic acid (Figure 4.2, CA) moieties as important for forming 
H-bonds with the catalytic residues (Williams et al., 2015). 
 
 
 
 
 
 
 
 
 
 
 
 
β-Amylase 
The irreversible inhibition of β-amylase by 2’,3’-epoxypropyl α-D-glucopyranoside (α-EPG) 
(Figure 4.3, C) was reported some time ago (Isoda et al., 1987). To build upon this a series of 
chemically synthesised epoxyalkyl α-D-glycopyranosides were screened against barley 
β-amylase I (Rejzek et al., 2011). The most potent of these compounds was identified to be 
α-EBG (Figure 4.3, B), giving 100 % inhibition at 25 mM. The most potent non-covalent 
inhibitor, 4-O-α-D-glucopyranosyl moranoline (G1M) (Figure 4.3, A), was identified by 
screening libraries containing iminosugars, iminosugar glycosides and cyclodextrins. G1M 
produces 90 % inhibition at 1 mM. These three glycone site binding inhibitors (α-EPG, α-EBG 
and G1M) have been crystallised in complex with β-amylase (Rejzek et al., 2011). 
 
 
 
 
 
 
 
 
Figure 4.2 The structure of α-amylase inhibitor montbretin A. 
M. Myricetin moiety. CA. Caffeic acid moiety. 
 
Figure 4.3 The structures of β-amylase inhibitors 
A. G1M. B. α-EBG. C. α-EPG. 
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α-Glucosidase 
In order to identify inhibitors of barley α-glucosidase 2,157 compounds were assayed at 1 µM 
using a chromogenic substrate (pNP-Glucose), alongside this a range of commercially available 
α-glucosidase inhibitors were evaluated (Stanley et al., 2011). From these experiments two 
very potent inhibitors were identified: DNJ and α-homonojirimycin (Figure 4.4). The results of 
this screen were further extended to look at the effects of similar compounds in planta, as 
discussed in Chapter 3. 
 
 
 
 
 
Limit Dextrinase  
To date, very few potent small molecule inhibitors for LD have been identified. The 
cyclodextrins are established as the most potent inhibitors of LD, discussed in detail in Chapter 
5. The only attempt at generation of an LD inhibitor involved the chemoenzymatic synthesis of 
hemithiomaltodextrins. Only one of these thio-linked substrate mimics (Figure 4.5) inhibited 
LD activity, with a Ki of 0.5 mM, an inhibitory concentration similar to that of cyclodextrin 
(Greffe et al., 2002). 
 
 
 
 
Figure 4.4 The structures of barley α-glucosidase inhibitors. 
A. DNJ. B. α-homonojirimycin. 
 
Figure 4.5 Hemithiomaltodextrin inhibitor of limit dextrinase. 
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4.1.2 Protein and Peptide Inhibitors of Glycosyl Hydrolases 
Peptide and protein based inhibitors represent another avenue for the generation of potential 
inhibitors of LD. Numerous proteinaceous amylase inhibitors exist in nature, these fall into 
different categories- lectin-like, knottin-like, cereal-type, kunitz-like, gamma-purothionin-like, 
thaumatin-like (Svensson et al., 2004, Franco et al., 2002) and are found in both plant and non-
plant species. Indeed, a proteinaceous inhibitor of LD exists (limit dextrinase inhibitor). This, 14 
kDa, protein has been shown to bind LD with picomolar affinity and is discussed further in the 
results section of this chapter, alongside Chapters 5 and 6. This section focuses on shorter, 
peptide based glycosyl hydrolase inhibitors. 
 
Tendamistat, an amylase inhibitor from Streptomyces, has been the focus of numerous studies 
due to its potential in treating diabetes. This small protein is able to inhibit porcine pancreatic 
α-amylase with picomolar affinity (Machius et al., 1996). The crystal structure of this protein 
complex has been solved (Figure 4.6) (Wiegand et al., 1995), which enabled the rational 
development of cyclic hexapeptides that mimic tendamistat. All of the peptide mimics 
contained a WRY amino acid motif, the most effective of these inhibited α-amylase with a Ki of 
14 µM (Etzkorn et al., 1994). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6 The crystal structure of tendamistat bound to α-amylase 
Blue: Tendamistat. Pink: porcine α-amylase (PDB: 1BVN). 
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Other examples of small peptide inhibitors exist within the literature. A 22 amino acid, 
disulfide linked, peptide (EPCCDSCRCTKSIPPQCHCANI) based on mung bean trypsin inhibitor 
has been crystallised in complex with bovine trypsin (Li et al., 1994). Peptides based on the N-
terminal domain of ragi alpha-amylase/trypsin inhibitor (RATI) (SVGTSCIPGMA) show 
competitive inhibition in amylase assays (Alam et al., 2001). Optimisation studies of these 
types of inhibitors shows further potential for rational and de novo design of peptide inhibitors 
for GHs (Heyl et al., 2005). 
 
Modelling inhibitors based on known structures requires prior knowledge of existing 
structures. Combinatorial chemistry is another method that is used to access a broad range of 
chemical space not utilised by nature, the de novo α-amylase inhibitor designated PAMI was 
identified using this method (Figure 4.7) (Doleckova-Maresova et al., 2005). This peptide 
inhibits α-amylase and α-glucosidase enzymes from a range of sources including human, pig, 
Bacillus, Saccharomyces and Aspergillus. A lead hexapeptide containing a HWXXXX motif was 
optimised by iterative rounds of synthesis and screening to produce a peptide with the 
sequence GHWYYRCW that gave IC50 values at low µM level. The PAMI peptide has been 
further optimised to give RHWYYRYW. Docking simulation with the active site of PPA revealed 
the importance of the WYY motif (Ochiai et al., 2012). These inhibitors have been shown to 
bind in, or near to the active site however there is the possibility that they may also bind 
elsewhere on the proteins. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7 The structure of α-amylase and α-glucosidase inhibitor PAMI. 
Note the C-terminal end is protected with an amino group to prevent degradation by peptidases 
(Doleckova-Maresova et al., 2005). 
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4.1.3 Biochemical Assays of Limit Dextrinase 
Limit dextrinase was originally assayed using limit dextrins (Manners and Rowe, 1971). Since 
this point numerous assays have been developed utilising different substrates and analytical 
methods. The most commonly used assays can be divided into two categories: reducing end 
assays and chromophore based assays.  
 
Reducing End Assays 
The reducing end assay is used for analysis of numerous glycosyl hydrolases, the substrate 
used within this assay determines the specificity. Pullulan is utilised as the substrate for LD. 
The reducing ends released by hydrolysis are measured using BCA (Figure 4.8) or DNS (Figure 
4.9) methods (Doner and Irwin, 1992, Wood et al., 2012). Both methods have been shown to 
work on LD, however BCA produces more reliable results (Gusakov et al., 2011), suffers from 
fewer background issues and is more amenable to miniaturisation (Green et al., 1989). Issues 
do however occur when using complex protein samples, as reduction by peptide backbones 
can affect these assays (Doner and Irwin, 1992). 
 
 
 
Figure 4.8 The bicinchoninic acid reducing end assay. 
Pullulan is hydrolysed by the activity of limit dextrinase or another 1,6-debranching enzyme. This 
generates reducing ends which in turn reduce Cu2+ to Cu+. Bicinchoninic acid is able to form a lavender 
coloured complex with Cu+. The absorbance of this complex is measured at 565 nm. 
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Chromophore Based Assays 
The chromophore based assays (Figure 4.10) utilise pullulan- both the red pullulan and limit 
dextrizyme assays were developed by Megazyme (Mccleary, 1992) and utilise procion red MX-
5B linked pullulan and azurine crosslinked pullulan, respectively. The red pullulan can also be 
used in substrate-in-gel electrophoresis (zymography) (Furegon et al., 1994). The assays based 
on reducing ends and chromophores each have their own drawbacks. These chromophore 
based methods require either high quantities of LD or long incubation times due to the 
relatively low level/activity of LD in malt. 
 
 
 
 
 
 
Figure 4.9 The dinitrosalicylic acid reducing end assay. 
Pullulan is hydrolysed by the activity of limit dextrinase or another 1,6-debranching enzyme. This 
generates reducing ends. When DNS is boiled in the presence of a reducing agent the colour changes 
from yellow to orange/brown. The absorbance of this compound is measured at 540 nm. 
 
Figure 4.10 The red pullulan and limit dextrizyme chromophore based assays. 
The chromophore linked pullulan is hydrolysed by limit dextrinase or another 1,6-debranching enzyme. 
This releases soluble chromophore linked fragments. These can be extracted and measured at 510 nm 
(procion red MX-5B) or 590 nm (azurine). Pink circle represents chromophore. 
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Advances in technology and synthetic methods have led to the development of new substrates 
for the assay of LD. A FRET based assay has been reported (Bøjstrup et al., 2012) however this 
is not commercially available. More recently, colourimetric/fluorimetric assay methods have 
been independently implemented by two groups for assay of pullulanase (PUL) and LD 
(Bojstrup et al., 2014, Mccleary et al., 2014). Both of these assays are based on maltotriosyl-
maltotriose derivatives, which are more similar in structure to the proposed natural substrate 
of LD (Figure 4.11). Mangan et al developed a non-reducing end blocked substrate, 
benzylidine-maltotriosyl-maltotriose, which is resistant to hydrolysis by exo-acting enzymes 
(Mangan et al., 2015). These substrates have been shown to be sensitive and specific for the 
activity of PUL and LD and are applicable to high throughput, miniaturised assays. Furthermore 
they are believed to be unaffected by transglycosylation (Mangan et al., 2015, Mccleary et al., 
2014). 
 
 
 
Figure 4.11 The hexachrom maltotriosyl-maltotriose assay of limit dextrinase. 
This assay involves the cleavage of a 1,6-linkage present in 4-nitrophenyl-63-α-D- maltotriosyl-
maltotriose. This opens the substrate up to breakdown by glucosidses which release the nitrophenyl 
group that is measured at 405 nm. A fluorescent, methylumbelliferyl, variant of the substrate is also 
available. 
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4.2 Aims of this Chapter 
Recent work on the inhibition of barley glycosyl hydrolases has identified a number of potent 
inhibitors for α-amylase, β-amylase and α-glucosidase. These inhibitors have been used as 
tools, alongside genetics, to dissect the role of enzymes in carbohydrate metabolism during 
grain germination. To date, no potent (µM/nM) small molecule inhibitors have been identified 
for LD.  
 
Currently the only known inhibitors for LD are cyclodextrins and thio-oligosaccharides. 
Iminosugars may have the potential to inhibit LD but have not been studied in any great detail. 
Proteinaceous inhibitors exist for numerous amylases and other GHs and represent another 
potential avenue for the development of novel inhibitors. As LD plays an important role in the 
hydrolysis of 1,6-glucans during malting and mashing the potential to inhibit or chaperone the 
protein may enable regulation of 1,6 branched glucan levels. It is also possible that an inhibitor 
could prevent the interaction between LD and LDI. A specific inhibitor would prove a useful 
tool to understand the biochemical role of LD during germination and starch synthesis, this 
would complement the genetic knock-down approach outlined in Chapter 6. The objectives of 
this chapter were twofold: firstly, to identify the effects iminosugars have on LD activity, 
secondly, to develop peptide inhibitors capable of inhibiting LD. 
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4.3 Results 
4.3.1 Limit Dextrinase is Strongly Inhibited by Cyclodextrins but not Iminosugars 
DNJ and G1M 
Preliminary screens performed using recombinant LD expressed in Pichia pastoris (Vester-
Christensen, 2010) were performed using an in-house library of iminosugars with potential 
activity against amylases and glucosidases (Appendix) (carried out by Malene Vester-
Christensen). This screen identified only two compounds that were capable of inhibiting LD 
activity by more than 20 % at a concentration of 1 mM, G1M- a glucosylated variant of DNJ and 
a glucose linked to a triazole amine (SD93). DNJ was screened within this assay and gave no 
inhibition; α-, β- and γ- CD were used as the positive controls within the screen. 
 
Recombinant LD was utilised in a BCA assay in order to confirm the effect of cyclodextrins, DNJ 
and G1M. SD93 was not further pursued due to limited compound availability. The data from 
an assay performed with 1 mM of inhibitor produced the results in Figure 4.12. β-CD was the 
strongest inhibitor of the three cyclodextrins tested, giving 95 % inhibition of LD activity. α-CD 
and γ-CD gave around 85 % inhibition. The iminosugar DNJ showed almost no inhibitory effect 
(5 % inhibition) whereas G1M, the α-1,4-glucosylated form of DNJ gave 30 % inhibition, 
indicating that extension of the iminosugar is a potential way enhance enzyme inhibition. 
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Figure 4.12 Percentage inhibition assay of limit dextrinase in the presence of cyclodextrins and 
iminosugars. 
A. Structures of inhibitors used in the assay. B. All compounds tested at 1 mM. Assay was incubated at 
30 °C for 30 min, 0.1 mg/mL pullulan, 4 nM recombinant LD. Reactions were monitored by BCA assay. 
Error bars show SEM calculated from three replicates.  
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4.3.2 Iminosugar Inhibitors have an Inhibitory Effect on Pullulanase and Limit 
Dextrinase Activity at High Concentrations  
The iminosugars G1M and G2M were synthesised by enzymatic transglycosylation using DPE1 
and DPE2 from Arabidopsis. (Latousakis, 2013, Tantanarat et al., 2014). These compounds 
were tested in a BCA assay for their ability to inhibit LD and Klebsiella planticola pullulanase 
(KpPUL). LD and KpPUL show similar patterns of inhibition, some differences arose due to the 
differences in specificity of each enzyme. At lower concentrations of inhibitor (0.001-0.1 mM) 
enzyme activity was high (above 60 %) (Figure 4.13). As the concentration of inhibitor 
increased enzyme inhibition became more pronounced, with G2M inhibiting LD and KpPUL by 
90 % and 95 %, respectively at 1 mM (Figure 4.13, B and C). β-CD shows inhibition one order of 
magnitude stronger than the iminosugars for LD whereas within the KpPUL assay G2M and 
G1M are stronger inhibitors than β-CD. 
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Figure 4.13 Inhibitory assay with pullulanase and limit dextrinase using iminosugars of different 
length. 
A. Structures of the inhibitors tested in this assay. Assay performed with B. KpPUL, 0.1 U. and C. LD, 4 
nM. Assay reactions were incubated at 30 °C for 30 min, 0.1 mg/mL pullulan. Reaction was monitored 
by BCA assay. Error bars show SEM calculated from three replicates. 
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4.3.3 Peptide Amylase Inhibitor is able to Inhibit Limit Dextrinase Activity  
The peptide based inhibitor (PAMI, sequence- GHWYYRCW-NH2), discussed in the introduction, 
has previously been shown to inhibit mammalian and bacterial α-amylase. This peptide was 
tested for the ability to inhibit LD. PAMI produced an IC50 of around 250 µM (Figure 4.14), 
making this one of the strongest inhibitors of LD identified so far. The inhibition is within a 
similar (µM) range to the strongest known LD inhibitor, β-CD, however there is still a distinct 
two fold difference in their inhibitory ability (Figure 4.14). 
 
The concentration of LD used in this assay was increased to 10 nM to help overcome issues 
caused by high background, caused by the reducing potential of the peptide backbone of 
PAMI, this explains the difference in the inhibitory ability of β-CD when compared to other 
assays.  
 
 
 
 
 
Figure 4.14 LD inhibitory assay comparing the effects of PAMI and β-CD 
A. Structure pf PAMI inhibitor peptide. B. BCA assay was incubated at 30 °C for 30 min, 10 nM LD and 
0.1 mg/mL pullulan. Reaction was monitored by BCA assay. Error bars show SEM calculated from three 
replicates.  
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4.3.4 Attempts to Crystallise Limit Dextrinase in Complex with PAMI  
Attempts to obtain a crystal structure of LD in complex with PAMI were made with support 
from collaborators (Marie Møller, DTU). Crystals were formed by hanging drop vapour 
diffusion and soaked with 1 mM PAMI. Crystals were obtained and successfully diffracted to 
4 Å resolution, however, due to problems with the collection of diffraction data, a full dataset 
could not be obtained. 
4.3.5 Peptides Based on the Sequence of Limit Dextrinase Inhibitor show Partial 
Inhibitory Activity Against Limit Dextrinase 
Prior to the publication of the LD/LDI complex crystal structure, data regarding the residues 
involved in the interaction was shared in the form of an interaction diagram (Figure 4.15, 
Figure 4.16) (Møller et al., 2015a). The interacting residues are highlighted within the entire 
protein structures in Figure 4.15. The information on the amino acid contacts was used to 
inform the design of peptide inhibitors of LD based on the structure of LDI. A patch of 12 
amino acids (RGPSRPMLVKER, corresponding to residues 34-45 of the LDI crystal structure) 
within LDI was found to be responsible for almost half of the interactions with LD, these 
interactions were composed of a selection of ionic, hydrogen bonding and hydrophobic 
contacts (Figure 4.15). A dodecapeptide (LDI12) based on this sequence was purchased, 
alongside hexameric (LDI6) synthetic truncations of the peptide covering residues 1-6, 4-9 and 
7-12 of the dodecapeptide (Figure 4.17, A 1-5) (LDI1-6, LDI4-9, LDI7-12). The hexameric truncations 
were generated in an attempt to infer which residues of the dodecapeptide may confer 
inhibitory activity. An L8W mutant was also generated (LDI4-9W), the corresponding LDI (L42W) 
mutant for this was reported to have stronger binding to LD than wild type LDI (Marie Møller, 
personal communication). 
 
  
 
Figure 4.15 Map of the interactions within the limit dextrinase/limit dextrinase inhibitor complex.  
LD and LDI complex interface contacts, including salt bridges, H bonds and hydrophobic contacts within 
4.0 Å (dotted line). LDI peptide is also represented, corresponding amino acids are shown by arrows. 
There are 41 interactions in total. Numbering corresponds to that found in the crystal structure (Møller 
et al., 2015a). 
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The peptide inhibitors were tested in a BCA assay and showed partial inhibition of LD (10-30 % 
inhibition) at 1 mM concentrations (Figure 4.17). RGPSRP (Figure 4.17, A 1) gives the strongest 
inhibition (30 %) of the five peptides. The dodecapeptide (Figure 4.17, A 5) gives 20 % 
inhibition. The tryptophan containing ‘mutant’ peptide gives stronger inhibition than the 
corresponding leucine containing compound, with a difference of 10 % (Figure 4.17, A 2 vs 4). 
None of the peptides gave inhibition comparable to PAMI and β-CD, which give 75 % and 80 % 
inhibition of LD, within this assay. 
 
Figure 4.16 3-D structures of limit dextrinase and limit dextrinase inhibitor and the residues involved 
in their interaction.  
Residues within a 4 Å distance were deemed as interacting. Amino acid side chain labelling: Red- Acidic. 
Blue- Basic. Green-polar. Orange- Nonpolar. Numbering represents the LDI helices in order from N to C 
terminus. 
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Figure 4.17 Limit dextrinase BCA activity assay in the presence of limit dextrinase inhibitor peptides. 
A. Structures of the LDI peptides. Numbers in brackets represent the number of interactions the 
peptide contributes to the binding of LDI to LD within the crystal structure. B. BCA assay of LD with LDI 
peptides, designed using the structure of LDI. Assay was incubated at 30 °C for 30 min, buffer 0.1 
mg/mL pullulan, 4 nM LD. Inhibitors were at 1 mM. Reaction was monitored by BCA assay. Error bars 
show SEM calculated from three replicates. 
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4.3.6 Molecular Modelling Reveals that Peptide Inhibitors have a Flexible Structure 
Previous work on peptide inhibitors of glycosyl hydrolases has revealed that secondary 
structure is important to the inhibitory activity of peptides (Etzkorn et al., 1994). Both PAMI 
and the LDI peptides show potential as inhibitors but may, however, not possess the optimal 
spatial orientation to bind LD with high affinity. The length of the inhibitors may be an 
important factor; longer peptides tend to form stable secondary structures, whereas small 
peptides are often of a more flexible nature (Huang and Nau, 2003). Secondary structure has 
implications in presenting amino acid side chains in the correct orientation to give optimal 
binding. 
 
To assess their secondary structures, the sequences for PAMI and LDI peptides were analysed 
using peptide folding modelling software which generates the 5 best predicted structural 
models. An additional glycine residue was added to make the PAMI peptide a suitable length 
for secondary structure prediction, a minimum of 9 amino acids are required by the program. 
Of the 5 models generated for PAMI (Figure 4.18, A), only one has a secondary structural 
element, a short helix. It is likely that PAMI has a flexible loop like structure. 
 
The LDI hexapeptides were too short to be modelled, the addition of three extra amino acids 
was considered too much of a deviation from the original short sequences. Two of the five 
predicted models for the LDI12 peptide have a helical structure (Figure 4.18, B), these two 
structures superimpose well. When the backbone of best model for LDI12 (Figure 4.18, green) is 
overlaid on the corresponding residues within the LDI crystal structure the short helix overlaps 
with the helix of LDI that interfaces with LD. However the helix of LDI12 extends beyond that of 
LDI by two amino acids this may lead to incorrect presentation of amino acid side chains and 
act to prevent optimal binding to LD. The other models generated have a much less defined 
structure, meaning there is a chance that LDI12 does not form a helix in solution. 
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4.3.7 Molecular Modelling Based on the Structure of Limit Dextrinase Inhibitor 
The publication of the LD/LDI structure enabled further modelling studies. Using the LDI crystal 
structure as a guide, a number of peptides were designed and modelled to compare their 
predicted structure to that of LDI. A core helix dodecamer (LDIHelix) and an extended helix 
(LDIHelixEx) were first analysed. The extended helix peptide includes the LDI12 peptide that was 
previously tested (Figure 4.17) and shown to partially inhibit LD. The models generated for 
both peptides all contain helical structural elements with the best models overlapping neatly 
with the backbone of LDI (Figure 4.20, C and D). 
 
The LDI crystal structure indicates that disulfide bonds are important linkers which hold the 4 
helices of LDI in shape. There is potential that the disulfides can be used to generate truncated 
peptides that maintain the native conformation of LDI.  
 
 
Figure 4.18 Molecular modelling of the 3-D structures of limit dextrinase inhibitor peptide and PAMI 
A. PAMI, the 5 strongest molecular models superimposed. B. LDI12 peptide Left, the 5 strongest 
molecular models superimposed. Right, the best model superimposed on the corresponding residues of 
limit dextrinase inhibitor (PDB: 4CVW) RSMD= 4.516. Numbering represents the helices in order from N 
to C terminus. 
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The sequence of LDI helixes 1 and 2, linked by a native disulfide, was first chosen as a potential 
peptide (LDI35C-C). The models produced using this sequence, with disulfides linked, indicate a 
β-sheet type structure that has no similarity to the LDI structure (Figure 4.20, A). A non-
disulfide linked variant of this sequence (LDI35) was also modelled, this too had a β-sheet type 
structure and does not mimic the structure of LDI (Figure 4.20, B). 
 
A larger disulfide linked peptide (LDI35C-C) was designed to test the hypothesis that a second 
helix (helix 1, Figure 4.18) within LDI may be important for holding helix 2 in the correct 
conformation. The close proximity of two cystine residues within the LDI structure led to the 
design of a non-native disulfide linkage between Cys 2 and 6 (Figure 4.19). The models 
generated using this peptide all possess a two helical structure. The best of these models 
overlays extremely well with LDI. A non-disulfide linked variant (LDI35) also overlays well with 
LDI but has a less rigid structure compared to the disulfide linked variant.  
 
Figure 4.19 Cysteine and cystine residues present in barley limit dextrinase inhibitor. 
Cystine disulfide bonds (solid underline) are formed between cys residues 1-6, 2-4, 3-8, 5-9. cysteine 7 
(dashed underline) is found coupled to either a free cysteine or glutathione via a disulfide bond. The 
non-native, 2-6, disulfide used in the LDI35C-C peptide is shown in blue.  
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Figure 4.20 The sequences and 3-D structural models of potential limit dextrinase inhibitory peptides.  
Left. Sequence of peptides designed using the sequence of LDI. Middle. Overlay of the 5 strongest 
peptide models. Right. The structure of the best model superimposed with LDI. RSMD values: A. 7.146, 
B. 7.599, C. 0.553, D. 1.092, E. 6.638, F. 7.451. 
138 
 
4.4 Discussion 
4.4.1 Inhibition of Limit Dextrinase by Iminosugars 
Iminosugars inhibit numerous glycosyl hydrolases at low (pM to µM) concentration. These 
compounds have been utilised to gain a deeper fundamental understanding of this class of 
enzymes, as well as having established commercial application as therapeutic agents (Nash et 
al., 2011). No iminosugar type inhibitors have been developed against α-1,6-linked glucose 
acting enzymes from plants. This chapter outlines the first example of the strong inhibition of 
LD by an iminosugar.  
 
Preliminary screens revealed that very few compounds within a library of synthetic and natural 
molecules, directed against starch active enzymes, appear able to inhibit LD at concentrations 
lower than 1 mM. DNJ, one of the compounds present in this library, showed no inhibitory 
activity towards LD, for instance. G1M, a glucosylated derivative of DNJ, however, showed 
potential as one of the only compounds capable of LD inhibition, albeit at a relatively high 
concentration of 1 mM. The inhibition of LD activity by G1M is likely indicative of binding to 
the active site as iminosugars act as transition state analogues; the imino group is protonated 
to form a structure that mimics an oxocarbenium ion. Within a crystal structure of barley β-
amylase, G1M was bound at subsites -1 and -2 within the substrate binding site (Rejzek et al., 
2011). LD is capable of performing transglycosylation reactions using a matlosyl fluoride donor 
and G1M as an acceptor to generate maltosyl-1,6-G1M this indicates likely binding at the +1, 
+2 subsites (Vester-Christensen, 2010). The precise binding site of G1M within the LD substrate 
binding site remains unclear. 
 
The extension of G1M via transglycosylation, mediated by Arabidopsis disproportionating 
enzyme (DPE 1), generated G2M. G2M is a stronger inhibitor of LD than G1M, this higher level 
of inhibition is likely due to the presence of an extra glycosyl moiety which increases the 
number of potential interactions that can form between inhibitor and enzyme. As with G1M, it 
is likely that G2M binds within the substrate binding site thus blocking substrate binding. There 
is potential for binding in the -1 to -3 or +1 to +3 subsites (Figure 4.21). 
 
G2M gives stronger LD inhibition than seen with any other iminosugar, associated with the 
observation that maltodextrins of higher DP are more effective inhibitors of LD (Dunn and 
Manners 1975). The increase in inhibition by increasing iminosugar length, as seen within this 
study, confirms this observation and supports the proposal that LD has a binding preference 
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for fragments of four/five glucose units in length (Manners and Yellowlees, 1971). Crystal 
structures of LD bound to maltotetraose have been solved confirming that molecules of these 
sizes can fit in the active site of LD (Møller et al., 2015b). Crystal soaks with different 
concentrations of maltotetraose revealed both high and low affinity sites binding sites, at a 
low concentration (25 mM), maltotetraose is seen in the main chain binding subsites (0’, +1, 
+2, +3) Figure 4.21. Wereas at high concentration (300 mM) glucose residues can also be fitted 
in to density seen within the branch chain binding site (-2, -3, -4) (Møller et al., 2015b). It is 
therefore likely that G2M binds within the main chain binding site at the concentrations used 
within this study. 
 
 
 
 
 
LD catalyses both transglycosylation alongside hydrolysis, as is identified by the generation of 
higher Mw products when maltotriosyl-APTS is incubated with LD in the presence of pullulan 
(Mcdougall et al., 2004). There is therefore potential for transglycosylation to mask true 
inhibition values by transferring an inhibitor onto to other glucans, this activity can also 
interfere with the release of reducing ends that are measured in the BCA assay used herein. 
 
β-CD was used as a positive control throughout the assays reported herein and remains one of 
the strongest identified LD inhibitors. The crystal structure of LD in complex with α and β-
cyclodextrin revealed these molecules bind at the +1 and +2 sub-sites (Vester-Christensen et 
al., 2010a). Cyclodextrins are proposed to mimic the structure of an α-glucan helix (Vester-
Christensen et al., 2010a). It is not fully understood how the intricate differences between α, β 
γ CDs relate to LD binding preferences. The differences in β-CD inhibition level between LD and 
PUL arise because of differences within the enzymes active sites (Manners and Yellowlees, 
1971). 
 
Figure 4.21 The sub-site numbering of the limit dextrinase binding cleft. 
The hydrolysed bond is indicated by an arrow. Numbering follows the rules set out by (Davies et al., 
1997). The non-main chain (side chain) is identified by (‘). 
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4.4.2 Inhibition of Limit Dextrinase by PAMI 
Peptide amylase inhibitor (PAMI) is a good general inhibitor of a number of glycosyl hydrolases 
within CAZy database family GH13, it has also been shown herein to be a good inhibitor of LD. 
Analysis of the PAMI inhibition of α-amylase showed a non-competitive mode of inhibition 
which suggests that some of the active site is blocked by the molecule (Doleckova-Maresova et 
al., 2005). Hydrophobic interactions, aromatic stacking and ionic/polar interactions were also 
important for the binding. A similar combination of interactions may be involved in the 
inhibition of LD. LD belongs to the same CAZy family (GH13) as α-amylase and shares some 
structural similarities, including acidic catalytic residues. The arginine residue of PAMI may be 
important for interacting with these amino acids, as is seen with barley amylase-subtilisin 
inhibitor (BASI) in complex with α-amylase (Abe et al., 1993) and LDI in complex with LD 
(Møller et al., 2015a). Hydrophobic residues (WYF) are also implicated as being important 
between peptide inhibitors and their targets, these residues are seen in high levels in 
numerous peptide based amylase inhibitors (Etzkorn et al., 1994, Wong et al., 1999, Heyl et al., 
2005, Ochiai et al., 2012). 
 
The molecular modelling reported herein indicates PAMI has a flexible structure, how the 
structure of this peptide relates to binding is unknown. The generation of a crystal structure 
with PAMI bound to LD could have answered some of these questions, crystallography was 
attempted, however, during the collection of diffraction data the crystal collapsed and the 
quality decreased beyond use. 
4.4.3 Inhibition of Limit Dextrinase by Peptides Based on the Sequence of Limit 
Dextrinase Inhibitor 
Peptides designed based on the LDI sequence were generated without knowledge of the LDI 
3-D structure, only details on the amino acid interactions were available at the time. As such, 
peptides containing the amino acids contributing highest number of interactions were chosen 
for analysis. Of the 5 peptides generated, LDI1-6 gives the highest inhibition. This peptide 
contains two arginine residues which account for 7 interactions with the residues of LD, 
including the catalytic acid residues, within the LD/LDI crystal strucutre. The three other 
hexameric peptides give weaker inhibition of LD, these peptides have a higher proportion of 
residues involved in LDI helix 2, and may potentially contain a small helix which could cause 
incorrect presentation of an arginine residue. The LDI hexapeptides are too short to model, 
however, alpha helical conformations have been seen in other peptides of this length (Esteve 
et al., 2001). 
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The mutation of LDI residues L41D and V42D causes an almost 500,000 fold decrease in LD 
binding affinity, determined using SPR (Møller et al., 2015a), is not clear that these residues 
are important in the peptides used in this study. The peptide based on an LDI L42W mutant 
(LDI4-9W) has slightly stronger inhibitory activity, which would be expected given that the 
corresponding LDI mutant binds to LD with higher affinity than the wild type (Marie Møller, 
personal communication).  
 
The LDI12 peptide would be expected to give stronger inhibition than the hexamers due to the 
presence of more interacting residues, however, this is not the case. A possible reason for the 
weaker inhibitory ability of LDI12 compared to LDI1-6 may be that the larger peptide forms a 
secondary structure which hinders binding. To test this hypothesis the structure of LDI12 was 
modelled which revealed a potential helical element that was seen to extend beyond helix 2 of 
LDI when overlaid (Figure 4.18). The extension of the helix may place residues important for 
the interaction with LD in an incorrect orientation. 
 
4.4.4 Molecular Modelling for the Design of Potential Peptide Inhibitors of Limit 
Dextrinase 
The publication of the LDI structure in complex with LD enabled better design of potential 
inhibitors using molecular modelling. The majority of the interacting residues of LDI lie within 
helix 2 and the loop linking this and helix 1 (Figure 4.16), this is the region on which LDI12 was 
based. 
 
It was believed that the precise helical nature of LDI is important to achieve correct 
presentation of the amino acids required for interaction with LD. To analyse this, a peptide 
including the residues of helix 2 was modelled (LDIHelix), an extended version of this peptide 
was also analysed (LDIHelixEx). The short helix formed an almost perfect match with the LDI 
structure whereas the extended helix shows extension beyond that of LDI, as seen within the 
LDI12 peptide. 
 
From analysis of the LDI structure it can be proposed that helix 1 is important for ensuring the 
correct residue presentation of helix 2 and acts to break the helix at the correct point. Helix 1 
and 2 are linked by a disulfide bond between cysteine residues number 2 and 4; the LDI 
sequence between these two residues, when modelled, generates a β-sheet structure with 
(LDI24C-C) (Figure 4.20) or without a disulfide (LDI24) (Figure 4.20). This indicates that other 
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elements (other helices or disulfides) are important in maintaining the correct conformation of 
LDI helices 1 and 2. 
 
Due to the observed close proximity of cysteine residues number 2 and 6, a peptide containing 
a non-native disulfide bond was designed (LDI35C-C) (Figure 4.20). The model generated from 
this sequence had a high similarity to LDI structure, with a break in helix 2 at the correct point. 
This indicates the use of non-native disulfides may be a novel way to generate a suitable LDI 
mimic. Modelling of the same peptide without disulfide bonds (LDI35) indicates the non-native 
disulfide may be a way to decrease flexibility and force the peptide to form two helices. A 
more rigid, disulfide linked, molecule avoids loss of conformation entropy upon binding and 
may generate a better inhibitor (Dekker et al., 2003). These peptide models represent the 
starting point of a rational design process to create a high affinity peptide based inhibitor.  
 
4.4.5 The Potential of the Inhibitors In Planta 
The potential of compounds from this chapter to affect plant growth was tested using barley, 
Arabidopsis or tef. Due to the high concentration, and therefore high quantities, required for 
inhibition there was insufficient G2M to test on plants. G1M was previously tested on barely 
and showed inhibition of endosperm starch metabolism alongside α-glucosidase inhibition 
(Stanley et al., 2011). Interestingly, no inhibition of root or shoot growth occurred, as seen 
with DNJ. The reasons for this are unclear, however, G1M may not be capable of inhibiting the 
target(s) of DNJ responsible for stunted root growth by virtue of its in situ hydrolysis, thus 
releasing DNJ (Field group, unpublished data). 
 
When tested on barley, Arabidopsis and tef, the peptides, LDI1-6, LDI4-9, LDI7-12, LDI4-9W and LDI12 
showed no effect on growth (Data not shown). This is likely due to degradation by proteases or 
inability to reach the correct cellular concentration or location to be effective. Peptides have 
been shown to be able to penetrate tissues within mammalian systems (Futaki et al., 2007)  If 
the peptides were to reach and inhibit LD it is questionable as to whether a visible growth 
phenotype would be generated (discussed further in Chapter 6). 
 
α-, β- and γ-cyclodextrins were tested for their ability to affect barley germination, when 
applied at concentrations above 100 µM the cyclodextrins had a distinct effect on grain 
germination and seedling growth (data not shown). This is proposed to be due to interference 
with hormone metabolism and signalling, cyclodextrins are known to complex hydrophobic 
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molecules within their hydrophobic core (Szejtli, 1983, Salminen et al., 1990, Del Valle, 2004). 
The impact on hormone metabolism can have many downstream effects, the precise 
mechanism of action is unclear and would require much work to clarify. It is possible 
cyclodextrins are able to enter the endosperm and impact directly on the enzymes involved in 
starch metabolism however this is masked by the interference with hormone metabolism 
which is required for the correct activation and release of these enzymes (discussed in Chapter 
6). 
4.5 Future Directions 
4.5.1 Further Analysis of the Interactions between Inhibitors and Limit Dextrinase 
Further characterisation of the inhibitors outlined within this chapter could be achieved by 
biochemical analysis of their interactions with LD by methods such as isothermal titration 
calorimetry (ITC) and surface plasmon resonance (SPR), which yield precise details on binding 
affinity. Detailed kinetic assays could be performed to generate Michaelis-Menten, 
Lineweaver-Burk or similar plots to determine the mode of action as competitive, 
uncompetitive or non-competitive. Structural analyses, including crystallography, could also be 
employed to determine how these molecules interact. The majority of these experiments are 
dependent on having sufficient quantities of recombinant LD, as outlined in Chapter 5.  
4.5.2 The Identification of Other Iminosugar Inhibitors of Limit Dextrinase 
Only a small proportion of the existing iminosugars have been screened against LD. Due to the 
large diversity of existing compounds there is scope that high throughput screening (HTS) of 
existing compound libraries could identify a strong, nanomolar Kd, inhibitor. The Overkleeft 
library (Chapter 3) is one potential library, though many other synthetic chemical and natural 
product libraries exist. Furthermore there are a number of avenues by which novel 
iminosugars can be generated, for example the transglycosylation mediated extension. Recent 
generation of a new assay for LD which utilises a soluble chromophoric substrate, specific for 
LD, enables convenient HTS of compounds against LD (Mangan et al., 2015). 
4.5.3 Screening of Peptide Libraries against Limit Dextrinase 
Peptide libraries offer the opportunity to screen a large number of compounds for binding or 
inhibitory activity. The display of random peptide libraries on bacteriophage (phage display) is 
one method to access large numbers of peptides (Matsubara, 2012). Peptide ligands that bind 
to pancreatic alpha-amylase were isolated from libraries displaying random 15-mer peptides. 
The lead peptide from this screen (TRWLVYFSRPYLVAT) bound barley alpha-amylase with a 4.4 
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µM affinity (Wong et al., 1998, Wong et al., 1999), a similar approach could be applied to LD. 
The other approach to generating a peptide library involves iterative rounds of combinatorial 
synthetic chemistry and screening, these are the methods by which PAMI was generated 
(Doleckova-Maresova et al., 2005). Peptide arrays offer similar opportunities with the benefit 
of the peptides being synthesised immobilised to a plate, making high throughput analysis 
convenient (Min and Mrksich, 2004). There is also scope for further rational design of peptides 
using in silico methods such as molecular docking (Li et al., 2014, Kurcinski et al., 2015). 
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5 Chapter 5- Cloning, Heterologous Expression and 
Purification of Barley Limit Dextrinase and Limit Dextrinase 
Inhibitor 
5.1 Introduction 
5.1.1 Limit Dextrinase 
Limit dextrinase (LD), also known as plant pullulanase, has been implicated as the sole enzyme 
responsible for the debranching of starch during grain germination i.e. isoamylase is not 
involved (Burton et al., 1999). LD acts to cleave the α-1,6-glucosidic linkages present in α- and 
β-limit dextrins derived by the activities of the other starch catabolising glycoside hydrolases. 
LD has only a low activity towards amylopectin (Manners and Yellowlees, 1971) and therefore 
requires the hydrolysis of starch via the concerted action of α-amylase and β-amylase to 
produce smaller soluble and branched glucans that are capable of serving as a substrate. As 
well as functioning during germination, LD has also been shown to be capable of functioning 
during leaf starch biosynthesis (Streb et al., 2012) and it is proposed to be involved with the 
pre-amylopectin trimming model of starch synthesis, alongside ISA (Sim et al., 2014, Martin 
and Smith, 1995, Streb et al., 2008). 
5.1.2 Previous Purification of Limit Dextrinase 
LD activity was first identified in barley malt in 1948 (Kneen and Spoerl, 1948). Following this, 
the first partial purification of a debranching enzyme capable of hydrolysing β-limit dextrin was 
performed using potato and broad bean (Hobson et al., 1950). To date, LD has been identified 
and characterised, on both proteome and genome levels, from numerous plant sources 
including both dicots and monocots (Table 5.1). 
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Common 
Name 
Latin Name Reference 
Dicots 
 
 
 
 
 
Arabidopsis 
Arabidopsis 
thaliana 
(Zeeman et al., 1998) 
Potato 
Solanum 
tuberosum 
(Hobson et al., 1950) 
Broad bean Vicia faba (Hobson et al., 1950) 
Pea Pisum sativum (Zhu et al., 1998) 
Spinach 
Spinacia 
oleracea 
(Renz et al., 1998, Ludwig et al., 1984) 
Sugar Beet Beta vulgaris (Li et al., 1992) 
Monocots 
 
 
 
 
 
 
 
 
Barley 
Hordeum 
vulgare 
(Manners and Yellowlees, 1973, Macgregor 
et al., 1994a) 
Maize Zea mays 
(Beatty et al., 1999, Wu et al., 2002, Dinges, 
2003) 
Oat Avena sativa (Manners and Yellowlees, 1973) 
Proso millet 
Panicum 
miliaceum 
(Zarnkow et al., 2010) 
Rice Oryza sativa (Nakamura et al., 1996, Li et al., 2009) 
Rye Secale cereal (Manners and Yellowlees, 1973) 
Sorghum Sorghum bicolor (Hardie et al., 1976) 
Tef Eragrosits tef (Gebremariam et al., 2012) 
Wheat 
Triticum 
aestivum 
(Kruger and Marchylo, 1978, Repellin et al., 
2008) 
 
Table 5.1 Plants confirmed to contain limit dextrinase. 
 
The primary sequences of cereal LDs are highly conserved within maize, rice, barley and 
wheat- having protein sequence identities of 70-95 %. Comparison of barley LD with that of 
Arabidopsis produces an overall protein sequence identity of 58 %, highlighting the 
phylogenetic distance between the monocots and dicots. 
 
H.v ID 
T.a 94.8 ID 
O.s 71.7 71.9 ID 
Z.m 75.3 74.8 70.8 ID 
A.t 57.9 57.8 54.7 57.5 ID 
 H.v T.a O.s Z.m A.t 
 
Table 5.2 Percentage identity between protein sequences for cereal and Arabidopsis limit dextrinase. 
Alignment performed using BioEdit software. H.v- Hordeum vulgare (barley), Acc. AAD34347.1. T.a- 
Triticum aestivum (wheat), Acc. ABL84490.1. O.s- Oryza sativa (rice), Acc. BAA09167.1. Z.m- Zea mays 
(maize), Acc. XP_008668612.1. A.t- Arabidopsis thaliana, Acc. AED90732.1. 
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The most focused and lengthy studies have been performed on the barley enzyme because of 
its important commercial role in the malting and mashing processes of beer and spirit 
production (Sissons et al., 1995). The first LD purified to homogeneity from barley malt was by 
Sissons et al. One kg of malt yielded 0.37 mg of LD purified by 4 steps (Sissons et al., 1992a). 
Further purification schemes were soon established, all of which included a combination of 
ammonium sulfate precipitation, anion and cation exchange, size exclusion and affinity 
chromatography (Sissons et al., 1992b, Sissons et al., 1992a, Macgregor et al., 1994a). An 
improved purification procedure gave higher yields of LD by heat treatment at 65 °C to release 
LD into a buffer including a divalent cation and a reducing agent (Kristensen et al., 1998). This 
produced 9 mg of LD per kg of malt. 
 
Further to purification from plant sources, attempts at production of recombinant LD from 
maize (Wu et al., 2002), spinach (Renz et al., 1998) and wheat (Repellin et al., 2008) have been 
carried out. All expression attempts resulted in relatively poor yields when compared to 
expected protein levels usually produced by E. coli (Tegel et al., 2011). Proposed reasons for 
these low levels include protein degradation, premature termination of translation, issues with 
codon usage or misfolding and targeting to inclusion bodies (Francis and Page, 2010). A codon-
optimised barley LD has reportedly been produced in E. coli, purified and used for X-ray 
crystallography analyses, however details regarding yield and activity were not disclosed 
(Møller et al., 2015b). The highest reported levels of pure, catalytically active, LD have been 
produced by a high-cell density fermentation system using Pichia pastoris secretion, followed 
by purification with β-cyclodextrin-Sepharose and gel filtration (Vester-Christensen et al., 
2010b). This enabled the multi-mg production of LD and its crystallisation in complex with 
numerous substrate analogues (Møller et al., 2015b). 
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5.1.3 The Structure of Limit Dextrinase and Other Pullulanases 
LD, also described as plant pullulanase, belongs to the glycoside hydrolase (GH) family 13 
(Cantarel et al., 2009), a diverse group of enzymes, containing nearly 26,000 members, 
characterised by a retaining catalytic mechanism, a catalytic Asp base and a Glu proton donor 
(Svensson et al., 2002). This family includes, amongst others, α-amylase, α-glucosidase, 
isoamylase, neopullulanase and cyclomaltodextrinase (Jespersen et al., 1993). GH13 members 
belong to the CAZy clan-H, a group that all share the same (β/α)8 barrel catalytic domain 
(Cantarel et al., 2009). LD is further grouped into the GH13 subfamily 13 (GH13_13, bacteria 
and eukaryote) with other pullulanases being assigned to subfamilies 12 (GH13_12, firmicutes) 
and 14 (GH13_14, bacteria) depending on their sequence and phylogenetic origin (Cantarel et 
al., 2009, Stam et al., 2006). The majority of well characterised pullulanases are of microbial 
origin, from organisms such as Bacillus subtilis (Bs), Bacillus acidopullulyticus (Ba) and 
Klebsiella pneumonia (Kp). Sequence alignment of barley LD with microbial pullulanases shows 
sequence identities around 30 % (Vester-Christensen et al., 2010b).  
 
Carbohydrate binding modules (CBMs) are protein sequences that fold into a structurally 
discrete module. The N-terminal domain of LD possesses structural similarity to CBM21 of 
Rhizopus oryzae glucoamylase and is speculated to be involved in protein-substrate/surface 
interactions (Møller et al., 2012). A mutant of sorghum LD has been identified which possesses 
two missense mutations in the N-terminal domain (Gilding et al., 2013). These mutations lead 
to increased LD activity and increased in vitro starch digestibility and have no deleterious trade 
off. It is proposed that the mutation is a reversion to a sequence nearer to that of barley. 
These observations support the idea that the N-terminal domain is related to substrate binding 
or catalytic activity. The plant LD and isoamylases only contain a single annotated CBM 
(CBM48) (Machovič and Janeček, 2008) in comparison to the structures of KpPUL and BaPUL 
which show two N-terminal CBMs (CBM41 and CBM48) (Figure 5.1, red domains) (Mikami et 
al., 2006, Turkenburg et al., 2009). There are still other domains that exist within these 
proteins that have an undefined function (Figure 5.1, purple domains). 
 
The N-terminal domain is followed by the (β/α)8 barrel catalytic domain that is common to all 
GH13 enzymes (Figure 5.1, blue domains) (Kuriki and Imanaka, 1999). A C-terminal domain 
follows the catalytic domain, this consists of a two-sheet β-sandwich motif (Matsuura et al., 
1984) (Figure 5.1, green domains).  
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The α-1,6 acting enzymes, including LD (EC3.2.1.142), pullulanase (EC 3.2.1.41) from bacteria, 
and isoamylase (EC 3.2.1.68,) are all composed of a similar domain organisation (Figure 5.1). At 
the N-terminus is a domain of varying length that can contain structural features such as 
carbohydrate binding modules (Figure 5.1, red and purple domains) (Vester-Christensen et al., 
2010b).  
 
The interaction of barley LD (recombinant, expressed in Pichia) with different size 
cyclodextrins reveal affinities (Kd) of 27.2, 0.7 and 34.7 µM for α-, β- and γ-CD, respectively 
(Vester-Christensen et al., 2010a). The distinct differences in binding to the different CDs 
indicates a higher level of plasticity within the substrate binding site of LD, which enables 
 
Figure 5.1 Domain organisation of limit dextrinase, isoamylase and pullulanase. 
Structures solved by crystallography. HvLD- Hordeum vulgare limit dextrinase (4AIO) (Moller et al., 
2012), BaPUL Bacillus acidopullulyticus pullulanase (2WAN) (Givens et al., 2004), CrISA Chlamydomonas 
reinhardtii isoamylase (4J7R) (Shu et al., 2014), PaISA Pseudomonas amyloderamosa isoamylase (1BF2) 
(Katsuya et al., 1998), KpPUL Klebsiella pneumoniae (2FHB) (Mikami et al., 2006), SaPUL Streptococcus 
pneumonia pullulanase (3FAW) (Gourlay et al., 2009). Colours refer to domains: purple- N-terminal, red- 
CBMs, blue- catalytic domain and green- C-terminal. 
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optimisation of substrate binding when compared to pullulanase (Vester-Christensen et al., 
2010a). β-CD is the preferred ligand for LD and its resemblance to the positioning of glucose 
within the glucan helices of amylopectin fits with the role of LD (Figure 5.2). A study on BaPUL 
revealed that the protein structure, observed by circular dichroism, decreased in helix and 
increased in sheet content, upon binding β-CD; this change was associated with loss of 
catalytic activity and supports the suggestion that conformational changes may be important 
for catalytic activity. 
 
 
 
 
 
 
 
The ability to generate high levels of pure protein (Vester-Christensen et al., 2010b) has 
enabled crystallisation of LD in complex with competitive inhibitors α- or β-cyclodextrin bound 
within the active site (Vester-Christensen et al., 2010a). The crystal structures of these 
complexes were solved to 2.5 Å and 2.1 Å, respectively, with the cyclodextrins occupying the 
active site carbohydrate binding sites +1 and +2 (Figure 5.3) and a glycerol and three water 
molecules mimicking a glucose residue at sub-site -1, thereby identifying the residues involved 
in catalysis as Asp473 and Glu510 (Figure 5.3). A catalytically inactive mutant of Glu510 (E510A) 
has been generated therefore confirming the role of this residue in catalysis (Møller et al., 
2015b). 
 
Figure 5.2 Representative structures of β-cyclodextrin and an amylose helix from starch. 
Cyclodextrins are constrained to a semi-rigid form because of their cyclic nature, however, β-
cyclodextrin can have an internal diameter between 5.40 and 8.34 Å, depending on its conformation 
(Pinjari et al., 2010). The helixes found within starch vary in width depending on conformation (Hancock 
and Tarbet, 2000). β-cyclodextrin represents the preferred shape for binding to the LD active site, as 
concluded by SPR studies (Vester-Christensen et al., 2010b), crystallography (Vester-Christensen et al., 
2010a)  and inhibition studies (Chapter 4).  
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5.1.4 The Mechanism of Limit Dextrinase-Catalysed Hydrolysis and 
Transglycosylation 
The α-1,6-glucoside hydrolysis reaction catalysed by LD occurs by general acid catalysis, which 
utilises a proton donor (Asp473) and a nucleophile/base (Glu510). A third acid residue is required 
for catalysis by LD and other GH13 enzymes (Macgregor, 2005) this residue is involved in 
distortion of the substrate via hydrogen bonding (Uitdehaag et al., 1999). Cleavage of the 
glycosidic bond results in retention of anomeric configuration around the anomeric carbon, 
taking place via a double displacement mechanism that is common to all GH13 family 
members. The reaction (Figure 5.4) occurs in two steps, beginning with nucleophilic attack of 
the substrate by the deprotonated Asp473 (Figure 5.4, A) to form a covalent β-glucosyl-enzyme 
intermediate and simultaneous protonation of the leaving aglycone by Glu510 (Figure 5.4, B). 
Stabilization of the oxocarbonium ion-like transition state is believed to be mediated several 
conserved amino acids, in particular His404 and His641 (Vester-Christensen et al., 2010a). Once 
deprotonated, Glu510 acts as a base, abstracting a proton from an activated acceptor which 
goes on to attack the anomeric carbon (Figure 5.4, C). The acceptor can be either a water 
molecule (hydrolysis) or the primary C6 hydroxyl group of a non-reducing glucose terminus of 
a glucan (transglycosylation). Hydrolysis occurs at the 1,6-linkage between glucose units at 
sub-sites -1 and +1 (Figure 5.5) (Davies et al., 1997, Bissaro et al., 2015). 
 
 
Figure 5.3 The structure of limit dextrinase in complex with β-cyclodextrin 
A&B LD and β-CD complex (2X4B). β-CD (purple). Asp473 and Glu510 (red) are the catalytic residues in 
active site. Met440 (blue) blocks the binding of long polymers.  
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Figure 5.5 The sub-site numbering of the limit dextrinase binding cleft. 
Other α-1,6 debranching enzymes sub-sites are numbered in the same way but may possess more or 
fewer sub-sites. The hydrolysed bond is indicated by an arrow. Numbering follows the rules set out by 
(Davies et al., 1997). The non-main chain (side chain) is identified by (‘). 
 
Figure 5.4 The catalytic mechanism of limit dextrinase and other retaining hydrolases. 
The catalytic process is explained in the text. Adapted from (Macgregor et al., 2001, Bissaro et al., 
2015). R1 and R2 represent residues within the polymeric substrate- pullulan or dextrin. R3 represents 
either a H, in the case of hydrolysis, or the C6 position of a glucose residue of another glucan, in the 
case of transglycosylation. 
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5.1.5 The Substrate Specificity of Limit Dextrinase 
The GH13 family has diverse substrate specificities. LD specifically hydrolyses α-1,6 bonds 
found within branched dextrins created during starch catabolism. It also shows activity 
towards the α-1,6 bonds of the α-1,4, α-1,6 glucose polymer pullulan (Manners and 
Yellowlees, 1971). The relative rates of LD, KpPUL and PsISA, when compared (Table 5.3), show 
that the pullulanase type debranching enzymes have a preference for short oligosaccharides 
over polymeric substrates. Long substrates, other than pullulan, cause a distinct drop in rate of 
hydrolysis (Greffe et al., 2003, Kainuma et al., 1978). In comparison, isoamylase has a 
preference for polymeric substrates, having a high activity towards amylopectin (Kainuma et 
al., 1978). α-Maltosylmaltotetraose is the preferred main chain length for LD (Manners and 
Yellowlees, 1971). The hydrolysis rate increase associated with the change from α-maltosyl to 
α-maltotriosyl indicates that the optimum side chain length is three glucose units long 
(Manners and Yellowlees, 1971). Neither LD nor KpPUL show activity with smaller di- and tri-
saccharides and are incapable of cleaving α-1,6 linkages between a single glucose residue 
attached to either a linear or cyclic oligosaccharide (Manners and Yellowlees, 1971, Greffe et 
al., 2003, Abdullah et al., 1966). It is worthwhile noting that the specificity of debranching 
enzymes from microbial origin, outlined in Table 5.3, do not precisely compare to those of 
plant limit dextrinase and isoamylase. 
 
Substrate Relative Rates 
 
LDa LDb KpPULc PsISAd 
63-α-maltosylmaltotriose - 13 49 3 
63-α-maltosylmaltotetraose - 123 169 7 
63-α-maltotriosylmaltotriose - 129 90 10 
63-α-maltotriosylmaltotetraose 358 243 123 33 
Nonasaccharide from pullulan - 114 - - 
Pullulan 100 100 100 <1 
Amylopectin β-limit dextrin - 68 - - 
Amylopectin - <<1 - 100 
Glycogen - 0 - - 
 
Table 5.3 Substrate preferences for limit dextrinase and other debranching enzymes. 
Data combined from the following references. a. (Greffe et al., 2003). b. (Manners and Yellowlees, 
1971). c. (Abdullah et al., 1966). d. (Kainuma et al., 1978). 
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The crystal structure of LD has implicated a number of residues in the specificity of LD action 
(Vester-Christensen et al., 2010a). The bulky Met440 (Figure 5.6, blue) is a residue in a position 
unique to LD that obstructs sub-site -4; it is proposed that the steric hindrance may affect the 
specificity of LD and be the cause of low activity towards amylopectin. Further to this, an 
extended loop (Asp513-Asn520) within the catalytic domain also appears to influence substrate 
specificity (Vester-Christensen et al., 2010a). LD has been crystallised in complex with a 
number of substrates and substrate analogues (Figure 5.7) (Møller et al., 2015b). This has 
revealed that 2 glucose units at the main chain non-reducing end of the substrate are required 
for optimal binding in the active site sub-sites -1 and -2. Sub-sites +1 and +2 are also important 
for substrate binding, these are the same sites in which CD was bound in the first LD crystal 
structures solved (Vester-Christensen et al., 2010a). All of these findings are in agreement with 
LD catalytic substrate preferences. The preference for 1,6 linkages is driven by Trp512 and 
Phe553 that flank the catalytic cleft and keep non-branched substrates away from the active 
site, but position 1,6-branched substrates correctly (Møller et al., 2015b) (Figure 5.6, orange 
and cyan residues). This study confirmed that GH13 proteins recognise their substrates based 
on shape and size, it is the combined effect of shape and interactions over a polymeric 
substrate that drives specificity. 
 
 
 
 
 
 
Figure 5.6 The structure of limit dextrinase in complex with 63-α-glucosyl-maltotriosylmaltotriose. 
A&B LD and 63-α-glucosyl-maltotriosylmaltotriose (4J3X). 63-α-glucosyl-maltotriosylmaltotriose (grey). 
Asp473 and Glu510 (red) are the catalytic residues in active site. Met440 (blue) blocks the binding of long 
polymers. Phe553 (magenta) and Trp512 (orange) flank the catalytic cleft and prevent binding of non-
branched substrates.  
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LD, Sulfolobus solfataricus debranching enzyme and PaISA have been shown to display 
transglycosylation activity (Abe et al., 1988, Svensson et al., 2002, Mcdougall et al., 2004, 
Yamasaki et al., 2008, Kang et al., 2008, Nguyen et al., 2014). Maximum LD transglycosylation 
activity has been seen with maltotriose, confirming that the optimum subsite chain length is 
three glucose units long (Mcdougall et al., 2004).  
 
Transglycosylation activity is dependent on donor and acceptor molecules (Mcdougall et al., 
2004). Further to this maltose to maltoheptose are capable of activation of LD at 
concentrations between 5 mM-12.5 mM. High levels of dextrins can cause inhibition of the 
enzyme (Macgregor et al., 2002, Mcdougall et al., 2004). The mechanisms of inhibition and 
activation are unknown. The effect of dextrins on LD can cause issues with interpretation of 
previous assay data if samples were not cleared of small glucans. Samples can be cleared by 
size exclusion or treatment with amyloglucosidase to hydrolyse glucans to produce glucose, 
which shows no inhibitory activity towards LD. Transglycosylation activity can be utilised for 
the synthesis of novel compounds, often requiring much less time than traditional chemical 
synthesis, examples of transglycosylation reactions catalysed by similar enzymes are outlined 
 
Figure 5.7 Substrates bound to limit dextrinase in published crystal structures. 
1. α-cyclodextrin (2X4C). 2. β-cyclodextrin (2X4B). 3. maltosyl-S-β-cyclodextrin (4J3U). 4. 63-α-glucosyl-
maltotriosylmaltotriose (1J3V). 5. maltotetraose (4J3T, 4J3S). 6. 63-o-α-maltosylmaltotetraose (4J3X). 
7. 62-α-maltotriosylmaltotriose (4J3W). 
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in Figure 5.8 (Kang et al., 2008, Kang et al., 2011, Leong et al., 2007, Abe et al., 1988, Shimura 
et al., 2011). The in planta of role of transglycosylation is not yet clear, it may be relevant to 
pre-amylopectin trimming and/or granule initiation (Mcdougall et al., 2004, Streb et al., 2008). 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.8 Products created by transglycosylation catalysed by proteins similar to limit dextrinase. 
1. The following compounds were generated using PaISA and glycosyl-β-CD, diglucosyl-β-CD, maltosyl-
β-CD or maltotriosyl-β-CD: 6A,6D-di-o-α-maltosyl-β-CD (1a: R1-1d, R2-H, R3-1d). 6-o-α-(62-o-α-
maltosyl)maltosyl-β-CD (1a: R1-1f, R2-H, R3-H). 6A,6D-di-o-α-maltotriosyl-β-CD (1a: R1-1b, R2-H, R3-1H). 
6-o-α-(63-o-α-maltotriosyl)maltotriosyl-β-CD (1a: R1-1e, R2-H, R3-H). 6-o-α-(62-o-α-
maltotriosyl)maltotriosyl-β-CD (1a: R1-1c, R2-H, R3-H). Sulfolobus sulfataricus was used to generate 
6A,6D-di-o-α-maltosyl-β-CD (1a: R1-1d, R2-H, R3-1d) and 6A,6c-di-o-α-maltosyl-β-CD (1a: R1-1d, R2-1d, 
R3-1H) from maltosyl-β-cyclodextrin (Abe et al., 1988, Kang et al., 2008). 2. Maltotriosyl-aesculin was 
produced using pullulan and aesculin, catalysed using Thermatoga neapolitana PUL (Kang et al., 2011). 
3. 1-o-α-panosylerythritol (3a, R-3b). 1-o-α-panosylxylitol (3a, R-3c). 2-o-α-panosylxylitol (3a, R-3d). 1-o-
α-panosylsorbitol (3a, R-3e). 6-o-α-panosylsorbitol (3a, R-3f) were produced from pullulan and the 
respective sugar alcohols (3b-f) using Thermoactinomyces vulgaris pullulan hydrolysing amylase 
(Shimura et al., 2011). 
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5.1.6 Limit Dextrinase Inhibitor  
The identification of limit dextrinase inhibitor (LDI) as the protein potentially responsible for 
low levels of LD activity during malting occurred alongside the studies of LD. LD inhibitory 
activity was first identified in cereal extracts (Yamada, 1981), where incubation of LD in the 
presence of a reducing agent was required for complete extraction and full LD activity 
(Mccleary, 1992). LD purified from barley malt was found to be in active (free) and inactive 
(bound) forms (Longstaff and Bryce, 1993). It was proposed that LD is bound to a protein that 
is affected by proteases or reducing agents. Two forms of LDI, which differed in migration in 
isoelectric focusing, were identified in barley malt. These two forms had identical amino acid 
sequences but differed in the attachment of glutathione or cysteine to a cysteine residue 
(Macri et al., 1993). The interaction between LD and LDI has been well studied in vitro, with 
the two proteins interacting with picomolar affinity (Møller et al., 2015a). It has been proposed 
that LDI is a specific inhibitor (Macgregor, 2004) controlling LD activity during germination and 
it is suggested to be responsible for low levels of LD during mashing, though these proposals 
are yet to be confirmed experimentally in planta (Macgregor, 2004). 
5.1.7 Previous Purification of Limit Dextrinase Inhibitor and Related Proteins 
LDI belongs to a family of CM proteins, which are named so as they can be extracted from 
cereal flour using chloroform-methanol because of their hydrophobicity. Analysis of this 
fraction reveals a complex mix of small proteins with a range of functions including: cereal type 
inhibitors (CTIs), lipid transfer proteins, stress enzymes and storage proteins (Wong et al., 
2004). The precise function of many of these proteins remains unclear. CTIs consist of a 
common protein fold utilised in widespread processes including: regulation of endogenous 
hydrolases (both carbohydrate and protein, sometimes with dual action), defence against 
pathogens and pests- fungi and insects, seed storage proteins that provide amino acids for 
germinating plants, lipid transfer and maintenance of cell wall structure (Svensson et al., 2004, 
Jose-Estanyol et al., 2004). 
 
Functional recombinant CTIs have proved extremely challenging to produce in high yields. Only 
a handful of these types of proteins have been expressed with success - α-amylase inhibitor 
from rye (Dias et al., 2005), wheat monomeric α-amylase inhibitor 0.28 (WMAI-1) (Garcia-
Maroto et al., 1991), allergenic wheat CM16 protein (Lullienpellerin et al., 1994), ragi 
bifunctional α-amylase/trypsin inhibitor (RBI) (Sen and Dutta, 2012), α-amylase inhibitor from 
wheat kernel (Okuda et al., 1997) and Hageman factor inhibitor from corn (CHFI) (Chen et al., 
1999, Hazegh-Azam et al., 1998). All of these proteins have been overexpressed in E. coli, and 
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in most cases purified from the insoluble fraction and refolded. Whilst the processes of 
expression, cell lysis, inclusion body preparation and solubilisation are all similar, precise 
conditions are required for each protein refolding procedure (Burgess, 2009). One commonly 
used refolding method for disulfide rich proteins involves dilution with a suitable redox system 
to catalyse disulfide bond exchange (Kohno et al., 1990). However, in general, low levels of 
active protein are often obtained following refolding. 
 
Recently LDI has been identified on a sequence level in wheat, rice and brachypodium 
(Brachypodium distachyon) (Møller et al., 2015a). These proteins have not been confirmed 
experimentally. The sequence identities between these proteins are outlined in Table 5.4. LDI 
has only been purified and analysed from barley grain. LDI consists of two forms of a 114 
amino acid protein. The two forms of LDI were found to differ in a thiol linked residue, having 
either cysteine or glutathione attached (position 7 in Figure 5.9), both forms were capable of 
inhibiting LD (Macgregor et al., 1994b, Macgregor et al., 2000). Modelling the sequence of LDI 
against known family member ragi amylase-trypsin inhibitor predicted four alpha-helices held 
together by four disulfide bridges (Figure 5.1) (Macgregor et al., 2000). A 1:1 ratio of LD:LDI 
caused complete inhibition of activity, their proposed stoichiometry was confirmed by ESI-MS 
(Macgregor et al., 2003). LDI has been tested against various bacterial, plant, mammalian and 
insect enzymes- pullulanase and isoamylase from Aerobacter aerogenes, isoamylase from 
Pseudomonas amyloderamosa, pullulanase from Bacillus acidopullulyticus (Macgregor et al., 
1994b), trypsin and α-amylase from Sus scrofa, barley malt α-amylase and α-amylase from 
Tenebrio molitor (Macgregor et al., 2000): no inhibitory activity against any of these proteins 
was identified. 
 
H.v ID 
T.a 77.5 ID 
B.d 55.4 54.3 ID 
O.s 45.0 44.7 43.1 ID 
 H.v T.a B.d O.s 
 
Table 5.4 Percentage identities between protein sequences for cereal limit dextrinase inhibitors. 
Alignment performed using BioEdit software. H.v- Hordeum vulgare (barley), Acc.ABB885733. T.a- 
Triticum aestivum (wheat), Acc. CAA68248. B.d- Brachypodium distachyon, Acc. XP_003561291. O.s- 
Oryza sativa (rice), Acc. ABK34477. 
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Attempts at producing LDI in E. coli and Lactococcus lactis have been reported (Bønsager et al., 
2007). Expression of a His6-tagged fusion protein construct yielded no soluble or insoluble 
protein. N-terminal fusion of thioredoxin to LDI yielded some soluble protein in E. coli, 
however cleavage of the thioredoxin tag caused a drop in LDI activity assessed by LD activity 
assay. Secretory expression of LDI in Pichia pastoris high cell density batch-fed fermentation, 
followed by nickel affinity chromatography and gel filtration produced high amounts of 
protein. This protein had twofold stronger inhibitory activity than barley LDI purified from 
grain (Jensen et al., 2011).  
 
5.1.8 The Structure of Limit Dextrinase Inhibitor and Other Cereal Type Inhibitor 
Proteins 
There are only 4 CTI protein structures that have been solved to date - ragi bifunctional α-
amylase/trypsin inhibitor (RBI) (Strobl et al., 1995), Hageman factor inhibitor from corn (CHFI), 
α-amylase inhibitor from wheat (WAI) (Oda et al., 1997) and LDI (Møller et al., 2015a). The 
structure of RBI bound to yellow mealworm α-amylase have also been solved (Strobl et al., 
1998). Further to this, CHFI has been shown capable of inhibiting mammalian trypsin, 
Hageman blood coagulation factor and α-amylases from insects (Behnke et al., 1998). LDI is 
the only known debranching enzyme inhibitor in this protein family and has been shown to 
inhibit LD specifically; many other known and unknown sources of possible targets for LDI have 
yet to be tested. All of these inhibitors possess a common fold of four alpha helices connected 
by short loops and held together via four disulfide bonds which are conserved (Jose-Estanyol 
et al., 2004, Juge and Svensson, 2006). The disulfide bridges are responsible for maintaining 
the tertiary structure of the helical core whilst the loops are variable, dependent on the 
necessary function (Figure 5.10, orange residues). 
 
 
Figure 5.9 Cysteine and cystine residues present in barley limit dextrinase inhibitor. 
Cystine  disulfide bonds  (solid underline) are formed between cys residues 1-6, 2-4, 3-8, 5-9. cysteine 7 
(dashed underline) is found coupled to either a free cysteine or glutathione via a disulfide bond. 
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5.1.9 The Structure and Interactions of Limit Dextrinase-Limit Dextrinase Inhibitor  
The successful expression of both LD and LDI using Pichia pastoris has enabled the structure of 
their complex to be solved to a 2.7 Å resolution (Møller et al., 2015a). The LD structure within 
the complex is identical to previous structures solved (Vester-Christensen et al., 2010a).  
 
 
 
 
 
 
 
Figure 5.10 The three dimensional structures of four cereal type inhibitor proteins. 
Hageman factor inhibitor from corn (CHFI)- red, ragi bifunctional α-amylase/trypsin inhibitor (RBI)- 
green, LDI- purple, α-amylase inhibitor from wheat (WAI)- blue. Top row. The common four helix 
structures with variable loops are visible. Bottom row. 90° rotation on the z-axis. The four disulfide 
bonds are highlighted in orange. PDB codes are shown below the abbreviated protein names.  
 
Figure 5.11 The structure of the limit dextrinase-limit dextrinase inhibitor complex. 
LDI (dark gray) binds in the active site cleft of LD (carbon- light gray, oxygen- red, nitrogen- blue, sulfur- 
yellow). 
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Analysis of the complex revealed that hydrophobic cluster and ionic interactions are vital for 
the affinity of the LD-LDI interactions. The catalytic Asp, Glu and Asp were in the same 
conformation in all structures, this active site is buried by LDI complexation. Key residues at 
the protein:protein interface were studied by site directed mutagenesis (SDM) followed by 
surface plasmon resonance (SPR) analysis (Table 5.5). LDI Arg34 contacts Glu729 and Asp730 in LD 
at the entrance to the active site and LDI Arg38 forms ionic interactions with the catalytic 
nucleophile Asp473 and acid/base catalyst Glu510. LDI Leu41 and Val42 are perhaps the most 
important residues that form a hydrophobic cluster with LD Trp512, Phe514 and Phe553. 
 
Variant Relative Kd 
 
WT 1 
LDI R34A 22 
 
R38A 33 
 
R38W 12 
 
L41G 100 
 
L41W 1.8 
 
V42D 4,048 
 
L41G-V42D 476,190 
LD D730W 7.9 
 
D730R 171 
 
Table 5.5 Binding affinity (Kd) between recombinant mutants of limit dextrinase and limit dextrinase 
inhibitor generated using surface plasmon resonance. 
Values from (Møller et al., 2015a). The importance of L41 and V42 is highlighted by the drastic change in 
affinity caused by mutation of these residues.  
 
The interaction between LD and LDI occurs at an affinity of 30 pM, with a pH optimum of 6.5. 
The LD: LDI complex has a thermal stability peak of 77 °C, this is 11 °C higher than LD alone. 
LDI is extremely thermally stable, alone it has a thermal stability peak of 97.4 °C and a half-life 
over 50 min at 90 °C (Møller et al., 2015a). The thermal stability that LDI confers to LD may 
well be relevant to the mashing step during brewing (Yang et al., 2008, Evans et al., 2010).  
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5.2 Aims of this Chapter 
Recent work on LD and LDI has centred on in vitro analysis of the proteins and their 
interactions. A large amount of structural data has been gathered and used to explain how LD 
and LDI interact. However there are still questions about the in planta roles of LD and LDI left 
to be answered. These include the subcellular localisation of LD and LDI, the temporal 
expression of both proteins and the question of whether LD and LDI actually interact in planta, 
during the processes of germination or endosperm starch synthesis. 
 
The genes and proteins for both LD and LDI are required in order to perform experiments that 
can answer these questions. Currently both proteins are produced by a lengthy and expensive 
procedure utilising P. pastoris as the expression host, where ideally E. coli would be used as 
the expression host. Recombinant protein is required for continuation of in vitro inhibition 
studies. Further to this, protein expression will enable the production of antibodies, which 
alongside the newly developed assays for LD (Mangan et al., 2015) will enable a more in depth 
analysis of LD and LDI within plants. 
 
The first objective of the current study was the cloning of the genes encoding LD and LDI from 
barley into entry vectors compatible with Gateway cloning. This cloning system enables easy 
sub-cloning into vectors for different end uses. The second objective was to overexpress both 
LD and LDI in E. coli and develop purification strategies that produce homogeneous proteins. A 
further objective was the utilisation of the recombinant proteins to raise polyclonal antibodies 
specific for LD and LDI, which could be utilised to gain a better understanding of LD, LDI and 
their interaction in planta. 
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5.3 Results 
5.3.1 Full length Limit Dextrinase Could Not be Cloned from Barley 
Total RNA was purified from tissue samples taken from whole grain (0 dpi), endosperm (3 dpi 
and 5 dpi), aleurone (3 dpi) and leaf tissue (21 dpi). cDNA was synthesised from this RNA and 
used in a PCR, no samples yielded amplicons corresponding to full length LD (2889 bp). To 
check cDNA quality, a fragment of barley housekeeping gene GAPDH (604 bp) was successfully 
PCR amplified (Figure 5.12, A) (Burton et al., 1999). The same RNA was further used in an RT-
PCR which also proved unsuccessful. Alongside a small amplicon of 900 bp, leaf RNA gave also 
a weak amplification product of around 2900 bp, possibly corresponding to full length LD 
(Figure 5.12, B), however further optimisation of this reaction proved unfruitful.  
 
To test for the presence of LD in the RNA samples an RT-PCR was performed using primers 
previously used to identify the presence of LD (Burton et al., 1999) and cDNA produced using 
21 dpi leaf RNA, 3 dpi endosperm RNA, and 3 dpi aleurone RNA. Amplicons of the correct size 
(621 bp) (Figure 5.12, C) were generated indicating that LD cDNA was present in all samples, 
however, the full length transcript was not present. 
 
A fragment based cloning methodology was devised in an attempt to clone parts of the LD 
sequence, followed by ligation to produce the full length gene. A GC rich PCR on 3 dpi aleurone 
cDNA was performed in an attempt to generate three independent PCR products (1-1443 bp, 
2-859 bp and 3-587 bp, (Figure 5.13). However the PCR yielded no amplicons of the correct 
size (Figure 5.12, D). 
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Figure 5.13 Map showing gene fragments designed for cloning limit dextrinase. 
 
Figure 5.12 Agarose gels from attempted cloning of limit dextrinase. 
A. PCR product, using cDNA prepared from 3 dpi aleurone layers, for housekeeping gene GAPDH, 
amplicon of correct size (604 bp) indicated by arrow. B. RT-PCR product, for full length LD, on 21 dpi leaf 
RNA, amplicons of ~2900 bp and ~900 bp indicated by arrows. C. PCR product, LD fragment probe, 
performed on cDNA from (1) 21 dpi leaf RNA, (2) 3 dpi endosperm RNA, and (3) 3 dpi endosperm, 
expected amplicons (621 bp) indicated by arrow. D. Agarose gel of PCR for LD cloning fragments, using 
cDNA prepared from 3 dpi aleurone layers (1) Fragment 1 (2)  Fragment 2 (3) Fragment 3- see Figure 
5.13. 
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5.3.2 The Gene Encoding Limit Dextrinase was Obtained by Gene Synthesis 
Due to the problems obtaining a full length gene, cloning was abandoned in favour of gene 
synthesis. Full length cDNA encoding LD (Genbank: AF122049.1) was ordered from Gene Art 
Gene Synthesis (Life Technologies, Carlsbad, CA, USA). A non-codon optimised version of the 
gene was chosen so that the native cDNA could be used for a number of final purposes. During 
the gene synthesis procedure the company experienced unforeseen problems with the 
synthesis, which caused a major delay in production. The full length gene was subdivided 
into four smaller sub-fragments (Figure 5.14, A, B, C and D) to be assembled separately and 
then ligated step by step in order to obtain the full-length construct. Problems arose with the 
synthesis of the 3' part of fragment C (bps 1434-2046), multiple E. coli clones screened by 
sequencing showed mutations within the same region, beginning at position 1491. This region 
(gttcctgggtac) contained either an insertion of 1 or 2 nucleotides or a deletion of 7, all of which 
would cause a frame shift when translated. Other codon optimisation options were considered 
for fragment C (Figure 5.15, A-D) however all options had relatively similar GC/AT levels. The 5’ 
end of full length LD has extremely high GC content (Figure 5.15, E) which hindered the gene 
synthesis process. Finally, the full length sequence for fragment C was obtained in one colony. 
DNA from this colony and other LD gene fragments were ligated together to give the full length 
sequence for LD (2889 bp). The gene was cloned into a pOK vector (details in Appendix). This 
gene was sequenced and shown to be correct. 
 
 
 
 
 
 
 
 
Figure 5.14 Map showing gene fragments used for gene synthesis of limit dextrinase. 
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Figure 5.15 GC base content of full length limit dextrinase and fragment gene sequences. 
A. GC Content of native LD bps 1434-2046 B. GC Content of LD bps 1434-2046 optimised for Arabidopsis 
codon usage. C. GC Content of LD bps 1434-2046 optimised for E. coli codon usage. D. GC Content of LD 
bps 1434-2046 optimised for Barley codon usage. E. GC Content of full length native Barley LD. 
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5.3.3 Limit Dextrinase was Successfully Cloned into Gateway Entry Vectors 
Previous literature suggests that barley LD has a putative transit peptide (Burton et al., 1999, 
Kristensen et al., 1999b). Mature barley LD has been shown, by N-terminal sequencing, to start 
at sequence ATQ, however 50 % of sequenced LD lacked the residues ATQ and began with the 
amino acids AFM (Figure 5.16, orange letters, dotted line) (Kristensen et al., 1998). Kristensen 
suggested MAV as the start point of the amino acid sequence (Figure 5.16, blue letters, dashed 
line) (Kristensen et al., 1999b), however this gene is shorter than that identified by Burton who 
proposed the protein to begin with MPM (Figure 5.16, green letters, solid line) (Burton et al., 
1999). Interestingly the first exon in the barley LD gene codes from residues MPM to ATQ 
(Figure 5.16, green and orange codons) however a methionine residue would be required as 
the first residue for translation if this first exon was to be skipped, this is not the case.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.16 DNA and corresponding protein sequence of the N-terminal section of limit dextrinase. 
Green letters and solid line corresponds to the starting Met proposed by Burton. Blue letters and 
dashed line shows start the starting Met proposed by Kristensen. Orange letters and dotted line show 
the N-terminal amino acids of mature LD identified by MS. (*) indicates the proposed N-terminal transit 
peptide cleavage sites identified by ChloroP software. 
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The gene for full length LD cDNA was subjected to analysis using sub-cellular localisation 
(Protein Prowler) (Bodén and Hawkins, 2005), secretion (SignalP-4.1) (Petersen et al., 2011) 
and chloroplast (ChloroP-1.1) (Emanuelsson et al., 1999) prediction software in order to 
determine the point at which to truncate the DNA to give a truncated protein product. SignalP 
predicted no secretory peptide present in the N-terminal domain of full length LD (Figure 5.17, 
A). Prowler indicated that that there was a 63 % chance that the transit peptide encoded a 
chloroplast targeting sequence (Figure 5.17, B). The peak of the chloroplast targeting sequence 
was the M residue present in the MAV sequence. ChloroP predicted a chloroplast targeting 
sequence with a length of 68 amino acids when the full length LD was analysed. The truncated, 
LD sequence, starting MAV, gave no strong prediction for any specific localisation. Other plants 
sequences for LD show the presence of the putative transit peptide (Table 5.6). In Arabidopsis 
LD has been shown to be plastid localised using proteomics (Zybailov et al., 2008). Alignment 
of the first 90 amino acids of barley and Arabidopsis LD shows 22 % identity meaning the two 
sequences are not considered significantly similar. There are, however, common features that 
are similar between both sequences including the presence of a semi-conserved consensus 
sequence for chloroplast transit peptide cleavage (Gavel and Von Heijne, 1990, Zybailov et al., 
2008). This motif, (V/I)-X-(A/C)-A, is present in the barley LD N-terminal sequence- VSAA 
(Figure 5.16, *). The whole LD protein sequences for barley and Arabidopsis have 58 % identity 
when aligned. The MAV sequence was chosen as the point of truncation as this was sufficient 
to stop predicted chloroplast targeting in ChloroP and has previously been successfully 
expressed in Pichia pastoris (Vester-Christensen et al., 2010b). 
 
 
 
 
 
Figure 5.17 Subcellular localisation signal prediction for limit dextrinase. 
A. Protein secretion signal prediction performed on the full length LD sequence using SignalP software 
shows no sign of a secretory peptide. B. Protein subcellular localisation prediction performed on the full 
length LD sequence using Prowler shows that the N-terminus likely encodes a plastid transit peptide. 
SP- signal peptide, MTP- mitochondrial transit peptide, CTP- chloroplast transit peptide. Arrow indicates 
proposed truncation point. 
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Organism Accession Length Score cTP cTP- length 
Triticum aestivum ABL84490.1 963 0.585 Yes 69 
Oryza sativa BAA09167.1 986 0.577 Yes 73 
Arabidopsis thaliana AED90732.1 965 0.585 Yes 62 
Setaria italica XP_004975057.1 958 0.585 Yes 45 
Sorghum bicolor EES10414.1 966 0.59 Yes 47 
Vitis vinifera XP_002271820.3 956 0.588 Yes 46 
Hordeum vulgare AAD34347.1 962 0.588 Yes 68 
 
Table 5.6 Analysis of plant limit dextrinase protein sequences for the presence of N-terminal 
chloroplast transit peptides. 
Calculated using ChloroP software. cTP- chloroplast transit peptide. 
 
 
A PCR, using gene synthesis LD DNA as a template, was performed to amplify LD with and 
without the putative transit peptide, variations of these were created with and without stop 
codons. The correct amplicon sizes were obtained (Table 5.7 and Figure 5.18). Further to this, 
the putative transit peptide alone was also PCR amplified- LD transit peptide 171 bp (gel not 
shown). These five PCR products were cloned into entry vector pCR8-TOPO-GW (Figure 5.18). 
This set of gene variations enables cloning into Gateway compatible vectors for different 
purposes. Constructs containing the correct sequences were obtained after a number of 
screening rounds. 
 
Name Abbreviation Size (bp) Primers 
Full length LD LD-FL 2889 MR3, MR4 
Full length LD with no stop codon LD-NS 2886 MR3, MR9 
LD with no transit peptide LD-NP 2718 MR 12, MR4 
LD with no transit peptide with no stop codon  LD-NPNS 2715 MR12, MR9 
LD transit peptide with no stop codon LD-TP 171 MR3, MR46 
 
Table 5.7 Limit dextrinase gene constructs created by PCR. 
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5.3.4 Limit Dextrinase was Cloned into Protein Expression Plasmids and 
Overexpression in E. coli was Optimised 
LD-FL and LD-NP were sub-cloned into vectors pDEST17 and pETG-10A which encode N-
terminal hexahistidine fusion proteins. Sub-cloning was performed using Gateway LR clonase 
which utilises site specific recombination. The plasmid recombination products were expressed 
in Rosetta and SoluBL21 E. coli hosts. The ability of the strains to produce LD in whole cells was 
tested by SDS-PAGE, to determine the best vector and gene combination for expression. The 
optimal conditions for expression of protein in whole cells, was LD with no transit peptide (LD-
NP) in pDEST17 expressed using SoluBL21 with induction using 0.2 mM IPTG and growth 
overnight at 28 °C (Figure 5.19, lane 4).  
 
The solubility of LD in the E. coli was next investigated. Soluble and insoluble protein fractions 
were produced and analysed by SDS-PAGE and anti-His6 western blot. Strain SoluBL21 gave the 
best expression of soluble LD (Figure 5.19, lanes 5 and 6) according to western blot. Further 
details on the optimisation of soluble expression are given in the Appendix. 
 
 
Figure 5.18 Agarose gel of PCR of gene variants of limit dextrinase for cloning. 
Agarose gel of LD PCR products. Lane 1 LD-FL, lane 2 LD-NS, lane 3 LD-NP, lane 4 LD-NPNS (see for full 
details of genes). 
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5.3.5 Limit Dextrinase was Overexpressed and Purified by Nickel Affinity, β-
Cyclodextrin Affinity and Gel Filtration Chromatography 
Nickel Affinity Chromatography 
LD was cloned into a pDEST17 vector that encodes an N-terminal His6 tag, thereby enabling 
purification by nickel affinity chromatography. Protein was expressed in SoluBL21, 8 L cultures 
of E. coil. Soluble protein extract was added to the nickel resin. Non-binding proteins were 
washed away, small traces of LD were seen in both the flow through and wash (Figure 5.20, A, 
B, lanes 3-5) this is possibly due to weak binding to the nickel column or column overloading. 
Bound proteins eluted in one sharp peak upon addition of 500 mM imidazole (Figure 5.20, B). 
Fractions from purification were analysed by SDS-PAGE and western blot. A band 
corresponding to the correct mass for His6-LD (101,974 Da) is present, although degradation 
products and other proteins appear to have bound to the nickel column. Degradation occurred 
during the purification process, as whole cell extracts show no signs of degradation. Other 
proteins may be bound to the resin because the low level of LD produced leaves capacity on 
the column for other proteins to bind. Activity of LD was shown using RP zymography (Figure 
5.20, D)- LD was highly active in elutions from the nickel column. 
 
 
Figure 5.19 Example of limit dextrinase overexpression and solubility screening in E. coli. 
A. pDEST17 constructs in SoluBL21. Lanes 1&2 correspond to LD-FL, lanes 3&4 correspond to LD-NT 
expressed at 28 °C overnight. 1&3 are uninduced, 2&4 are induced with 1 mM IPTG. All lanes loaded 
with the same volume of whole cells. B. SDS-PAGE and C. Western blot with anti-His6 antibody of 
pDEST17-LD-NT construct expressed at 28 °C overnight.  5&6 SoluBL21 strain. 5- soluble fraction, 6- 
insoluble fraction. LD-NT (101,974 Da) is indicated by an arrows. 
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Figure 5.20 Nickel Affinity Chromatography Purification of His-limit dextrinase. 
A. SDS-PAGE 12 % gel showing fractions. B. Chromatogram showing UV trace and corresponding elution 
from the column. Purification performed using 5 mL HisTrap column (GE), elution was performed with 
500 mM imidazole. 1 CV = 5 mL C. Western blot with anti-His6 antibody. D. Red Pullulan zymogram. 
Lanes: 1- soluble lysate 2- insoluble fraction 3- column flow through, 4&5- wash steps, 6-10- elutions. 
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Anion Exchange and β-Cyclodextrin Affinity Chromatography 
MonoQ anion exchange was attempted to further purify LD from nickel affinity purification 
however contaminating proteins were not removed, further details are in the Appendix. 
 
The product from nickel affinity chromatography was further purified by β-CD affinity 
chromatography. A β-CD affinity column was prepared by chemical modification of β-CD to 
give 6-deoxy-6-amino-β-cyclodextrin (amino-β-CD) and conjugation to NHS-activated 
Sepharose resin via the free amino group of amino-β-CD.  
 
Protein from nickel affinity chromatography was loaded onto the β-CD Sepharose resin. The 
flow through contained only a very small amount of LD, this is likely mis-folded protein that is 
not able to bind β-CD (Figure 5.21, A, lane 1). The flow through also contained a large number 
of other proteins with masses smaller than 100 kDa that had not been removed by the nickel 
affinity purification step (Figure 5.21, B, lane 2). The column was washed with prior to elution, 
this was sufficient to remove any traces of non-binding proteins as seen by the absorbance of 
zero on the chromatogram (Figure 5.21, between 25 mL and 75 mL). LD was eluted from the 
column by the addition of 7 mM β-CD. Bound protein elutes after 1 CV and eluted over 1 CV as 
one sharp peak. LD containing elution fractions were combined and buffer exchanged to 
remove traces of β-CD, which would otherwise inhibit the protein. The β-CD affinity 
purification process removed the vast majority of contaminating proteins. 
 
 
 
 
 
 
 
 
Figure 5.21 β-Cyclodextrin Affinity chromatography of limit dextrinase from nickel affinity 
purification. 
A. SDS-PAGE 12 % gel showing fractions from purification. 1-2- flow through fractions. 3-14- elution 
fractions. B. Chromatogram showing UV trace and elutions. Elution performed with 7 mM β-CD. 1 CV = 
25 mL 
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Gel Filtration 
The product from β-CD affinity purification was concentrated and applied to a Superdex S200 
gel filtration column. Protein eluted between 75 and 125 mL as one sharp peak (Figure 5.22, 
B). There is little indication of other proteins on the chromatogram, small peaks at 135 mL and 
300 mL can be seen (Figure 5.1, A) however when analysed by SDS-PAGE no protein was 
identified because the protein concentration was too low. LD eluted over a volume of 50 mL, 
fractions were combined and concentrated. 
 
A band at 25 kDa is visible by SDS-PAGE (Figure 5.22, A), this has occurred throughout all 
purification steps. The smaller protein fragment should have been removed by gel filtration 
and therefore it can be concluded that this fragment is a thermal degradation product 
produced during the heating step in preparation of samples for SDS-PAGE. Gel filtration was a 
successful method to obtain pure LD, there is little sign of other proteins on GF elution. 
 
 
  
Figure 5.22 Size Exclusion Chromatography on limit dextrinase. 
A. SDS-PAGE 12 % gel showing fractions from purification. 1- elution after 50 mL. 2-11- elutions 
corresponding to 75-125 mL. 1 CV = 320 mL B. Chromatogram showing UV trace and elutions fractions 
were collected when abs went above 0.2 mAU.  
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5.3.6 Overall Purification of Recombinant Limit Dextrinase to Homogeneity  
The overall protein purification procedure is summarised in Table 5.8. The procedure involved 
expression of LD-NT, harvesting and lysis of cells to produce a soluble lysate which was applied 
to a nickel affinity column. Proteins eluted from this were added to a β-CD affinity column and 
further purified. LD was then purified to homogeneity by gel filtration. The activity of LD was 
analysed throughout the procedure using the Limit Dextrizyme assay (Megazyme). The overall 
purification procedure enriched LD 75.4 fold. 
 
A large amount of protein was present in the soluble lysate however only a small proportion of 
this was LD, as identified by activity and SDS-PAGE. A large amount of the LD expressed in 
E. coli is found in the inclusion bodies. The process of nickel affinity chromatography purified 
the protein 42.3 fold, giving a highly enriched LD sample although numerous contaminating 
proteins remained present (Figure 5.23, lane). β-CD affinity chromatography produced a 
70.5-fold enrichment of LD, producing almost pure protein. Gel filtration removed the trace 
contaminants left over from β-CD affinity purification, however a large amount of total activity 
is lost with only a small increase in specific activity. It is possible that the contaminants present 
after β-CD affinity purification are fragments of LD that possess some form of activity. Nickel 
affinity purification gives good recovery (94 %) with only 10 % of total activity being lost. 
During β-CD purification a large, ten-fold, amount of total LD activity is lost. The protein may 
have been lost during concentration and buffer exchange steps during which some protein can 
be lost to aggregation or nonspecific binding to membranes. Protein products from each step 
were visualised by SDS-PAGE and western blot, an increase in LD purity can be seen 
throughout the purification procedure. The specific activity increases as purity increases (Table 
5.1). A band at 25 kDa can be seen throughout the procedure. The presence of LD was 
confirmed by MS on the SDS-PAGE bands at 101974 Da from β-CD and GF. 
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Step 
 
Total Protein 
(mg) 
Total 
Activity (U) 
Recovery 
(%) 
Specific Activity 
(U/mg) 
Purification 
(fold) 
Soluble 
Lysate 
1832.40 111.36 100.0 0.1 1.0 
HisTrap 40.89 105.19 94.5 2.6 42.3 
β-CD-
Sepharose 
2.36 10.12 9.1 4.3 70.5 
Gel Filtration 1.44 6.61 5.9 4.6 75.4 
 
Table 5.8 Purification Table for Recombinant limit dextrinase expressed in E. coli 
LD activity was analysed using the Limit Dextrizyme assay, following manufacturer’s (Megazyme) 
instructions. Total protein was quantified by Bradford assay with BSA a standard. 
 
 
 
 
 
 
Figure 5.23 Overall purification of His-tagged limit dextrinase. 
A. SDS-PAGE 12 % gel showing products from purification steps. B. Western blot with anti-His6 antibody. 
1- Soluble lysate from E. coli. 2- Product from nickel affinity chromatography. 3- Product from β-CD 
affinity chromatography. 4- Product from gel filtration. 
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5.3.7 Production of Polyclonal Antibodies against Limit Dextrinase 
Antibodies were raised using recombinant LD produced in E. coli. Antibody production was 
performed in two rabbits (Eurogentec). Four immunisations were performed at days 0, 14, 28, 
56. Four bleeds were taken at days 0 (pre-immune), 38 (small bleed), 66 (large bleed), 87 (final 
bleed). An ELISA was performed on the bleed samples from both rabbits. LD was adsorbed to 
an ELISA plate, blocked to prevent non-specific binding, incubated with sera dilutions, then 
incubated with anti-rabbit HRP conjugate secondary antibody. Figure 5.24 demonstrates that 
the sera raised against LD has activity against the recombinant protein bound to the surface of 
the ELISA plate. Pre-immune sera from both rabbits shows little activity towards LD. These sera 
represent the background binding of rabbit sera prior to immunisation and show that the 
polyclonal antibodies lack pre-existing activity. Any activity observed by the sera following 
immunisation represents specific activity of the antibodies towards LD. Small bleed and final 
bleed sera from both rabbits show a strong activity at high to medium concentrations. Rabbit 
03 shows an increase in response between the small bleed (38 d) and final bleed (87 d) this is 
due to an increased antigen exposure time leading to a stronger immune response. The anti-
LD sera from both rabbits have good affinity for LD and can be utilised in further analyses. 
 
 
 
Figure 5.24 ELISA of rabbit sera activity against recombinant limit dextrinase produced in E. coli. 
Blue- preimmune sera (0 d), red- small bleed (38 d) green- final bleed (87d). Data was recoded in 
triplicate using ELISA protocol. 
182 
 
The following section describes the work performed on the proteinaceous inhibitor of limit 
dextrinase- LDI. This protein is proposed to be responsible for low levels of LD activity. To 
analyse the interaction between the two proteins in planta recombinant protein was 
generated used and raise antibodies. 
 
5.3.8 The Gene Encoding Limit Dextrinase Inhibitor was Detected in Barley 
The total barley RNA samples used for the attempted cloning of LD were utilised for the 
cloning of LDI. RNA from 0 dpi and 3 dpi endosperm were utilised in an RT-PCR to successfully 
amplify the 444 bp gene encoding LDI ( 
Figure 5.25, lanes 1&2).  
 
 
 
 
 
 
 
 
 
 
 
 
 
5.3.9 Limit Dextrinase Inhibitor was Cloned from Barley mRNA into Gateway 
Compatible Entry Plasmids 
The LDI sequence (acc. DQ285564.1) was analysed using SignalP-4.1, Protein Prowler and 
ChloroP-1.1 software to identify the presence of any localisation signal. A secretion signal was 
identified when full length LDI was analysed by SignalP (Figure 5.27, A). The cleavage site 
identified was VAAA/TLE (Figure 5.27, arrows). This cleavage point has been experimentally 
validated by N-terminal sequencing of mature LDI from barley (Figure 5.26) (Macgregor et al., 
2000). The cleavage product, beginning TLE when re-analysed with SignalP produces no 
indication of a secretion signal. Protein prowler analysis supports the SignalP prediction (Figure 
 
Figure 5.25 Agarose Gel of PCR amplified limit dextrinase inhibitor from barley mRNA. 
Amplicons produced using mRNA from, Lane 1- 0 dpi endosperm, Lane 2- 3 dpi endosperm. 
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5.27). ChloroP showed no indication of a chloroplast transit peptide. TLE was chosen as the 
cleavage point for the production of LDI genes with and without secretory peptide. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.26 DNA and protein sequence of limit dextrinase inhibitor. 
Green letters and solid line correspond to the starting Met proposed by (Stahl et al., 2007). Blue letters 
and dashed line represents the cleavage site of the proposed secretory peptide (Macgregor et al., 
2000).  
 
 
 
 
 
 
Figure 5.27 Subcellular Localisation Signal Prediction for limit dextrinase inhibitor. 
Protein secretion signal prediction performed on the full length LDI sequence using A. SignalP software, 
B. Protein Prowler, SP- signal peptide. MTP- mitochondrial transit peptide, CTP- chloroplast transit 
peptide. Arrow shows predicted secretory peptide cleavage point. 
184 
 
An RT-PCR reaction was performed, using 0 dpi endosperm RNA as the template. The LDI gene 
with and without putative secretory sequence were amplified with and without stop codons 
(Table 5.9). The product of the PCR for each gene can be seen in, D. The secretion signal alone 
was also amplified however this amplicon is small (69 bp) and not easily visualised by agarose 
gel electrophoresis. The five PCR products were cloned into pCR8-TOPO-GW using TOPO 
cloning. Constructs containing the correct sequences were obtained after screening. 
Sequencing revealed one natural polymorphism (C62T) when compared with accession 
DQ285564.1. This causes a V21A change to the protein sequence. SNPs similar to this have 
been identified in LDI genes from numerous wild barley cultivars (Huang et al., 2014). 
 
Name Abbreviation Size (bp) Primers 
Full length LDI  LDI-FL  444 MR5, MR6 
Full length LDI with no stop codon  LDI-NS  441 MR5, MR10 
LDI with no secretion peptide  LDI-NP  375 MR13, MR6 
LDI with no secretion peptide with no 
stop codon  
 LDI-NPNS  372 MR13, MR10 
LDI secretion peptide with no stop 
codon 
 LDI-SP  69 MR5, MR36/37 
 
Table 5.9 Limit dextrinase inhibitor gene constructs created by PCR. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.28 PCR of limit dextrinase inhibitor gene variants for cloning. 
Agarose gel of LDI PCR products. Lane 1 LDI-FL, lane 2 LDI-NS, lane 3 LDI-NP, lane 4 LDI-NPNS (see  
Table 5.9). 
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5.3.10 Limit Dextrinase Inhibitor was Cloned into Protein Expression Vectors and 
Insoluble Protein was Expressed 
LDI-FL and LDI-NS were sub-cloned into hexahistidine fusion vectors pDEST17 and pETG-10A. 
Sub-cloning was performed by Gateway LR cloning. Vectors harbouring the correct sequences 
were transformed into Rosetta and SoluBL21 E. coli expression hosts. The strains ability to 
express LDI in whole cells was tested by SDS-PAGE, to determine the best vector and gene 
combination for expression alongside the optimal IPTG concentration and growth 
temperature. The optimal conditions for expression, in whole cells, was LDI-NS in pDEST17 
expressed using SoluBL21 at 28 °C overnight (Figure 5.29, A, lane 4).  
 
The solubility of LDI in E. coli strains was next investigated. Soluble and insoluble protein 
fractions were generated and analysed using SDS-PAGE and anti-His6 western blot (Figure 5.29, 
B and C). No soluble LDI was identified in any E. coli strains. Further details on expression 
screening are in the Appendix. 
 
 
 
 
 
Figure 5.29 Example of limit dextrinase inhibitor overexpression and solubility screening in E. coli. 
A. pDEST17 constructs in SoluBL21. SDS-PAGE. Lanes 1&2 correspond to LDI-FL (18624 Da), lanes 3&4 
correspond to LDI-NS (16318 Da) all expressed at 28 °C overnight. 1&3 are uninduced, 2&4 are induced 
with 1 mM IPTG. All lanes loaded with the same volume of whole cells. B&C. pDEST17- LDI-NS construct 
expressed in SoluBL21 at 28 °C overnight. B. SDS-PAGE C. Western blot with anti-His6 antibody. Lane 5- 
soluble fraction. Lane 6- insoluble fraction. Lanes loaded with the same volume of cell lysate. 
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5.3.11 Attempted Expression of Limit Dextrinase Inhibitor as a Secretory Protein 
As no soluble protein was produced by cytosolic expression, protein secretion to the 
periplasmic space was attempted. First secretion was attempted using the secretory peptide 
present in full length LDI. The previously cloned LDI-NS was cloned into pDEST42 which 
encodes a C-terminal His6 tag. Expression was performed in strains Rosetta and SoluBL21. 
These strains are compatible with periplasmic expression as they lack the plysS lysozyme 
system which can interfere with secretion. Periplasmic protein fractions were created using 
cold osmotic shock. The osmotic shock and whole cell fractions were analysed by SDS-PAGE 
and western blot (Figure 5.30). LDI (20726 Da) could only be identified in the whole cell 
fractions meaning it had not been secreted. The LDI signal peptide was not sufficient to drive 
protein secretion in E. coli. 
 
 
 
 
 
 
 
Figure 5.30 Gel of attempted periplasmic expression of limit dextrinase inhibitor using the native 
plant secretory peptide. 
A. SDS-PAGE B. Western blot with anti-His6 antibody. Lanes correspond to the following: 1-6 SoluBL21 
and 7-9 Rosetta. Lanes 1, 4, 7- whole cells. 2, 5, 8- concentrated periplasmic fraction. 3, 6, 9 dilute 
periplasmic fraction LDI (20726 Da) is only present in whole cells according to western blot. 
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As LDIs own secretion signal was not sufficient to enable periplasmic expression LDI-FL was cloned 
into pOPIN27b- a derivative of pET27b that encodes a PelB secretion signal as well as a C-terminal His6 
tag. Expression was performed in Rosetta and SoluBL21. Whole cell, concentrated and dilute 
periplasmic fractions were analysed by SDS-PAGE and western blot  
Figure 5.31. No expression could be seen at the correct size (16,318 Da). LDI could not be 
targeted to the periplasmic fraction using the PelB secretion signal.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.31 SDS-PAGE gel of attempted periplasmic expression of limit dextrinase inhibitor in E. coli 
using the PelB secretory peptide. 
SDS-PAGE gel. Lanes correspond to the following: 1-6 SoluBL21 and 7-9 Rosetta. Lanes 1, 4, 7- 
uninduced whole cells. 2, 5, 8- induced whole cells. 3, 6, 9 dilute periplasmic fraction LDI (20726 Da) is 
not present according to western blot (not shown). Arrow indicates where LDI should be seen. 
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5.3.12 Insoluble Limit Dextrinase Inhibitor was Purified and Refolded  
 
Purification and refolding by dilution in redox buffer 
As no method for producing soluble LDI was achieved, a protocol for solubilisation, purification 
and refolding was established. Insoluble LDI was produced in SoluBL21 and solubilised using 
urea and β-ME. The solubilised sample was refolded by dilution in a cysteine-cystine redox 
system that catalyses disulfide exchange and therefore rearranges the linkages found within 
the protein. Soluble product was concentrated by nickel affinity chromatography. The elution 
from the nickel column was subjected to SDS-PAGE in both reducing and non-reducing 
conditions. Non-reducing conditions reveal the existence of three separate species (Figure 
5.32, A, arrows) with masses ranging from ~13-18 kDa. These bands correspond to different 
intramolecular disulfide linkage combinations. A 32 kDa dimer is also present alongside higher 
order multimers corresponding to inter protein disulfide bonds or covalent multimers. The 
different species became one diffuse band under reducing conditions (Figure 5.32, B), the 
breakdown of disulfide bonds produces only one species of unfolded and reduced LDI. The gels 
show that the refolding process generated a number of soluble forms that represent misfolded 
LDI. The LDI from this procedure was tested in a Limit Dextizyme assay however it showed no 
inhibitory activity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.32 SDS-PAGE gel showing refolded limit dextrinase inhibitor. 
A. Non-reducing gel B. Reducing gel. Arrows indicate forms of LDI. 
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On-column refolding 
As multiple forms of LDI were produced using the refolding by dilution method, an on-column 
folding method was attempted. β-ME solubilised LDI was loaded directly onto a HisTrap 
column. The column was washed to remove non-specifically bound proteins. Buffer was slowly 
added to the column to allow the concentration of β-ME to slowly decrease to support 
refolding of LDI. Proteins were eluted using 500 mM imidazole. The latter elution fractions 
contain monomeric and dimeric LDI forms (Figure 5.33, lanes 14-15). LDI is already relatively 
pure prior to affinity column purification, this method helps refold LDI to the monomeric form 
which can be seen by the decrease in larger proteins in the elution and the increase in LDI 
protein at 16 kDa (Figure 5.33, lanes 13-15). LDI containing fractions were combined and 
concentrated. Refolding on HisTrap column produced some protein that remained in solution 
however most protein was prone to aggregation. LDI refolding using a QuickFold protein 
refolding kit was attempted with the product from on column refolding. Analysis of 15 
different refolding buffers showed no enhancement of folding and solubility (Appendix). 
 
 
 
 
 
MonoQ anion exchange chromatography was attempted to further purify LDI from on column 
refolding (Appendix). The protein added to the MonoQ column and the elutions were almost 
identical, only one large peak was produced. It was therefore concluded that LDI had been 
purified to homogeneity by the previous steps. 
Figure 5.33 Solubilisation and nickel affinity chromatography purification of limit dextrinase inhibitor. 
SDS-PAGE 12 % gel showing purification fractions. Monomeric form of the protein can be seen at 16 
kDa. Lanes 1-6 pre-loading onto nickel resin. 7-9 flow though. 10-11 wash steps 12-15 elution steps.  
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5.3.13 Overall Purification and Solubilisation of Limit Dextrinase Inhibitor 
LDI was purified by an overall procedure involving extraction of insoluble material from E. coli 
followed by solubilisation of the disulfide linked aggregate using β-ME. The solubilised LDI was 
concentrated and refolded using column assisted refolding with a nickel affinity resin. Protein 
quantification was hampered by the lack of any aromatic residues within the protein, 
alongside the tendency to aggregate. Estimates of protein concentration were made using 
densitometry on an SDS-PAGE gel alongside BSA standards of known concentration. It was 
estimated that 4 mg of protein were purified from 4 L of E. coli culture.  
 
The LDI produced by this procedure is prone to aggregation. Incubation at room temperature 
leads to the reformation of aggregates (Figure 5.34, A, lane 2) with sizes which correspond to 
multiples of LDI (16, 32, 48, 64, 80, 94 kDa). Some LDI remained soluble and could be 
separated from insoluble material by centrifugation. This protein was used for the generation 
of antibodies for LDI. Inclusion of this protein in a limit dextrizyme assay for LD resulted in no 
inhibition.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
. 
 
Figure 5.34 Purification of His-tagged limit dextrinase inhibitor. 
A. SDS-PAGE 12 % gel. B. Western blot with anti-His6 antibody. Lanes correspond to, 1- Protein from 
solubilisation using β-mercaptoethanol. 2- Protein following purification using nickel affinity 
chromatography and incubation at room temperature for 2 days. 
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5.3.14 Production of Antibodies for Limit Dextrinase Inhibitor 
Antibodies were raised using recombinant refolded LDI produced in E. coli. Protein was 
combined with adjuvant and administered to two rabbits over a period of three months. 
Antibody production was performed by Eurogentec. Four immunisations were performed on 
days 0, 14, 28, 56. Four bleed samples were taken at days 0 (pre-immune), 38 (small bleed), 66 
(large bleed), 87 (final bleed). An ELISA was attempted on the bleed samples from both rabbits 
however issues arose due to the insoluble nature of recombinant LDI. The protein would not 
adsorb to the ELISA plate and therefore gave low immunogenic readings. To overcome the 
insolubility issues caused by recombinant LDI a western blot was performed using recombinant 
LDI, blot slices were incubated with different sera at different concentrations. Both rabbits 
produce sera that is able to detect LDI, whereas the pre-immune sera does not detect LDI 
Figure 5.35. 
 
 
 
 
Figure 5.35 Western blot on limit dextrinase inhibitor produced in E. coli. using rabbit sera antibodies 
raised against the recombinant protein 
Strips from western blot were incubated with different concentrations of sera. Lanes: Pre- immune 1. 
1/100. 2. 1/1000. 3. 1/10000. Large bleed 4. 1/10. 5. 1/100. 6. 1/1000. 7. 1/10000. 8. No primary 
control. 
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5.4 Discussion  
This chapter presents the first detailed outline of the production of recombinant LD and LDI in 
E. coli. In order to achieve this, the genes encoding LD and LDI were obtained by gene 
synthesis and cloning, respectively. The genes were cloned into E. coli expression vectors and 
protein expression was optimised. The proteins were purified and utilised for the generation of 
polyclonal antibodies. 
5.4.1 The Gene Encoding Limit Dextrinase 
The large gene, encoding LD was produced by Gene synthesis. Methods to obtain the full 
length gene from germinating barley grains failed. Previous cloning of the full length gene 
outlined in the literature involved lengthy efforts which utilised cDNA libraries or fragment 
based cloning and ligation (Kristensen et al., 1999a). Strategies similar to these were 
attempted but yielded only fragments of the cDNA sequence. LD is a large gene (11 kbp) with 
27 introns that are spliced to produce a cDNA of 2,889 bp (Burton et al., 1999). The struggle in 
cloning was likely due to a combination of the length of the gene and the high number of 
introns. The LD gene has a high GC content which may form secondary structures that can 
block polymerase activity and prevent amplification. Low transcript levels may also contribute 
to the inability to amplify full length LD. 
 
Gene synthesis of the cDNA for native barley (i.e. non-codon optimised) LD was hampered as 
the sequence was not well tolerated by E. coli, with one gene section giving repeated 
mutations in independent transformants. The portion of the gene causing mutations was 
analysed, however, there was no obvious explanation for the mutations. Furthermore, 
extremes of GC/AT content, as seen within the LD gene, can cause issues during gene 
synthesis. A correct LD sequence was obtained in one colony and the gene was successfully 
synthesised. A codon optimised version of the gene would likely make gene synthesis easier 
and may be better for E. coli expression. However, due to length of the gene, synthesis was 
costly and it was decided that the native barley gene would be of more use for expression in 
other hosts. 
 
A putative chloroplast transit peptide has been identified within the N-terminal protein 
sequence of LD, the significance of this targeting sequencing has not yet been studied within 
plants. The generation of vector constructs containing LD with and without the putative cTP 
now enables experiments to gain a better understanding of LD localisation. 
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5.4.2 The Gene Encoding Limit Dextrinase Inhibitor 
The gene encoding LDI was easily amplified from barley mRNA, this is likely due to its small size 
(444 bp) and the absence of introns within its gene sequence (Stahl et al., 2007). Others have 
reported the cloning of LDI, the procedures described suggest cloning was problem free 
(Jensen et al., 2011, Stahl et al., 2007). The LDI transcript is present in endosperm mRNA at 
both 0 and 3 dpi. It has been proposed that the LDI transcript is not expressed during 
germination (Stahl et al., 2007). However, there is a possibility that small amounts of transcript 
remain present from grain filling, these can be amplified by RT-PCR. 
 
To date LDI has only been identified in the gene sequence data for wheat, brachypodium, rice 
and barley. Searches performed with the full length protein or gene sequences against other 
plant genomes transcriptomes and proteomes, including sorghum, tef, and millet, yielded no 
significant hits. There is a possibility that LDI is only found within a small group of closely 
related grasses. LD has been identified in both dicot and monocot species, as such it is not 
clear why some plants would require LDI when others do not. The protein family to which LDI 
belongs has a common fold which is used for multiple purposes including antimicrobial 
defence, cell wall metabolism and signal transduction (Svensson et al., 2004, Yeats and Rose, 
2008, Maldonado et al., 2002, Liu et al., 2015). It is possible that this protein fold acts as a 
general scaffold with variable loops that have evolved to perform a range of functions (Jang et 
al., 2008). 
5.4.3 The Heterologous Overexpression and Purification on Limit Dextrinase 
A recent publication, published whilst this work was ongoing, outlined the use of E. coli for the 
production of pure LD for the use in crystallography (Møller et al., 2015b). However, no details 
on expression optimisation and conditions were given, except that a codon-optimised version 
of the LD gene was used. Within this study a non-codon optimised (i.e. the native barley 
sequence) gene for LD was utilised to generate soluble protein. 
 
When expressed in E. coli, a large proportion of the LD produced is found in an insoluble form, 
although low levels of active soluble protein are present and can be purified. The insolubility 
issues were overcome to some extent by using SoluBL21, an E. coli strain developed to give 
better soluble expression. The likely explanation for the insolubility of LD in E. coli is that it is a 
large, multi-domain protein, which is prone to incorrect folding. Expression at 37 °C does not 
give high yield of active protein and produces higher levels of aggregated and precipitated 
protein. Decreasing the growth temperature from 37 °C to 28 °C and reducing the IPTG 
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concentration used for induction of protein synthesis, from 1 mM to 0.2 mM, generated 
increased levels of soluble protein. Furthermore, expression of genes containing high levels of 
rare codons can deplete the E. coli tRNA pools and lead to sub-optimal translation that can 
cause protein misfolding. This issue can be overcome by the use of strains that contain extra 
tRNAs for rare codons as outlined in this study, however the gold standard for expression is 
the use of a gene that is codon optimised for expression in E. coli. 
 
Previous purification of LD, expressed using Pichia, involved an untagged protein which was 
purified by β-CD affinity and GF (Vester-Christensen et al., 2010b). This simple two step 
purification method was enabled by the secretion of the protein into the culture supernatant 
which therefore enriched the protein sample before purification. The purification of LD 
outlined within this work involved an additional nickel affinity purification step, this was due to 
the large number of protein contaminants seen within the cytosol of E. coli. It is likely that β-
CD affinity chromatography and GF would not be sufficient to remove all contaminants. 
However, if the E. coli crude protein was applied directly to the β-CD the CD coupled to the 
resin may be hydrolysed or modified by E. coli proteins therefore degrading the column. 
 
Anion exchange was attempted as an alternative separation method following a nickel affinity 
purification step. This procedure gave poor separation of LD, with contaminant proteins from 
E. coli eluting alongside LD. Anion exchange performed on LD following β-CD affinity 
purification revealed the existence of multiple forms of LD. This type of microhetereogeneity 
has been described previously with spinach and wheat enzyme (Schindler et al., 2001, Renz et 
al., 1998, Repellin et al., 2008). This is the first evidence for similar behaviour in the barley 
protein.  
 
A high level of LD degradation products are present following nickel affinity purification the 
expected cause of this is proteolysis enabled by incorrect folding. β-CD affinity 
chromatography works well to remove most contaminants left over from the nickel affinity 
step, and GF effectively removes all contaminants to produce very pure LD. Throughout the 
purification procedure a band is seen at 25 kDa, this band is likely a product of LD thermal 
degradation as it remains present in all samples and is proportional to the amount of LD 
loaded on a gel. LD has a thermal stability of 65 °C (Møller et al., 2015a), during sample 
preparation for SDS-PAGE a temperature of 70 °C is used, therefore supporting this argument. 
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When analysed using the limit dextrizyme assay or red pullulan zymography, the activity of LD 
expressed in E. coli is much lower when compared with the P. pastoris expression system. This 
may arise because of a difference in protein folding within the different hosts, although the 
longer purification process also introduces more points for loss of protein activity. In terms of 
quantity E. coli produces similar protein levels to Pichia grown in regular culture conditions, it 
is only when fed batch production is used that multi-mg quantities are produced (Vester-
Christensen et al., 2010b). E. coli does, however, generate higher quantities of LD than 
purification from barley malt which would be the alternative to recombinant expression. 
5.4.4 The Heterologous Overexpression of Limit Dextrinase Inhibitor 
LDI was insoluble in all E. coli expression conditions tested. Previous expressions of LDI in 
E. coli encountered similar problems, yielding only low levels of insoluble protein. As the 
protein contains 9 cysteine residues, 8 of which form disulfides, it is likely that incorrect 
disulfide folding is the reason LDI does not form soluble protein (Trivedi et al., 2009). Evidence 
for covalent disulfide multimers are seen in non-reducing SDS-PAGE. A covalent dimer is also 
generated which is resistant to disulfide cleavage using β-ME. Covalent dimers can also form 
by oxidation of thiol groups (Figure 5.36) (Trivedi et al., 2009) and has been previously 
identified in this type of protein (Chen et al., 1999, Yoo et al., 2003).When expressed in Pichia, 
secretion and batch feeding enabled the production of high levels of correctly folded LDI, the 
yeast extracellular environment is conducive to the generation of correctly linked disulfides. 
 
 
 
 
 
 
 
Figure 5.36 The generation of covalent dimers in disulfide containg proteins 
A hydroxyl attacks a disulfide bond (A) generating sulfinic acid and a thiolate ion (B), this can undergo 
an intermolecular reaction between the sulfur atom of the sulfinic acid group and a disulfide present in 
another molecule thus producing an intermediate dimer (C). This intermediate can form a dimer 
molecule containing two free thiols (D). 
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The role of the secretion peptide within the LDI protein sequence is unclear. The peptide is yet 
to be proven to direct secretion however the mature form of LDI found in barley lacks the 
peptide, implying it is cleaved (Macgregor et al., 2000). Generation of gene constructs with and 
without the secretory peptide enabled demonstration that the secretory peptide is unable to 
direct secretion within E. coli. It would not necessarily be expected that a Eukaryotic secretion 
signal could direct protein secretion within a Prokaryote, however there is precedent for 
crossover between the two systems (Hall et al., 1990, Moeller et al., 2009). Secretion of LDI 
using the native E. coli PelB secretion signal also yielded no recombinant protein in the 
periplasmic fraction.  
 
A procedure for the solubilisation of insoluble LDI using urea and β-ME was developed. This 
procedure produced relatively pure LDI because the inclusion bodies of E. coli contain high 
levels of the expressed protein and the extraction process removed the majority of other urea 
soluble proteins. This solubilised protein was used in refolding experiments by dialysis, dilution 
or on-column refolding. All methods yielded LDI that would remain in solution for short 
periods of time however precipitation occurred upon storage for days. There is no overarching 
method by way to refold proteins and one can easily become embroiled in process of testing 
numerous different methods. Other disulfide containing proteins, similar to LDI, have been 
produced in an insoluble form in E. coli and refolded in many different ways (Okuda et al., 
1997, Lullienpellerin et al., 1994, Dias et al., 2005), though the analysis of refolding yield is 
limited by analytical techniques. With this type of inhibitor proteins there is no way to easily 
asses folding. Assays utilise either inhibition of another enzymes activity or the use in variable 
biological assays. Neither of which give a direct and definitive indication of correct folding. 
Optimisation of soluble expression within a host or changing host can be much simpler than 
the protein refolding process. 
 
5.4.5 The Generation of Polyclonal Antibodies Specific for Limit Dextrinase and 
Limit Dextrinase Inhibitor 
The immunisation of rabbits with recombinant LD and LDI enabled the production of protein- 
specific polyclonal antibodies. When tested in an ELISA the LD antibodies show strong specific 
binding to recombinant antigen. The LDI antibodies give a good response to recombinant LDI in 
western blot although issues caused by insolubility give an imprecise result and hamper the 
use of an ELISA. Both sets of antibodies show a specific response at a 1 in 1000 dilution of sera, 
when compared to pre-immune sera of the same concentration. There are slight differences 
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between the binding capability of the sera produced in different rabbits however all are 
capable of detecting the protein they have been raised against. The antibodies are a useful 
tool for further studies of LD and LDI in planta. Other antibodies have previously been 
produced for LDI, however these were generated decades ago and have been passed between 
researchers to the point that their origins have become untraceable (Stahl et al., 2007). 
5.5 Future Directions  
5.5.1 Understanding the Genes Encoding Limit Dextrinase and Limit Dextrinase 
Inhibitor 
It remains unclear why LD possesses many introns and exons, and how this relates to its 
function. Only the LD cDNA has been generated and utilised within this study. There may be 
potential to better understand the gene and its expression by analysis of the promoter, 
flanking regions and splice sites. 
 
It is yet to be determined whether the putative chloroplast transit peptide of LD and secretory 
peptide of LDI are important for their function in cereals in the context of the aleurone layer 
and the leaf. As both genes for LD and LDI were cloned into Gateway compatible entry vectors, 
cloning into other expression vectors, in order to answer these questions, will be convenient.  
5.5.2 Further Optimisation of Limit Dextrinase Protein Expression 
There is scope for further optimisation of LD expression and purification to obtain more 
soluble protein. An E. coli codon optimised version of the gene may generate more soluble 
protein. IPTG concentration, batch induction, additional of osmolytes, growth temperature 
and other growth media are all avenues for potential optimisation. 
 
Periplasmic expression of pullulanase alongside the addition of betaine and a detergent to the 
growth media has also been reported to produce high quantity of active protein (Duan et al., 
2013, Duan et al., 2015). Periplasmic secretion would also enable a streamlined purification 
procedure as fewer potential contaminant proteins are present in the periplasmic space 
compared to inside the cell. 
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5.5.3 Expression of Limit Dextrinase Inhibitor Protein in a Soluble Form 
There are a number of other avenues that can be explored in an attempt to generate correctly 
folded, soluble, LDI. Further opportunities for optimisation in E. coli include the use of other 
peptides for secretion, the use of disulfide folding strains and the generation of thioredoxin 
fusion proteins to aid the generation of correct disulfide linkages (Kong and Guo, 2014, De 
Marco, 2009). 
 
There is already precedent for the production of LDI in Pichia, however this expression system 
requires an expensive batch bioreactor to yield high levels of protein. Expression in another 
bacterial host which can be easily cultured (in a way similar to E. coli) may be possible. One 
potential host may be Streptomyces, which is known to secrete a number of enzymes, and has 
been used for the secretory expression of disulfide linked heterologous proteins (Tremblay et 
al., 2002, Lussier et al., 2010). There is also the possibility of expression in plants (N. 
benthamiana) using the pEAQ-HT overexpression system developed at John Innes Centre 
(Peyret and Lomonossoff, 2013). 
5.5.4 Use of Antibodies 
Both sets of antibodies have been shown to be able to detect the proteins they have been 
raised against. This result suggests that the antibodies will be useful for further analysis of 
native and recombinant-fusion proteins, in planta, using techniques such as Co-IP, 
immunolocalisation and western blots. 
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6 Chapter 6- Steps Towards Understanding the in Planta Roles 
of Limit Dextrinase and Limit Dextrinase Inhibitor  
6.1 Introduction 
6.1.1 The Release of Starch Active Enzymes During Germination 
Temporal and spatial control over carbohydrate active enzymes during germination is essential 
for plant growth. Proteomics on grain tissues has identified that a large number of the proteins 
present during germination are glycosyl hydrolases (Finnie et al., 2011). Changes in the protein 
profile occurs as early as 4 h after the onset of germination (or GA addition in culture) which 
indicates that some processes involved in germination are pre-programmed into the grain 
during seed maturation. Other processes including the hydrolytic action of proteases, 
activation by redox and programmed cell death (PCD) of the aleurone act to regulate and 
control the process of germination (Finnie et al., 2011). 
 
β-Amylase 
β-Amylase is synthesised in the endosperm during grain filling. Upon germination the protein is 
released from an inactive “bound” form. The “free” form of β-amylase can be generated by 
incubation with reducing agents (Buttimer and Briggs, 2000, Duke et al., 2012). Both serine and 
cysteine proteases are capable of producing active β-amylase (Guerin et al., 1992, Schmitt and 
Marinac, 2008) (Figure 6.2). β-amylase in maize is reported to not be involved in starch 
degradation. The protein is synthesised and retained in the aleurone layer and is therefore 
proposed to be unimportant for germination (Wang et al., 2004, Wang et al., 1997, Subbarao 
et al., 1998). 
 
α-Glucosidase 
α-Glucosidase is proposed to be released from the aleurone in a way similar to α-amylase. 
mRNA levels increase strongly after the application of GA, with a similar pattern to that 
exhibited by α-amylase (Tibbot and Skadsen, 1996). Little else is known about the role of 
glucosidases, however knockdown of the main isoform AGL97 does not have dramatic effects 
on germination (Stanley et al., 2011, Frandsen et al., 2000). 
 
α-Amylase 
The release of α-amylase from the aleurone layer in response to GA has long been studied 
using isolated aleurone layers in liquid culture (Chrispeels and Varner, 1967, Locy and Kende, 
1978, Ranki and Sopanen, 1984) (Figure 6.2). Cultured aleurone layers produce comparable α-
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amylase levels to GA treated deembryonated half grains (Chrispeels and Varner, 1967). Indeed, 
GA responsive elements have been identified in the promoter of the barley α-amylase gene 
(Gubler and Jacobsen, 1992). Ca2+ also stimulates the release of amylase, although the 
mechanism of action is yet to be elucidated (Bush et al., 1986). Cyclic guanosine 
monophosphate (cGMP) is required for GA induced gene expression in barley. LY83583, a small 
molecule inhibitor of guanylate cyclase prevents GA induced α-amylase synthesis and 
secretion (Penson et al., 1996). α-amylase production is blocked when protein and RNA 
synthesis are inhibited, indicating the protein is synthesised de novo by the aleurone layer 
(Chrispeels and Varner, 1967). During the first 24 h of germination the enzyme is retained 
within the aleurone cells. Protein and RNA synthesis inhibitors added at 24 h prevent 
formation of the release mechanism, indicating it is likely protein based (Chrispeels and 
Varner, 1967). It is suggested that a breakdown of the aleurone cell walls is responsible for the 
release of α-amylase (Gubler et al., 1987).  
 
It is not clear how all of these processes come together to control the release and activity of α-
amylase though it is a tightly regulated process. Timing of germination is essential to a 
seedlings survival. Germination at the wrong time, as is seen during pre-harvest sprouting 
(PHS), can have dire consequences for both the growing plant and farmers (Figure 6.1) (Ren et 
al., 2012). It is likely that other glycosyl hydrolases within the aleurone and endosperm are 
under similar control, however, details regarding this are scarce. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1 Pre-harvest sprouting in wheat 
Upper. Sprouted heads which have undergone pre-harvest sprouting. Lower. Non-sprouted heads. 
Adapted from (Ren et al., 2012). 
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6.1.2 The Release of Limit Dextrinase During Germination 
In barley, expression of the sole gene encoding for LD is induced by GA during grain 
germination by GA (Hardie, 1975, Shahpiri et al., 2015) (Figure 6.2). Transcripts corresponding 
to LD can be identified within the aleurone layer as early as 12 h after the onset of 
germination. However, LD activity isn’t present at high levels until two days post imbibition, 
with activity increasing almost tenfold from day 2 to day 5 (Burton et al., 1999, Schroeder and 
Macgregor, 1998, Macgregor et al., 1994). The activity and precise timing of LD release 
depends on germination conditions and variety (Ross et al., 2003).  
 
Transcripts for LD are also present during grain development. RT-PCR shows LD mRNA is 
present in the endosperm at low levels during early stages (1-10 days post anthesis, dpa) and 
increases steadily until 24 dpa (Radchuk et al., 2009, Burton et al., 1999). LD activity is present 
at very low levels in ungerminated grain, this is likely to be protein that is carried over from 
grain filling (Macgregor et al., 1994, Schroeder and Macgregor, 1998). Interestingly, LD in rice 
and peas has been shown to be present in a mature, active form within the endosperm of 
dormant seeds (Vlodawsky et al., 1971, Yamada, 1981, Mangan et al., 2015). 
 
The slow release of LD is not fully understood. LD has no signal peptide to direct secretion and 
has a putative plastid transit peptide as discussed in Chapter 5. It is unclear what role this plays 
and whether LD is directed to plastids within the aleurone. There is very little recent 
information on plastids in the aleurone layer (Wise, 2006). LDI, cell wall metabolism, 
proteases, cell death and redox have all been linked to LD release and activity levels. 
 
 
 
 
 
Figure 6.2 The release of starch active enzymes during barley grain germination. 
A. β-Amylase is activated by proteolysis. B. α-Amylase and α-glucosidase are secreted from the 
aleurone layer. C. The precise mode of limit dextrinase release remains unknown. 
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Limit Dextrinase Inhibitor 
When extracted from germinating barley grains LD is found in a “bound”, inactive from as well 
as a “free” enzymatically active form (Longstaff and Bryce, 1993). The inactive form of LD has 
been proposed be in complex with the endogenous inhibitor LDI (Mccafferty et al., 2004). No 
LDI activity has been identified in maize, pearl millet, sorghum or rice (Macgregor 2004).  
 
Barley LDI is encoded by a small multigene family (giving at least 3 bands by Southern blot). 
Transcripts encoding LDI are only detected in starchy endosperm during grain development, 2 
and 4 weeks post anthesis; no expression is seen in germinating grains or vegetative tissue by 
northern blot (Stahl et al., 2007). The expression of LDI is controlled by an endosperm specific 
promoter (Morris and Stahl, 2004). Western blot shows LDI protein in developing and 
germinating grain (Stahl et al., 2007). During germination the protein is present for the first 1-3 
days but is not detectable by day 4 (Stahl et al. 2007). LDI is purified from ungerminated grain 
supporting the proposal that it is only produced in the developing endosperm (Macgregor 
1994). 
 
A 14-3-3 protein interaction motif (RGPSRP) has been identified within LDI and the proteins 
have been shown to interact (Stahl et al., 2007). 14-3-3 proteins are involved in regulation of 
metabolism by phosphorylation. The interaction motif is the same residues that are seen 
binding LD within the solved crystal complex (Møller et al., 2015). The inaccessibility of 14-3-3 
proteins to LDI when bound to LD may be important for regulation. 
 
Cell Wall Degradation 
Cell wall breakdown is one of the main hydrolytic events within the germinating grain, 
alongside starch hydrolysis and protein degradation (Jamar et al., 2011). The cell walls act as a 
physical barrier which can prevent the release and movement of hydrolytic enzymes required 
for seedling establishment (Gianinetti et al., 2007, Gibbons, 1980). The degradation of cell 
walls is also important in malting and brewing as problems with viscosity and haze can arise 
due to incomplete cell wall hydrolysis (Jamar et al., 2011, Burton et al., 2010). A large 
proportion of the cell wall material in the endosperm and aleurone is either heteroxylan or 
1,3-1,4-β-glucan (Table 6.1) (Bacic and Stone, 1981, Wilson et al., 2012). 
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Glucan Aleurone (%) Endosperm (%) 
Arabinoxylan 71 20 
(1-3,1-4)-β-D-glucans 26 75 
Cellulose 2 2 
Glucomannan 1 2 
 
Table 6.1 The composition of cell walls found within germinating barley. 
Data from (Bacic and Stone, 1981, Wilson et al., 2012). 
 
The model for starchy endosperm cell wall architecture proposed by Bamforth and Kanauchi 
suggests that arabinoxylan masks β-glucan, making it inaccessible to enzymatic attack 
(Kanauchi and Bamforth, 2002). The actions of arabinofuranosidase and endoxylanases are 
required to allow the action of endo-β-glucanases on the β-glucan (Bamforth, 2009). Endo-β-
1,4-xylanase alongside β-xylopyranosidase and α-arabinofuranosidase  have all been shown to 
be stimulated by GA (Taiz and Honigman, 1976). These enzymes have been implicated in 
enabling the release of enzymes from the aleurone layer (Figure 6.1, AL) by digesting the cell 
wall (Taiz and Honigman, 1976, Eastwell and Spencer, 1982). The cell wall composition can be 
determined by stepwise fractionation into different solvents followed by hydrolysis, separation 
and identification of the components by chromatography techniques, more recently gas 
chromatography-mass spectrometry has been implemented (Pettolino et al., 2012). 
 
 
 
 
 
Figure 6.3 Cross section of a barley grain visualised by scanning electron microscopy. 
AL. Aleurone layer. CW. Cell wall. ST. Starch granules. Courtesy of Vasilios Andriotis and Elaine Braclay. 
Scale bar: 200 µm 
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More recently, an endo-β-1,4-xylanase has been studied in more detail (Caspers et al., 2001). 
This enzyme is expressed as a inactive precursor with N-and C-terminal pro-peptides. The 
enzyme remains in the cytoplasm of aleurone cells and only become active at a late stage of 
germination, when the aleurone has ceased to secrete hydrolases. Cysteine proteases are 
responsible for cleaving the pro-peptides to yield active enzyme, this processing can be 
enhanced by DTT. The processing and release of this xylanase coincide with PCD associated 
loss of plasma membrane integrity. 
 
Endo-β-1,4-xylanase is not involved in the degradation of the aleurone layer outer cell wall 
(Caspers et al., 2001). This process, which is proposed to facilitate hydrolase secretion, is 
catalysed by other enzymes (Figure 6.4, A&B). Once the outer cell wall is degraded, cysteine 
proteases are able to enter the aleurone and activate the breakdown on the inner cell wall via 
endo-β-1,4-xylanase (Figure 6.4, C&D) (Caspers et al., 2001). It is possible that this pathway 
plays a role in releasing “trapped” intra-cellular hydrolases such as LD (Figure 6.4, E). The delay 
in aleurone breakdown is important as integrity is required to allow hydrolase production and 
secretion (Fincher and Shewry, 1992). 
 
 
 
 
 
 
Figure 6.4 The control of protein release from the aleurone layer. 
A. Degradation of the aleurone layer outer cell wall enables B. the release of secretory enzymes. Further 
cell wall metabolism enables the activating enzymes to cross the inner cell wall and C. enter the 
aleurone cells. D. Activated hydrolytic enzymes can attach the inner cell wall, enabling E. the release of 
trapped enzymes. 
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Cell Death of the Aleurone Layer 
Apoptosis is important for many processes in plants, being an integral part of plant growth, 
development and death (Domínguez and Cejudo, 2014). Programmed cell death (PCD) is 
controlled by cellular oxidation status, phytohormones and DNA methylation.  PCD occurs 
within cultured aleurone protoplasts, triggered by GA (Bethke et al., 1999). 4 to 8 days 
following GA treatment 70 % of protoplasts were dead.  ABA treated aleurone protoplasts, 
however, are viable in liquid culture up to 3 weeks. The protoplasts undergoing PCD become 
highly vacuolated and lose plasma membrane integrity, alongside this α-amylase production 
ceases. Cell death can be prevented by guanylate cyclase inhibitor LY83583 which interferes 
with GA signalling (Bethke et al., 1999). Reactive oxygen species (ROS) also play an important 
role in GA induced cell death (Bethke and Jones, 2001).  
 
Proteases  
Barley contains a complex set of proteases that differ in temporal and spatial expression 
(Wrobel and Jones, 1992). Numerous proteases have been characterised within the 
germinating grain: cysteine, metallo, aspartic and serine proteases have all been identified 
(Koehler and Ho, 1990, Jones, 2003, Jones and Budde, 2005). Some of these proteases have 
been associated with storage protein proteolysis and cell death (He and Kermode, 2003).   
 
Longstaff has proposed that proteolysis plays a role in the activation of LD, as addition of 
protease inhibitors, antipain and leupeptin to barley protein extracts prevented LD activation. 
The proteolytic activity was kept active or activated by DTT (Longstaff and Bryce, 1993). 
Extraction under reducing conditions produces higher levels of active LD leading to the 
suggestion that LDI may be regulated by thioredoxin although it is not yet clear that this is the 
case, degradation of LDI by proteases has also been suggested (Macgregor et al., 1994, Heisner 
and Bamforth, 2008). 
 
Redox and Thioredoxin 
The redox environment of a linked set of redox couples as found in a biological fluid, 
organelle, cell, or tissue is the summation of the products of the reduction potential and 
reducing capacity of the linked redox couples present. 
The redox environment of a cell is the summation of the products of reduction potential and 
reducing capacity of the redox active molecules. Redox is an important process in all 
organisms: driving respiration and photosynthesis. Key players in cellular redox are thioredoxin 
(Trx) and glutaredoxin proteins, disulfide reductases which possess similar structural fold and 
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mechanism (Figure 6.5) (Meyer et al., 2008). Starch active enzymes from different species have 
also been shown to be affected by redox (Blennow and Svensson, 2009). BAM1 (Sparla et al., 
2006), GWD (Mikkelsen et al., 2005) and SEX4 (Silver et al., 2013) from crop plants are all redox 
sensitive. Starch metabolic enzymes have also been shown to be regulated by redox conditions 
in Arabidopsis (Kotting et al., 2010). These include: ISA1/2, LD, SS1, SS3, SBE2 and likely β-
amylase (BAM3) and α-amylase (AMY3) (Glaring et al., 2012). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The Effect of Thioredoxin on Limit Dextrinase and Limit Dextrinase Inhibitor 
Limit dextrinase was one of the first starch active enzymes identified as linked to redox.  
Thioredoxin h (Trx h) overexpression in barley endosperm produced enhanced limit dextrinase 
activity (Cho et al., 1999). It was speculated that LDI was not linked to the LD activity in this 
study as protein extracts were generated at a time point after LDI became inactive. The same 
overexpression lines were further studied and revealed that Trx h accelerated germination 
rate, with α-amylase activity increasing 1 day earlier than control. This was proposed to be 
linked to GA via the embryo, but deembryonated half grains treated with GA also produced 
amylase at a faster rate, highlighting an embryo independent pathway (Wong et al., 2002).  
 
 
Figure 6.5 Pathways for thioredoxin catalysed reduction. 
Reduction within the chloroplast involves ferredoxin-thioredoxin reductase (FTR). NADP-thioredoxin 
reductase (NTR) is believed to reduce thioredoxins in the mitochondria and cytoplasm. Certain 
thioredoxins are also reduced vi glutathione (GSH/GSSG)/glutaredoxin (Grx) (Gelhaye et al., 2005). 
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The role of thioredoxin with regard to releasing LD during malting and brewing was 
investigated (Heisner and Bamforth, 2008). Recombinant Trx h had no direct effect on LD 
activity or release in protein extracts produced following a malting regime. LD was, however, 
activated by reducing agents (DTT) and pH change (Heisner and Bamforth, 2008).  It is possible 
that the thioredoxin is linked to LD activity by an indirect process. In contradiction to the 
barley study, maize leaf LD activity is increased twofold by direct interaction with Trx h. There 
is no evidence for LDI in maize and recombinant barley LDI tested against maize LD has no 
effect (Wu et al., 2002). 
 
Direct or indirect LD sensitivity to redox has been identified in Arabidopsis, wheat, spinach, 
maize and barley (Renz et al., 1998, Repellin et al., 2008). DTT is required for full activity of the 
enzyme in all cases. Three surface exposed cysteine residues were proposed to be involved in 
microheterogeneity in spinach and Arabidopsis, however the residues are a significant distance 
apart, meaning a large conformational change would be required to form disulfide bridges 
(Glaring et al., 2012). It is likely that an alternative mechanism is responsible for the effect of 
Trx and DTT on LD (Glaring et al., 2012). DTT effects on protein activity that are not linked to 
disulfide modulation have been reported, although the alternate mechanism of action is not 
clear (Alliegro, 2000). 
 
Experiments involving incubation of recombinant LD, LDI and Trx h revealed inactivation of 
barley LDI can be catalysed by disulfide reduction (Jensen et al., 2012). Trx h progressively 
reduced LDI disulfides which was accompanied by loss of LDI activity. LDI bound to LD was not 
affected by Trx h, meaning Trx is not directly responsible for the dissociation of the LD/LDI 
complex. It was proposed that Trx aids conformational destabilisation of LDI which may 
support cysteine protease activity (Longstaff and Bryce, 1993). Thioredoxin has independent 
effects on LD and LDI. There is a large gap in the knowledge relating to the effect of redox on 
these proteins.  
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6.1.3 Genetic Manipulation of Carbohydrate Active Enzymes in Crop Species 
Introduction 
Mutation in Arabidopsis can be useful to dissect the role of enzymes within the context of a 
dicot, however metabolic pathways can often differ between species, in particular between 
dicots and monocots. Dicots utilise lipid reserves within their seed as opposed to cereals which 
utilise starch as their primary energy reserve for germination (Raven et al., 2005). Differences 
also exist in the way monocots and dicots synthesise and degrade starch (Morell et al., 2003, 
Zhu et al., 2015). As such, to identify the precise role of proteins within a monocot crop 
species, genetic manipulation of the organism of interest is required. Alternative models to 
Arabidopsis have been proposed, such as Brachypodium and rice, however there can still be 
distinct differences between these model organisms and the crop being studied (Goff, 1999, 
Opanowicz et al., 2011, Guillon et al., 2012, Tanackovic et al., 2014). The increasing power of 
molecular genomics, plant transformation and growth facilities enables the production of 
transgenic non-model species, allowing work to be carried out in the organism of interest 
(Morrell et al., 2012). With advances in technology the lines between model and non-model 
species are becoming blurred. 
 
Traditional breeding techniques and genetic mapping have long been the paradigm for the 
identification of novel traits (Varshney et al., 2014). More recently Target Induced Local 
Lesions IN Genomes (TILLING) has enabled a leap forward in the generation of mutants within 
crop species (Mccallum et al., 2000, Talame et al., 2008, Mrizova et al., 2014). TILLING 
populations avoid issues with genetic modification (GM) and remain a useful tool to 
complement GM in research (Kurowska et al., 2011). However backcrossing is required to 
“clean up” induced mutations and lines may need crossing into elite cultivars which can be 
expensive and time consuming (Mccallum et al., 2000). 
 
The discovery of gene silencing in plants (Baulcombe, 1996) and animals (Fire et al., 1998) led 
to the development of RNA interference (RNAi) (Figure 6.6). This technique was heralded as 
the next genetics revolution (Wasi, 2003) and has indeed proved a useful technique. There are 
numerous examples of the genetic manipulation of many different targets within cereals 
(Table 6.2) (Goedeke, 2007, Mcginnis, 2010, Mrizova et al., 2014). It is this technique that is 
utilised to generate knockdown lines for LD and LDI within this study. 
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Figure 6.6 The process of RNAi 
RNAi initiated by the Dicer enzyme complex which processes double-stranded RNA into ~22- nucleotide 
small interfering RNAs. These siRNAs are incorporated into the multicomponent nuclease RSC (RNA- 
induced silencing complex). RSC the nunwinds the siRNA and used the unwind sequence as a guide for 
substrate selection. Substrates, endogenous mRNA in the case of RNAi, are then degraded. 
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Gene of interest Comments Reference 
GWD 
RNAi mediated GWD downregulation increased 
vegetative growth and seed mass in wheat. 
(Ral et al., 2012) 
β-AMY1,  
GBSSI, LD, SSI 
and SSII 
Barley TILLING lines. Starches with different features 
generated.  Modified amylose/amylopectin ratios. 
Different A:B granule ratios. 
(Bovina et al., 
2011, Sparla et 
al., 2014) 
 SBE IIa and b 
Barley RNAi. Grains possessed a high amylose 
phenotype. Reduced branching frequency in 
amylopectin. 
(Regina et al., 
2010) 
Amylopullulanase 
Overexpression of a bi-functional and thermostable 
amylopullulanase in transgenic rice seeds led to 
autohydrolysis and altered composition of starch. 
(Chiang et al., 
2005) 
α-amylase and α-
glucosidase 
Overexpression in barley. Introgressed into an elite 
cultivar, amylase gave no effect, glucosidase levels 
were higher. 
(Matthews and 
Jacobsen, 2001) 
β-1,3-1,4 
glucanase 
Overexpression in barley under α-amylase (secretion) 
or D hordein (endosperm storage) promoters. Barley 
has low nutritional value in poultry as β-glucan limits 
nutrient uptake. Grains were tested and showed 
benefits to poultry nutrition. 
(Jensen et al., 
1996, Horvath 
et al., 2000, Von 
Wettstein et al., 
2000) 
GWD 
Overexpression of GWD in barley endosperm 
generated hyperphosphorylated starch, plants 
exhibited no severe phenotype. When germinated, 
grains degraded starch similarly to wild type. 
(Carciofi et al., 
2011, Shaik et 
al., 2014) 
SBE I, SBE IIa and 
SBE IIb 
Simultaneous suppression of all three starch 
branching enzymes by RNAi produced amylose only 
starch granules. 
(Carciofi et al., 
2012) 
 α-amylase 
Endosperm specific overexpression of AMY3 
generated no significant impact on starch content. 
(Whan et al., 
2014) 
 
Table 6.2 Selected examples of genetic modification and TILLING in carbohydrate metabolism in crop 
species 
GWD. Glucan water dikinase. SS. Starch synthase. SBE. Starch branching enzyme.  
 
 
Mutants of Limit Dextrinase and Limit Dextrinase Inhibitor 
TILLING mutants have been identified for LD within barley. No truncation or nonsense 
mutations, which would decrease or knock out LD activity, were generated (Bovina et al., 2011, 
Sparla et al., 2014). A missense V270I mutant was associated with a higher percentage of small 
B-granules (Sparla et al., 2014). It was proposed that the enzyme plays a role in starch granule 
initiation. The possibility that modification of LD activity has a pleiotropic effect on other 
enzymes involved in starch granule biogenesis was not analysed.  
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Null mutation of LD has been reported in maize (Dinges, 2003). Homozygous plants were 
impaired in transient and storage starch degradation. The developing endosperm accumulated 
branched maltooligosaccharides and were deficient in linear maltooligosaccharides suggesting 
that LD functions in glucan hydrolysis during kernel starch formation.  Knockout of LD affected 
the levels of other starch metabolic enzymes (SBE and BAM) (Dinges, 2003). Germination of LD 
mutant grains was briefly analysed. The number of kernels that germinated was the same as 
wild type. Cotyledon emergence was, however, 1 day later in mutant lines. There are 
differences between maize and barley LD. LDI does not appear present in the maize genome 
and recombinant LDI has no effect on maize LD (Wu et al., 2002). 
 
A rice LD insertion knockout mutation has been generated and analysed (Fujita et al., 2009). 
Knockout of LD had no effect on other enzymes in starch biosynthesis. Levels of short chain 
amylopectin were increased in the mutant, however, amylose, amylopectin and water soluble 
polysaccharide (wsp) were almost identical to wild type. Germination of the rice LD mutants 
was not analysed. 
 
There is only one case of the genetic manipulation of LDI. Transgenic antisense RNA barley 
lines were generated by bombardment (Stahl, 2004).  LDI levels were analysed by western blot 
and LD inhibitory assay. LDI was present in all western blot samples albeit at different levels. 
Inhibitory assay showed some lines which have lower inhibitory activity on LD, however the 
replicates gave large levels of variation. The knockdown of LDI was suggested to have a 
pleotropic effect on α and β-amylase, which increased in activity in developing endosperm (14 
dpa) (Stahl, 2004). The importance of this is questionable as neither enzyme is directly 
involved in starch synthesis. No effect was seen on SBE and only a small effect on SS activity. 
The main conclusion from this study was that knockdown of LDI largely impacted on the A/B 
ratio of starch granules, with a reduced number of B type being generated. 
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6.2 Aims of this Chapter 
Questions arise regarding the importance of LD in starch degradation in barley endosperm as it 
is reported that the newly synthesised enzyme is not released from the aleurone layer until 
germination is well underway (3-5 dpi) (Burton et al., 1999, Schroeder and Macgregor, 1998). 
The levels of LD activity within the endosperm during germination remain unclear. The 
endogenous, proteinaceous inhibitor of LD, limit dextrinase inhibitor (LDI) has been shown to 
tightly bind LD in vitro (Jensen et al., 2011) This inhibitor is present in ungerminated cereals 
however its importance in grain germination remains unclear. LD and LDI have never been 
shown to interact within a plant. 
 
The aims of this chapter were to develop techniques which can be utilised to study the 
temporal and spatial separation of LD and LDI in planta, in order to gain a better 
understanding of the roles of these proteins during germination and how this relates to their 
functions during malting and beer manufacture. Antibodies were generated against 
recombinant LD (Chapter 5) showed the ability to detect barley LD within crude extracts, with 
the presence of LD being proportional to its activity. Sub-cellular localisation studies using LD 
and LDI GFP fusions expressed in N. benthamiana indicate these proteins may be localised to 
the plastid and the apoplast, respectively. Homozygous transgenic barley lines containing an 
RNAi cassette for the knockdown of LD or LDI were also generated using Agrobacterium 
transformation.  
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6.3 Results 
6.3.1 The Antibodies Generated Against Recombinant Protein Specifically Detect 
Limit Dextrinase in Grain Extracts 
In order to gain a better understanding of LD release and activation in planta antibodies were 
generated against recombinant protein. This enables the observation of LD at a protein level, 
rather than analysing activity, which can be variable depending on the extraction method and 
assay used. Protein samples from grain at 0, 3, 5, 7 and 9 dpi were analysed using SDS-PAGE, 
western blot and red pullulan zymography. LD cannot be seen by SDS-PAGE (Figure 6.7, A). The 
antibodies specifically detect a protein of the correct mass, ~104 kDa, for LD (Figure 6.7, B). 
The western blot shows an increase in the amount of LD throughout germination. Only trace 
levels of LD are detected in 0 dpi grain. An increase in LD activity can be seen over the time 
course (Figure 6.7, C), this correlates well with the protein levels identified by western blot. 
When incubated with DDT for 16 h a second pullulan degrading activity band appears within 
the zymogram (Figure 6.7, D). 
 
 
 
 
Figure 6.7 Analysis of protein extracts from barley for limit dextrinase 
Lanes 1- 0 dpi. 2- 3 dpi. 3- 5 dpi. 4- 7 dpi. 5- 9 dpi. A. SDS-PAGE  B. Anti-LD western blot. C. Red pullulan 
zymogram for LD activity, 2 h incubation. D. 16 h incubation. 
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6.3.2 Subcellular Localisation of Limit Dextrinase and Limit Dextrinase Inhibitor 
GFP-Fusion Proteins 
In order to determine the importance of the LD chloroplast transit peptides (cTP) and the LDI 
signal peptide (SP), discussed in Chapter 5, the genes encoding LD and LDI with and without 
targeting sequences were cloned into C-terminal GFP fusion protein vectors for plant 
expression. Agrobacterium harbouring the expression plasmids was infiltrated in to 
N. benthamiana leaves. The expression of GFP fusion proteins was analysed by confocal 
microscopy. Protein expression is analysed in leaf epidermal cells. Cytosolic proteins appear 
around the edge of a cell due to the presence of a large vacuole that pushes the cell contents 
up against the cell wall (Figure 6.8, Left). A gap corresponding to the cell wall and apoplastic 
space can often be seen between cells. Secreted or cell wall associated proteins appear ase a 
green band following the shape of a cell (Figure 6.8, middle). Chloroplasts autofluoresce when 
excited at the wavelength used to detect GFP, as such plastid localised proteins are seen as an 
orange colour in defined structures (Figure 6.8, right). 
 
 
 
 
 
 
 
 
 
Figure 6.8 Cartoon representation of subcellular localisation analysis using GFP 
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Expression of SP-LDI-GFP in N. benthamiana generated a GFP-tagged protein that appears to 
localise to the cell wall or apoplast, as would be expected in the presence of the secretion 
signal peptide. Deletion of the signal peptide and expression of ΔSP-LDI-GFP led to the 
generation of large aggregate structures (Figure 6.9, D, star), furthermore a distinct line can be 
identified between the cells, likely indicating the cell walls (Figure 6.9, D, arrow). 
 
 
 
 
 
 
 
 
 
 
Figure 6.9 The sub-cellular localisation of limit dextrinase inhibitor GFP fusion visualised by confocal 
microscopy 
Epidermal cells of N. benthamiana. GFP- green. Chloroplast autofluorescence- red. Arrow indicates a 
gap between the cytosol of two cells. Star indicates aggregate structures.  
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Expression of cTP-LD-GFP yields an orange colour within the chloroplasts (Figure 6.10, A, 
arrow) indicative of GFP and chloroplast merged fluorescence. Under the same conditions Δ-
cTP-LD-GFP does not show co-fluorescence, with GFP fluorescence visible at the edges of the 
cells (Figure 6.10, B, star). 
 
 
 
Figure 6.10 The sub-cellular localisation of limit dextrinase GFP fusion visualised by confocal 
microscopy 
Epidermal cells of N. benthamiana. GFP- green. Chloroplast autofluorescence- red. Arrow indicates co-
localisation of GFP and plastid. Star indicates GFP tagged protein not in the cytosol. 
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6.3.3 Generation of Transgenic RNAi Knock-down Lines for Limit Dextrinase and 
Limit Dextrinase Inhibitor 
RNAi lines were generated with the support of the BRACT facility at John Innes Centre. 
RNAi constructs were generated for LD and LDI using sequences of 301 bp and 243 bp, 
respectively, which cover the 3’ end of the mRNA sequence and the 3’-UTR (Appendix). 
Fragments were PCR amplified from barley gDNA and cloned into the pCR8-GW-TOPO vector. 
These were then used in a Gateway LR reaction to transfer the sequences into pBRACT-207 
transformation vector, which contains two sets of att recombination sites and therefore 
generates hairpin RNA (Figure 6.11). The pBRACT-270 vector encodes a constitutive ubiquitin 
promoter and hygromycin resistance cassette for selection of transformants. 
 
 
 
 
 
 
 
 
 
 
 
Immature embryos of barley cultivar golden promise were transformed using Agrobacterim, 
plants were regenerated from callose and selected using hygromycin. 32 lines were generated, 
20 LD, 19 LDI and 3 GUS control lines, grown to maturity and allowed to self-fertilise (Figure 
6.12). 
 
 
 
 
 
 
 
 
 
 
Figure 6.11 Map showing the RNAi cassette transformed into barley. 
 
 
Figure 6.12 T0 barley lines growing in a controlled environment room. 
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Leaves from T0 plants were analysed for copy number using the G-count gene copy number 
testing (iDNA Genetics) with hygromycin resistance gene specific primers. 10 LD, 9 LDI and 3 
GUS single copy lines were identified (Table 6.3). Seeds were collected from all lines. 
 
T0 # of Plants 
Hygromycin 
Copy Number 
LD LDI GUS 
1 10 9 3 
2-8 10 10 0 
Total 20 19 3 
 
Table 6.3 Copy number analysis of T0 transgenic lines 
 
6.3.4 Generation of T1 Transgenic Plants 
10 seeds for each of the 10 LD, 9 LDI and 3 GUS single copy lines were germinated, potted on 
and allowed to grow for 2 weeks. Leaf samples were taken from these lines and used to 
prepare gDNA, problems arose with the preparation of DNA. Due to time restrictions it ws 
decided to grow 4 plants from each single copy line. Plants were grown to maturity and 
allowed to self-fertilise. Leaves from T1 plants were analysed for copy number. 12 LD, 8 LDI and 
1 GUS homozygous lines were identified (Table 6.4). Seeds were collected from all lines. The 
lines generated were from 8 (LD) and 5 (LDI) different single copy parental lines. These RNAi 
lines have not been further analysed. 
 
T1 # of Plants 
Hygromycin 
Copy Number 
LD LDI GUS 
0 8 15 5 
1 16 11 4 
2 12 8 1 
Other 4 2 2 
Total 40 36 12 
 
Table 6.4 Copy number analysis of T1 transgenic lines 
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6.4 Discussion 
6.4.1 The Release and Activation of Limit Dextrinase During Germination 
The analysis of germinated barley grains showed that LD is neither active nor detectable at 
high levels in whole grain at 0 dpi. By 3 dpi LD is detectable by both anti-LD antibody and using 
red pullulan zymography, this agrees with the literature precedent for whole grain (Longstaff 
and Bryce, 1993); when LD was studied in GA treated aleurone layer cultures its release may 
be earlier (Shahpiri et al., 2015). Incubation of the red pullulan zymogram in the presence of 
DTT indicates that multiple forms of LD are present, this phenomenon has previously been 
identified in wheat and spinach LD (Repellin et al., 2008, Schindler et al., 2001). It is not clear 
how DTT activates LD or what impact the different forms of LD have on glucan metabolism. 
Within this work multiple forms of LD were identified during the purification of recombinant 
protein from E. coli (Appendix) indicating the redox and pH sensitivity is an inherit property of 
the enzyme and is not dependent on the source. 
6.4.2 Limit Dextrinase and Limit Dextrinase Inhibitor Sub-cellular Localisation 
Fusion of LDI to GFP enabled the study of the proteins subcellular localisation. The N-terminal 
sequence of LDI contains a putative secretory peptide. In the presence of this peptide LDI 
appears to be localised to the cell wall. Deletion of the secretory peptide leads to the 
generation of aggregate like structures. LDI is prone to aggregation when expressed in E. coli; it 
is possible that conditions may also generate aggregates in planta. LD has been shown to be 
targeted to the chloroplast in Arabidopsis leaves. Comparison of the barley LD N-terminal 
sequence with that of Arabidopsis revealed the presence of similar motifs associated with 
plastid targeting (Chapter 5). Fusion of LD to GFP shows putative targeting to the plastid. It 
remains unclear what the role the cTP plays in the aleurone of germinating grain. This data 
hints that LD and LDI may be spatially separated, however, further experiments are required to 
fully validate the protein subcellular localisation. 
6.4.3 Generation of Limit Dextrinase and Limit Dextrinase Inhibitor RNAi Barley 
Lines 
12 LD, 8 LDI and 1 GUS homozygous lines have been generated. Due to the time taken to 
generate the lines time for analysis was limited. These lines, once analysed, will give a better 
understanding of the importance of LD and LDI during germination, in contrast to other studies 
which were focussed on the role of LD during starch synthesis. 
228 
 
6.5 Future Directions 
6.5.1 Further Studies on the Localisation of Limit Dextrinase and Limit Dextrinase 
Inhibitor in Planta 
A repeat of the subcellular localisation experiment is required with necessary markers of cell 
localisation as controls. The co-localisation of LD and LDI could also be analysed using two 
different fluorescent markers or a split YFP system. Barley protoplasts and transformed 
aleurone layers provide suitable alternatives to N. benthamiana leaves. 
6.5.2 The Release of Limit Dextrinase During Germination 
To determine whether LD release coincides with cell death, inducers or inhibitors of PCD can 
be utilised in conjunction with the LD specific antibodies that have been developed. Nitric 
oxide (NO) donors can act as an antioxidants and delay PCD but do not inhibit metabolism. 
α-amylase has been studied in aleurone cultures treated with SNAP (S-Nitroso-N-acetyl-DL-
penicillamine, a NO donor) (Beligni et al., 2002), a similar methodology could be applied to the 
study of LD release. Aleurone protoplasts could also be studied (Gopalakrishnan et al., 1991). 
6.5.3 Analysis of Limit Dextrinase and Limit Dextrinase Inhibitor RNAi Lines 
The RNAi lines developed in this chapter require further analysis by qRT-PCR to determine the 
levels of LD and LDI transcripts, but also require analysis using assays to determine protein 
activity and western blots to determine protein abundance. The antibodies generated against 
recombinant LD and LDI are suitable for this purpose.  
 
The protein extracts for assay of LD and LDI must be generated at different time points as LDI 
levels are at their highest in the early stages of germination whereas LD is not seen at high 
levels until 3 day in to germination. The amount of DTT used in protein extraction may also 
effect protein levels, particularly if DTT enables the degradation of LDI. Recombinant LD 
generated herein can be utilised to assay the levels of LDI present in samples. 
 
Once strong knock-down lines have been identified, these can be father analysed to determine 
the effect of decreasing LD or LDI levels. Potential techniques for analysis include: 
micromalting to test effect of protein levels in brewing; microscopy to determine the effect on 
starch granules; measurements of grain yield and size; germination and measurement of root 
and shoot length; capillary electrophoresis, gel permeation chromatography of mass 
spectrometry to study dextrin levels. 
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7 Chapter 7- General Discussion  
7.1 Inhibition of Plant Growth by Iminosugars 
DNJ was shown to affect N-linked glycoprotein metabolism, this phenomenon has been 
previously identified (Mega, 2005), however, advances in analytical techniques have enabled 
the identification of a root specific increase in Man8/9. The root specific growth inhibition 
caused by DNJ is likely linked to the changes seen in N-linked glycan structure. The precise 
mode by which DNJ perturbs root growth remains to be identified. Other, unidentified, targets 
of DNJ probably exist in plants, mammalian proteins capable of binding DNJ (Cruz et al., 2013) 
have orthologues in Arabidopsis. 
 
GCS was also shown to be a likely target for the inhibition of root growth, two types of known 
GCS inhibitors both showed root inhibition, this hypothesis is further supported by a recent 
publication identifying GCS as an important protein for plant development (Msanne et al., 
2015). It remains to be tested whether there is cross talk between interference with 
glycoprotein processing and GCS within plants. Ceramide metabolism has been linked to 
glycoproteins within mammalian systems, with correct N-linked glycans being required for the 
formation of protein complexes involved in glycosphingolipid metabolism (Bieberich, 2014). 
 
Ido-AEP-DNJ will prove a useful tool to help dissect the roles of GC and ceramide in plants, as 
mutants in GCS are lethal the ability to add a compound to knock out protein activity enables 
study at particular time points that could not be achieved using genetics. Ceramide has been 
implicated in important developmental processes, including PCD, in plants. This has potential 
application in regulation of plant pathogen resistance, yield and stress tolerance (Berkey et al., 
2012). 
 
Both Arabidopsis and tef have proven to be suitable models for chemical genetic screens to 
identify novel inhibitors of root growth. There are numerous potential libraries that can be 
screened using these systems. 
7.2 In Vitro Inhibition of Glycosyl Hydrolases 
It has been demonstrated that compounds with partial inhibitory activity towards recombinant 
LD (expressed in P. pastoris, by collaborators) can be developed. Current iminosugars show 
only partial inhibition of LD due to small size and weak binding, there is potential for the 
generation of novel iminosugars which may show strong (µM/nM) LD inhibition. A potent, 
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specific, inhibitor could complement genetic knock-down studies. There is also further 
potential that an inhibitor could modulate LD activity during the malting and mashing steps of 
brewing, to control the glycan profile of beer (Petersen et al., 2014). Chemical leads also have 
implications in medicine, the pullulanase of Streptococcal species is a key virulence factor (Van 
Bueren et al., 2007). 
 
The peptide based inhibitors identified represent a starting point that could be further 
rationally designed, particularly in the light of the publication of the LD:LDI crystal structure. 
Peptides modelled on LDI are inhibitors of LD at high concentration, good structural mimics 
can be modelled based on the LDI structure and sequence. There is the potential to modify the 
specificity of proteinaceous inhibitors, such as LDI, for biotechnological applications. For 
example transgenic expression of an insect antimicrobial peptide in potato enhanced pathogen 
resistance (Osusky et al., 2000). 
 
The biosynthetic pathway of DNJ is different between plants and bacteria, identification of the 
enzymes involved in these pathways may enable the manipulation of DNJ metabolism to 
generate novel iminosugars (Shibano et al., 2004, Kang et al., 2011). Mining the genomes of 
iminosugar producing plants, such as mulberry (He et al., 2013), may offer opportunities to 
engineer biosynthesis into a heterologous host for the production of modified iminosugars. 
7.3 Cloning and Expression 
LD and LDI were cloned, expressed in E. coli and purified to meet the need for recombinant LD 
for further chemical screening. Utilising recombinant LD protein in further compound screens 
opens up the potential of identifying a chemical inhibitor that may have use in dissecting the 
roles of LD and LDI in planta. Soluble LD was produced however there remains room for 
further optimisation of the expression and purification methods. LD and LDI were used for 
antibody production which will enable better analysis of these proteins in barley grains. 
 
The role of transglycosylation catalysed by LD remains an unanswered question. It is unknown 
whether transglycosylation is important for either starch synthesis or degradation. 
Recombinant LD can be utilised to better understand this process as well as having the 
potential in the synthesis of novel compounds (Wang and Huang, 2009). 
 
There is commercial interest in LD as a standard for use in analysis of brewing or as an 
exogenous enzyme to add during mashing to reduce branching levels. Currently pullulanase is 
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used for this purpose. The complete conversion of starch to glucose is important in the 
creation of distilled spirits, in which the concentration of ethanol generated is proportional to 
the amount of available glucose for metabolism by yeast. Yeast is unable to efficiently 
hydrolyse starch and limit dextrins meaning incomplete conversion to glucose during mashing 
represents a loss of fermentable material (Sapińska et al., 2014). Efficient use of starch 
feedstocks is also important in bioethanol production (Nahampun et al., 2013, Favaro et al., 
2013). 
7.4 The Roles of Limit Dextrinase and Limit Dextrinase Inhibitor 
It remains unknown whether LD and LDI interact within plants, it is possible that temporal and 
spatial separation mean the two proteins never come into contact in the context of the 
germinating endosperm. The question that arises is why do the two proteins interact in vitro. 
To enable the study of LD and LDI sub-cellular and tissue specific localisation GFP-fusion 
constructs and protein specific antibodies have been generated. 
 
Cereals have been bred to contain more starch than is required for seedling establishment. It is 
imaginable that LD played an important role in the hydrolysis of dextrins in the progenitor of 
barley, allowing for a gradual breakdown of starch at a steady rate. Rapid starch hydrolysis 
could lead to the production of glucose at a rate faster than it can be used by a growing 
embryo. Excess glucose may leave a grain more susceptible to pathogen attack. LDI may also 
act as a failsafe to stop rapid exhaustion of carbohydrate reserves or may confer resistance to 
a hitherto unidentified pathogen via inhibition of glycosyl hydrolases. Brachypodium may be 
suitable as a tool to look into starch metabolism before domestication (Tanackovic et al., 
2014), this is particularly useful as LDI has been identified in Barchypodium (Møller et al., 
2015). 
 
To better understand the roles of LD and LDI during germination homozygous RNAi lines have 
been generated. All grains used in this study germinated normally and transgenic plant growth 
was identical to controls suggesting that LD or LDI are likely not essential. Further testing is 
required to determine the level of knock-down within these lines and understand how LD and 
LDI contribute to starch metabolism. If the LD and LDI RNAi lines show promising results there 
is the possibility to look into TILLING populations that can potentially be crossed into the 
barley lines used for brewing. 
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Sphingolipids, including ceramide and derivatives act as intracellular signalling molecules, 
linked to redox regulation and cell death in mammals (Won and Singh, 2006). If this is also the 
case for plants there may be a link between GCS inhibition and other endosperm processes 
during germination. Thioredoxin, hormone control and PCD have all been shown to be 
important for seed germination (Hagglund et al., 2013, Domínguez and Cejudo, 2014). 
Transcriptomics, proteomics and metabolite profiling have all been carried out on germinating 
barley (Sreenivasulu et al., 2008, Frank et al., 2011, Barba-Espin et al., 2014). Complete 
integration of this data will generate a thorough analysis of the germination process and may 
help elucidate the roles and importance of LD, LDI and other hydrolytic enzymes. 
7.5 The Future of Starch Metabolism 
Starch is important, not only as a foodstuff, but also as a higher value commodity generated 
bymodification through physical, chemical or enzymatic treatments. Their remains large gaps 
in our understanding of this abundant biopolymer. Recently a number of advances have been 
made in the understanding of regulation of starch biosynthesis and degradation (Stitt and 
Zeeman, 2012, Smith, 2012). The regulation of starch metabolism by phosphorylation, redox, 
T6P and circadian clock have been shown in Arabidopsis (Lloyd and Kossmann, 2015) 
 
One of the most pressing questions is: how do plants to make starch? The synthesis of 
glycogen is well understood, however the process by which amylopectin, a similar polymer, 
forms insoluble, crystalline, starch granules remains unclear (D'hulst and Merida, 2010). 
Protein-protein and protein-substrate interactions are implicated as important for correct 
starch synthesis and degradation (Cockburn et al., 2015, Seung et al., 2015). Furthermore 
branch point distributions and glucose chain length are important for correct starch structure 
in planta (Zhu et al., 2015, Pfister et al., 2014). An understanding of these enzymes requires 
analysis of their function, these type of studies are often performed using solubilised 
substrates. Analysis of enzymes on a surface more similar to a starch granule surface may 
enable a more realistic analysis of their activities (O'Neill et al., 2014). 
 
GM crops offer advantages over existing crops for farmers, giving increased yield and lower 
reliance on chemicals such as pesticides (Klumper and Qaim, 2014). The advent of CRISPR/Cas9 
within wheat, rice and maize offers an exciting avenue for the production of plants lacking 
genes of interest (Shan et al., 2014, Bortesi and Fischer, 2015, Liang et al., 2014, Cong et al., 
2013, Belhaj et al., 2013). CRISPR/Cas9 has recently been developed in barley at the John Innes 
Centre (Lawrenson et al., 2015). 
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The use of complementary in vitro and in vivo techniques using both plant and microbial 
enzymes and expression systems offers the widest scope for the manipulation of starch 
metabolism (Hebelstrup et al., 2015, O'neill and Field, 2015). 
7.6 Conclusions and Perspective 
A vast proportion of the human diet comes from carbohydrates. With the growing global 
population and the increasing prevalence of carbohydrate linked diseases, such as diabetes 
and obesity (Boling et al., 2009), improvements in the way we utilise cereals are required 
(Lafiandra et al., 2014, Blennow et al., 2013). A fundamental understanding of the roles that 
carbohydrates play in metabolism is essential if we are to manipulate processes such as starch 
and cell wall biosynthesis, modification and degradation. 
 
Chemical genetics and genetics provide complementary approaches that can be utilised in 
conjunction to dissect complex biological processes and pathways. Both techniques have 
advantages and disadvantages. Chemical inhibitors can often target multiple proteins, this can 
be a blessing or a curse. The rigorous identification of biological targets represents the key step 
in chemical genetics (Kaschani and Van Der Hoorn, 2007, Kasper et al., 2009, Hicks and Raikhel, 
2014). Perhaps the largest benefit in the use of chemical genetics is the ability to study 
essential developmental processes, such as embryo growth, as seen in germinating seeds. 
 
Chemical genomics (genome scale chemical genetics) coupled with genomics, transcriptomics 
and proteomics offers the potential to obtain and analyse a large amount of data to better 
elucidate a chemicals effect on a system (Norambuena et al., 2009). The sheer diversity and 
complexity of carbohydrates within biological systems implies many undiscovered avenues 
remain for future scientific discovery and study, using both chemical genetics and transgenics. 
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8 Chapter 8- Appendix 
8.1 Supplementary Data Chapter 3 
8.1.1 Glycoprotein Analysis 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.1 Analysis of glycoprotein from barley by MS, PNGase F treated, first analysis. 
7 d germinated barley protein samples grown in the presence of 200 µM DNJ or H2O. Arrows indicate a 
root specific increase in relative levels of Man9(GlcNAc)2 and Man8(GlcNAc)2.  
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Figure 8.2 Analysis of glycoprotein from barley by MS, PNGase A treated, first analysis. 
7 d germinated barley protein samples grown in the presence of 200 µM DNJ or H2O. No distinct 
difference in glycan structures can be seen between H2O and DNJ treated samples. 
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Figure 8.3 Analysis of glycoprotein from barley by MS, PNGase F treated, second analysis. 
7 d germinated barley protein samples grown in the presence of 200 µM DNJ or H2O. Arrows indicate a 
root specific increase in relative levels of Man9(GlcNAc)2 and Man8(GlcNAc)2. A mannosidase treatment 
was used alongside MS/MS (data not shown) on the DNJ treated root sample to confirm the structures 
of the glycans. 
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Figure 8.4 Analysis of glycoprotein from barley by MS, PNGase A treated, second analysis. 
7 d germinated barley protein samples grown in the presence of 200 µM DNJ or H2O. No distinct 
difference in glycan structures can be seen between H2O and DNJ treated samples. 
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8.1.2 Overkleeft Library Compounds on Arabidopsis  
 
 
 
 
Figure 8.5 Average root lengths for all Overkleeft library compounds analysed on Arabidopsis. 
Mean of 10 root length measurements.  
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8.1.3 Other Compounds from Overkleeft Library Showing Partial Root Growth 
Inhibition in Arabidopsis  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.6 Compounds which gave partial inhibition of root growth but were not considered hits in 
the first round of analysis. 
All are gluco-configured iminosugars. 
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8.1.4 Overkleeft Library Compounds on Tef 
 
 
 
 
 
 
Figure 8.7 Average root lengths for all Overkleeft library compounds analysed on Arabidopsis. 
Mean of 8 root length measurements.  
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8.1.5 Comparison of Tef and Arabidopsis Overkleeft Library Hits 
 
  
Teff Arabidopsis 
 
code 
% of 
control 
Root 
length 
(mm) 
% of 
control 
Root 
length 
(mm) 
Te
ff
 h
it
s 
60 8 0.39 111 5.9 
361 15 0.71 100 5.3 
540 18 0.89 132 7 
61 21 1.03 102 5.4 
433 25 2.01 108 5.7 
514 27 1.73 108 5.7 
437 29 2.32 96 5.1 
both 41 11 0.41 8 0.4 
A
ra
b
id
o
p
si
s 
h
it
s 
360 37 1.85 23 1.2 
701 63 3.4 28 1.5 
441 53 4.23 36 1.9 
64 40 3.16 47 2.5 
523 77 3.8 49 2.6 
 
Table 8.1 Root length and percent of control measurements for comparison of inhibitors identified 
using Tef and Arabidopsis. 
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8.1.6 Assay for Glucosylceramide Synthase Activity 
 
 
 
 
 
The TLC shows a product in the presence of mung bean micrsomes, attempts to identify 
glycosylated NBD-ceramide using LC-MS did not yield positive results. It is possible that the 
new product generated in the presence of mung bean microsomes is a deacetylated or 
oxidised NBD-ceramide variant. 
 
The GCS gene from Arabidopsis and barley were cloned from RNA in order to overexpress 
these proteins for use in enzyme inhibition assays. 
 
 
Figure 8.8 Fluorecsent based assay for glucosylceramide synthase 
The assay involves the incubation of liposomes containing the fluorescent ceramide mimic with plant 
microsomes. Products are separated by TLC and visualised by fluorescence. 
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8.2 Supplementary Data Chapter 4 
8.2.1 Limit Dextrinase Assay with Compounds from Starch Library 
 
 
Figure 8.9 Selected compounds from starch library of iminosugars other compounds with potential 
activity against starch active enzymes. 
Experiment performed by Malene Vester-Christensen (DTU). 
Very few compounds are capable of inhibiting LD by over 10 %. Only SD93 and G1M give inhibition over 
20 %. 100 % inhibition is caused by β-CD. Screen performed using BCA assay. 
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8.3 Supplementary Data Chapter 5 
8.3.1 Expression and Solubility Screening of Limit Dextrinase 
 
 
 
 
Figure 8.10 Screening for optimal limit dextrinase expression in E. coli. 
SDS-PAGE analysis. A. pETG-10A constructs in Rosetta B. pDEST17 constructs in Rosetta C. pETG-10A 
constructs in SoluBL21 D. pDEST17 constructs in SoluBL21. In all gels lanes 1&2 correspond to LD-FL, 
lanes 3&4 correspond to LD-NT all expressed at 28 °C overnight. Lanes 5&6 and 7&8 are in the same 
order but expressed at 37 °C for 3 h. Odd numbers are uninduced, even numbers are induced with 1 
mM IPTG. All lanes loaded with the same volume of whole cells. 
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Figure 8.11 Limit dextrinase expression 
level screening in various E. coli strains 1 
pDEST17- LD-NT construct expressed at 28 
°C overnight. A. Ponceau stain for protein 
B. Western blot with anti-His6 antibody. 
Lanes correspond to the following: 1&2 
BL21 Codon +, 3&4 Rosetta PlysS, 5&6 
Rosetta, 7&8 Rosetta Gami 2, 9&10 
SoluBL21. Odd numbers are uninduced, 
even numbers are induced with 0.2 mM 
IPTG. All lanes loaded with the same 
volume of whole cells. 
 
Figure 8.12 Limit dextrinase expression 
level screening in various E. coli strains 2 
pDEST17- LD-NT construct expressed at 28 
°C overnight. A. SDS-PAGE B. Western blot 
with anti-His6 antibody. Lanes correspond 
to the following: 1&2 BL21 Codon +, 3&4 
Rosetta, 5&6 SoluBL21, 7&8 Rosetta PlysS, 
9&10 Rosetta Gami 2. Odd numbers are 
soluble fraction, even numbers are 
insoluble fraction. All lanes loaded with 
the same volume of cell lysate. 
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Supplier and 
Strain 
Expression Solubility Comments 
Agilent 
++ soluble protein -- 
BL21 Codon Plus 
Novagen 
++ soluble protein -- 
Rosetta 2 (DE3) 
Novagen 
+++ soluble protein -- Rosetta 2 (DE3) 
pLysS 
Novagen 
+ soluble protein Slow growing Rosetta-gami (DE3) 
pLysS 
Genlantis 
+++ soluble protein 
Highest levels of 
soluble LD SoluBL21(DE3) 
NEB 
Not tested -- -- 
SHuffle 
 
Table 8.2 Summary table of E. coli stains screened for expression of soluble limit dextrinase. 
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8.3.2 MonoQ Anion Exchange on Limit Dextrinase 
 
 
The elution from a LD nickel purification was used in MonoQ anion exchange. A number of 
distinct protein bands were observed in the elutions. The protein corresponding to the highest 
elution peak contained a His-tagged LD protein of ~100 kDa, other protein bands were also 
present in this fraction (masses ~85 kDa and ~67 kDa). Selected protein bands were excised 
from the gel, digested with trypsin and analysed by MALDI-ToF. Peptides fragments were 
compared to the MASCOT database to identify the parent protein. Band 1’ was identified as 
H. vulgare LD. Bands 2’ and 3’ were E. coli catalase HPII (84224 Da, pI 5.54) and glutamine-
fructose-6-phosphate aminotransferase (66965 Da, pI 5.6) respectively. These proteins both 
have a pI value that will give them a net negative charge at pH 7.5 which explains why they 
bind to the MonoQ column, their charge may also explain why they bound to the nickel resin. 
The other bands, 4’-7’, could not be identified by MS.  
 
 
Figure 8.13 Anion Exchange Chromatography on LD form Nickel Affinity Chromatography Purification 
A. SDS-PAGE 12 % gel showing fractions. B Western blot with anti-His6 antibody. C. Chromatogram 
showing UV trace and corresponding elution from the column. Purification performed using MonoQ 
elution was with 0-100 % 1 M NaCl. Boxes show gel bands analysed mass spectrometry. 
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LD protein from a β-CD affinity purification was further purified by anion exchange. The 
protein eluted as multiple peaks between 20-40 % 1 M NaCl. The discrete peaks were analysed 
by SDS-PAGE and all contained LD. Different elution peaks are proposed to arise because of 
different species or conformations of LD that exist on the column. The strongest band in the 
SDS-PAGE for each elution fraction corresponds to the correct size for LD. As the protein used 
in this purification is the product of β-CD purification it is almost pure LD. This phenomenon 
has been seen with spinach pullulanase and has been termed microheterogeneity. 
Degradation products, likely from thermal degradation caused by heating during SDS-PAGE 
sample preparation, are visible on the SDS-PAGE gel. Different degradation products are seen 
for the different LD species and are proportional to the concentration of LD in each fraction. 
Because of these phenomena it was concluded that LD from β-CD purification could not be 
further purified using anion exchange chromatography. 
 
 
Figure 8.14 Anion Exchange Chromatography on His-LD from β-Cyclodextrin Affinity Chromatography 
A. SDS-PAGE 12 % gel showing fractions from purification. B. Chromatogram showing UV trace and 
elutions. Elution was by stepwise gradient of 0-20 % for 6 mL 20-50 % for 30mL and 50-100 % for 10mL 
using 0-100 % 1 M NaCl 
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8.3.3 Generation of β-CD-Sepharose Resin 
 
 
Figure 8.15 Generation of β-cyclodextrin Sepharose column 
A. Scheme showing chemical derivatisation of β-CD. B. MALDI-ToF performed on derivatised 
amino-β-CD, a peak corresponding to the correct mass for a sodium adduct is present (1257), 
unreacted starting material is also present as a sodium adduct (1159). C. Scheme showing the 
process for conjugation of amino-β-CD to NHS-Sepharose resin. 
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8.3.4 Expression and Solubility Screening of Limit Dextrinase Inhibitor 
 
 
 
 
 
 
Figure 8.16 Screening for optimal limit dextrinase inhibitor expression in E. coli. 
A. pETG-10A constructs in Rosetta B. pDEST17 constructs in Rosetta C. pETG-10A constructs in 
SoluBL21 D. pDEST17 constructs in SoluBL21. In all gels lanes 1&2 correspond to LDI-FL, lanes 3&4 
correspond to LDI-NS all expressed at 28 °C overnight. Lanes 5&6 and 7&8 are in the same order but 
expressed at 37 °C for 3 h. Odd numbers are uninduced, even numbers are induced with 1 mM IPTG. 
All lanes loaded with the same volume of whole cells. 
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Figure 8.18 Limit dextrinase inhibitor 
expression level screening in various E. coli 
strains 2 
pDEST17-LDI-NS construct expressed at 28 °C 
overnight. A. SDS-PAGE B. Western blot with 
anti-His6 antibody. Lanes correspond to the 
following: 1-4 SoluBL21 5-8 Rosetta Gami 2. 
Even numbers are soluble fraction, odd 
numbers are insoluble fraction. All lanes 
loaded with the same volume of cell lysate.  
Figure 8.17 Limit dextrinase inhibitor expression 
level screening in various E. coli strains 1 
pDEST17-LDI-NS construct expressed at 28 °C 
overnight. A. SDS-PAGE B. Western blot with 
anti-His6 antibody. Lanes correspond to the 
following: 1&2 BL21 Codon +, 3&4 Rosetta, 5&6 
SoluBL21, 7&8 Rosetta PlysS. Odd numbers are 
soluble fraction, even numbers are insoluble 
fraction. All lanes loaded with the same volume 
of cell lysate. Lane 1 was incorrectly loaded due 
to protein aggregation. 
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Supplier and 
Strain  
Expression Solubility Comments 
Agilent 
++ no soluble protein -- 
BL21 Codon Plus 
Novagen 
++ no soluble protein -- 
Rosetta 2 (DE3) 
Novagen 
++ no soluble protein -- Rosetta 2 (DE3) 
pLysS 
Novagen 
+  no soluble protein Slow growing Rosetta-gami (DE3) 
pLysS 
Genlantis 
+++ no soluble protein 
High levels of 
insoluble LDI SoluBL21(DE3) 
NEB 
+ no soluble protein 
Low amounts of 
LDI produced SHuffle 
 
Table 8.3 Summary table of E. coli stains screened for expression of soluble limit dextrinase inhibitor. 
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8.3.5 MonoQ on Limit Dextrinase Inhibitor 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MonoQ anion exchange was attempted on LDI from HisTrap refolding in an attempt to further 
purify the protein. The pI of LDI is 6.81, at pH7.5 thus the protein will possess a negative 
charge and will therefore bind to the MonoQ column. Some protein did not bind to the resin as 
indicated by a peak in the low through (Figure 8.19, B). The protein eluted as one peak 
between 10-20 % 1 M NaCl. Both monomeric (16 kDa) and dimeric (32 kDa) forms LDI eluted 
together. The eluted protein is of a similar purity as that which was loaded (Figure 8.19, A, lane 
1). It was concluded that LDI from the solubilisation, refolding and HisTrap purification was 
sufficiently pure. 
 
Figure 8.19 Anion exchange chromatography of solubilised and refolded LDI 
A. SDS-PAGE of samples from anion exchange. Lane 1 sample prior to anion exchange. Lanes 2-10 
elution fractions. B. Chromatogram showing UV trace and elutions. 
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8.3.6 Limit Dextrinase Inhibitor Refolding Using Quickfold 
 
 
 
 
Solubilised LDI was used in a protein refolding experiment using the Quickfold protein 
refolding system. Quickfold is a protein refolding screening kit which contains 15 buffers, each 
with a different composition. LDI in urea buffer was combined with each buffer and incubated 
to allow refolding. Protein was then centrifuged to remove insoluble aggregates and the 
soluble product analysed by reducing and non-reducing SDS-PAGE. Diffuse bands at a correct 
size for LDI were present in both gels for all buffer conditions. It was concluded that the 
starting material was already folded to some extent and incubation in refolding buffer made 
little difference. 
 
Figure 8.20 Refolding of LDI using Quickfold 
Reducing SDS-PAGE and Non-reducing SDS-PAGE. Lanes 1-16. Different refolding conditions tested. 
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8.4 Sequences 
8.4.1 Vector Map of Limit Dextrinase from Gene Synthesis 
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8.4.2 Limit Dextrinase Sequences 
Hordeum vulgare tissue-type aleurone limit dextrinase mRNA complete cds 
atacaaaatgccaatgccgatgcgaacgatgctgctccgccaccttagtcccccctccgc 
cgtgcccaatccccggcgctcctccgtctcctcgccgcagcggataccggtgagggcccg 
gccaccgccgctgcattccgcccgcgccaccgcgctccgggcccggcggaggacgcccat 
ggcggtcggggagaccggcgcctccgtctccgccgccgaggccgaggccgaggccaccca 
ggcgttcatgccggacgccagggcgtactgggtgacgagcgacctcatcgcctggaacgt 
cggcgagctggaagcgcagtccgtctgcctgtacgccagcagagccgccgcgatgagcct 
ctcgccgtcgaatggcggcatccaaggctacgactccaaggttgagctgcaaccggagag 
cgccgggctcccggaaaccgtgacccagaagttccctttcatcagcagttacagagcatt 
cagggtcccgagctctgtcgacgtcgccagccttgtgaaatgccaactggtcgtcgcttc 
tttcggcgctgacgggaaacacgtagatgttactggactgcaattacccggcgtgctgga 
tgatatgttcgcatacacgggaccgctcggtgcggttttcagcgaggactctgtgagcct 
gcacctttgggctcctacagcacagggcgtgagcgtgtgcttctttgatggtccagcagg 
ccctgcgctagagacggtgcagctcaaggagtcaaatggtgtttggagtgtcactggacc 
aagagagtgggaaaaccggtactatttgtatgaagtcgacgtgtatcatccaactaaggc 
gcaggttctgaaatgtttagctggtgacccttatgctagaggcctttctgcaaatggagc 
gcgtacctggttggttgacattaacaatgagacattgaagccggcttcctgggatgaatt 
ggctgatgagaagccaaaacttgattccttctctgacataaccatctatgaattgcacat 
tcgtgattttagcgcccacgatggcacagtggacagtgactctcgtggagcatttcgtgc 
atttgcatatcaggcctcggcaggaatggagcacctacggaaattatctgatgctggttt 
gactcatgtgcatttgttgccaagctttcattttgctggcgttgacgacattaagagcaa 
ctggaaatttgtcgatgagtgtgaactagcaacattccctccagggtcagatatgcaaca 
agcagcagtagtagctattcaggaagaggacccttataattgggggtataaccctgtgct 
ctggggggttccaaaaggaagctatgcaagtgaccctgatggcccgagtcgaattattga 
atatcgtcagatggtccaggccctcaatcgcataggtcttcgtgttgtcatggatgttgt 
atacaatcatctagactcaagtggcccctgcggtatcagctcagtgcttgacaagattgt 
tcctgggtactatgttagaagggatactaatggccagattgagaacagtgcagctatgaa 
caatacagcaagtgagcatttcatggttgataggttaatcgtggatgaccttttgaactg 
ggcagtaaactacaaagttgacgggttcagatttgatcttatgggccatatcatgaaacg 
cacaatgatgagagcaaaatctgctcttcaaagccttacaacagatgcacatggagttga 
tggttcaaaaatatacttgtatggtgaaggatgggacttcgctgaagttgcacgcaatca 
acgtggaataaatgggtcccagcttaatatgagtggaacggggattggtagcttcaatga 
tagaatccgggatgctattaatgggggtaatccctttggtaatccgctccagcaaggctt 
caatactggtctgttcttagagccgaatgggttttatcagggcaatgaagcagataccag 
gcgctcgctcgctacttatgctgaccaaatacagattggactagctggtaatctcaggga 
ttatgtactaatatctcatactggagaagctaagaagggatcagaaattcacacttttga 
tggattaccagtaggctatactgcgtccccaatagaaacgataaactatgtttctgctca 
tgacaatgagactctatttgatgttatcagtgtgaagaccccaatgatcctttcagttga 
tgagagatgcaggataaatcatttggcctccagcatgatggcattatcccagggaatacc 
cttcttccacgctggtgacgagatactaagatctaagtccatcgaccgagattcatataa 
ctctggtgattggtttaacaagcttgattttacctatgaaacaaacaattggggtgttgg 
gcttcctccaagtgaaaagaacgaagataattggcccctgatgaaaccaagattggaaaa 
tccgtcttttaaacctgcaaaaggacacattcttgctgccctagacagttttgttgacat 
cttgaagatcagatactcatctccactttttcgtctcagtacagcaaatgacattaagca 
aagggtacgctttcacaacacagggccctccttagtcccaggtgttattgtcatgggcat 
tgaagatgcacgaggtgagagccccgagatggctcaattagacacgaacttctcttatgt 
cgtaaccgtcttcaatgtgtgtccgcacgaagtgtccatggatatccccgctctcgcttc 
gatggggtttgaactgcatcctgtgcaggtgaattcatcagatactttggtgaggaaatc 
tgcgtacgagtccgcgacgtgcaggttcaccgtgcccggaagaaccgtgtcagtctttgt 
cgaacctcggtgttgatgcctcctcggtttcaacacgaggatctgttctacaagttgtcg 
aagcaaccgaagatctttctgtttttgtgttgaagtaaataataaatgaagaataagaga 
ggagaggcgctgctgcctgccagattacactgctgaaggaacaaacccaagaataagaag 
gttggcttatgtatatgtatagtgcccaagctgcctagtcctgtttttctttcctaatcc 
attttgattttatatatcaaaaggaaaacacatatatcgtgttataagtattgtataaca 
tgtactccctccaactgaaaatacttgtcataggaatgtatgtatctagatgtattataa 
ttctagatacatccatttttatacatttatgtgacaagtaattccggacggagggagtat 
gtgttaaacaaatttcacaaaaatgtatgtgttaaacaaggatgcataatgattttgtac 
tgtactctctttttactatgtatattacatattattttttaccgaagaaaagaaagtaca 
atttctcta 
 
 
 
267 
 
Hordeum vulgare limit dextrinase protein 
mpmpmrtmllrhlsppsavpnprrssvsspqripvrarppplhsaratalrarrrtpmav 
getgasvsaaeaeaeatqafmpdaraywvtsdliawnvgeleaqsvclyasraaamslsp 
snggiqgydskvelqpesaglpetvtqkfpfissyrafrvpssvdvaslvkcqlvvasfg 
adgkhvdvtglqlpgvlddmfaytgplgavfsedsvslhlwaptaqgvsvcffdgpagpa 
letvqlkesngvwsvtgprewenryylyevdvyhptkaqvlkclagdpyarglsangart 
wlvdinnetlkpaswdeladekpkldsfsditiyelhirdfsahdgtvdsdsrgafrafa 
yqasagmehlrklsdaglthvhllpsfhfagvddiksnwkfvdecelatfppgsdmqqaa 
vvaiqeedpynwgynpvlwgvpkgsyasdpdgpsriieyrqmvqalnriglrvvmdvvyn 
hldssgpcgissvldkivpgyyvrrdtngqiensaamnntasehfmvdrlivddllnwav 
nykvdgfrfdlmghimkrtmmraksalqslttdahgvdgskiylygegwdfaevarnqrg 
ingsqlnmsgtgigsfndrirdainggnpfgnplqqgfntglflepngfyqgneadtrrs 
latyadqiqiglagnlrdyvlishtgeakkgseihtfdglpvgytaspietinyvsahdn 
etlfdvisvktpmilsvdercrinhlassmmalsqgipffhagdeilrsksidrdsynsg 
dwfnkldftyetnnwgvglppseknednwplmkprlenpsfkpakghilaaldsfvdilk 
iryssplfrlstandikqrvrfhntgpslvpgvivmgiedargespemaqldtnfsyvvt 
vfnvcphevsmdipalasmgfelhpvqvnssdtlvrksayesatcrftvpgrtvsvfvep 
rc 
 
8.4.3 Limit Dextrinase Inhibitor Sequences 
Hordeum vulgare limit dextrinase inhibitor mRNA complete cds 
actagtatcaacaatggcatccgaccatcgtcgcttcgtcctctccggcgccgtcttgct 
ctcggtcctcgccgtcgccgccgccaccctggagagcgtcaaggacgagtgccaaccagg 
ggtggacttcccgcataacccgttagccacctgccacacctacgtgataaaacgggtctg 
cggccgcggtcccagccggcccatgctggtgaaggagcggtgctgccgggagctggcggc 
cgtcccggatcactgccggtgcgaggcgctgcgcatcctcatggacggggtgcgcacgcc 
ggagggccgcgtggttgagggacggctcggtgacaggcgtgactgcccgagggaggagca 
gagggcgttcgccgccacgcttgtcacggcggcggagtgcaacctatcgtccgtccagga 
gccgggagtacgcttggtgctactggcagatggatgacgatcgaaatgcgccaaggtaat 
gaagcggagtactgtatacagaataaaagta 
 
Hordeum vulgare limit dextrinase inhibitor protein 
masdhrrfvlsgavllsvlavaaatlesvkdecqpgvdfphnplatchtyvikrvcgrgp 
srpmlvkerccrelaavpdhcrcealrilmdgvrtpegrvvegrlgdrrdcpreeqrafa 
atlvtaaecnlssvqepgvrlvlladg 
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8.4.4 Glucosylceramide synthase sequences 
Barley GCS Gene 
atgaggcgcaaaatggcatctggacatagttttgcctttctttgtgatgacgtagatgagcttgagcactccgtgcag
cagaaattacctatggtctctgtagtcatgcctttgaagggctttggggagcacaatttgcaaaattggagaactcag
attacttctctttatgggggaccattggaattcttgtttgtagtagaaagcaaagatgatccagcttatcgtgccgtc
tcccgattgattgtagagtacaaggacaaattggacgcaaaggtggttgtagctgggttttcaacaacttgtagccag
aaaattcataatcagttaattggtgttgaaaagatgcacaaggacagcaaatatgttctatttctggacgatgatgtc
agactgcatcctgggacagtcggagctctcacaaaagaaatggagaagaaccctgagatatttatccaaacgggatac
cctcttgacttgccttctggcagcttgggaagctattgcatatatgaatatcacatgccctgttcgattggatttgca
actggcgggaggactttctttttgtggggtggctgtatgatgatgcatgctgatgatttccggcaagacctgtatggt
ttagtcacagcactaaaaaatggtggttactcagatgatatgacccttgctgcaatcgctgggcaacataagaggctg
ataacttcaccacctgttgctgtgtttccacaccctcttgcaagtgatctcagcttctccagatactggaattatcta
aggaaacaaacttttgttcttgaatcgtatgtttcaaaggtcaactggataatgaaccgtgcactgtttggtgtacat
ttctatttgtcatggggatttgtttgtccctatgttatggctttggtacatattgcgactactcttagagcaccatat
agcgcaattgtaaaggaagcagctgagtcgtcttgtggtctgaaactagtgagcttcttgttaatatgcactctcact
gaactcgtttcgatgtggaatttgacgagagttgagatccaactctgcaacatgttatctccagaaggaccacaagac
tcccttcgttcatataactgggggcttgtgttcgttgccgtgttagtagacaatttcctctacccgatatctgccatc
cggtccaatttctcccaatcaatcaattggtctggtatcaggtactacctgagagatgggaaaataagcaagattgaa
agggagaacagttcgaagtacaccgatctcggtgggaagcatctctatggcaagaggacataccctgctggaaagtcg
ttgctcggctacctgtccataagcctagcccaatggcaccagccgaagaagtatgatgtctga 
 
Arabidopsis GCS gene 
atgtctacattggactccattgatgcgattctcttctctcttagcagagcttttacaagccctttcgctgtcttcgtt
cagatccaggggtgtacaatatgcttactacttgctctcggctggttattggctgaatatgtcaggaatcgtgaggtt
aagagaattaaaaacagcataaaagcgggcaatagcttggcgtttctttatcaagatatcaatgaacttgagcactct
aggcaggttaaacttcctagagtttcagttgtcatgcctctaaaaggttttggagaacacaatttacacaactggaga
agtcagattacttctctctatggtgggccattggaattcctttttgttgtagaaagtacggaagaccctgcatatcac
gctgtttcccgtctattatctatgtatcaggatcatgttgaagctaaggtcgtggttgctggtttatcaacaacatgt
agccagaaaattcataatcagttgattggagttgaaaaaatgcacaaagataccaaatatgtgttatttttggatgat
gatgttagactgcatcctggaacaatcggagctctcacgactgagatggagaaaaatccagagatatttattcaaact
gggtatcctctagacttgccgtctgggactcttgggagttattgcatctatgagtaccacatgccttgctcaatggga
tttgcgactggtggaagaacattctttttgtggggaggatgtatgatgatgcatgctgatgatttcagacaagatcgg
tacggtgttgtctctggcttacgtgatggtggatattcagatgatatgacacttgcctctctagcaggtgctcataag
aggctcattacatctcctcctgttgctgttttccctcaccctctcgcgagtgatctaagttttggacgatactggaac
tacttgagaaaacaaacctttgtgctagaatcatacatatcgaaagttaactggataatgaacaaggctttgtttgct
gtccattgttatctttcatggggttttgttgcaccatatgttatggctatcattcacatcacatcagctttaagaatc
tacatcaagggctatcatcaacttgaagacacgacctctgcttctggtggtatgatgcttgttataacgttggcgatc
tgcaccttcatcgagcttctgtcaatgtggaatttgacgagacgagaagttcagctatgcaatatgttatcccctgag
gctccccgtctctctcttgcaacttacaactggggacttgtttttgtagcaatgcttgtagacaacttcctatatccg
atatcagctttccggtctcatttttctcaatccataaactggtctggaatcagataccacttgaaagatggaaagata
ttcaagattgagagacgaaaggatatgggaccaacaaagactgatttaggaggcaaacatttgtatggtaagaaagga
gctcctcagaaagcttcattcttaagctcattgggaagaaatttggctcactggcgacaaccgaaaaaattcgatgta
a 
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8.4.5 RNAi Sequences 
Limit Dextrinase Inhibitor 
LDi F ctgcgcatcctcatggac 
LDi R actccgcttcattaccttgg 
ctgcgcatcctcatggacggggtgcgcacgccggagg 
gccgcgtggttgagggacggctcggtgacaggcgtgactgcccgagggaggagcagaggg 
cgttcgccgccacgcttgtcacggcggcggagtgcaacctatcgtccgtccaggagccgg 
gagtacgcttggtgctactggcagatggatgacgatcgaaatgcgccaaggtaatgaagc 
ggagtactgtatacagaataaaagta 
243 bp 
 
Limit Dextrinase  
LD F aaagcgaaacattgcaaacc 
LD R aaagatcttcggttgcttcg 
aaagcgaaacattgcaaaccctaacagctgaccactgtcc 
aatcctaaaacccaatgaatcatcaacccaaaaggttgtgaaactgggagagcaattctg 
aatacgcaacggctattccggactgtttcaggtgaattcatcagatactttggtgaggaa 
atcggcgtacgagtccgcgacatgcaggttcaccgtgcccggaagaaccgtgtcagtctt 
tgtcgaacctcggtgttgacgcctcctcggtttcaacacgaggatctgttctacaagttg 
tcgaagcaaccgaagatcttt 
301 bp 
 
 
 
 
 
